CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: aminobenzoic acid
Accession: CHEBI:22495
browse the term
Synonyms: related_synonym: Aminobenzoesaeure; Formula=C7H7NO2
cyclic_relationship: is_conjugate_acid_of CHEBI:22494
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
multiple interactions
ISO
[INS1 protein co-treated with 3-aminobenzoic acid] results in increased activity of GPD1 protein
CTD
PMID:2523799
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
G
Ins1
insulin 1
multiple interactions
ISO
[INS1 protein co-treated with 3-aminobenzoic acid] results in increased activity of GPD1 protein
CTD
PMID:2523799
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Creb1
cAMP responsive element binding protein 1
affects expression
ISO
4-Aminobenzoic Acid affects the expression of CREB1 mRNA
CTD
PMID:20385217
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Il2
interleukin 2
increases expression
ISO
4-Aminobenzoic Acid results in increased expression of IL2 protein
CTD
PMID:22381623
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4i1
interleukin 4 induced 1
decreases activity
ISO
4-Aminobenzoic Acid results in decreased activity of IL4I1 protein
CTD
PMID:15383589
NCBI chr 1:95,299,457...95,324,564
Ensembl chr 1:95,295,601...95,324,562
G
Nat1
N-acetyltransferase 1
multiple interactions increases metabolic processing affects acetylation increases acetylation
ISO
Dehydroepiandrosterone Sulfate inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid]; Dehydroepiandrosterone Sulfate promotes the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid]; Pentachlorophenol inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid] NAT1 protein results in increased metabolism of 4-Aminobenzoic Acid NAT1 protein affects the acetylation of 4-Aminobenzoic Acid
CTD
PMID:11470991 PMID:15627487 PMID:15880531 PMID:16003948 PMID:23958860 PMID:29043425 PMID:30358977 More...
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
G
Nat2
N-acetyltransferase 2
increases acetylation multiple interactions
ISO EXP
NAT2 protein results in increased acetylation of 4-Aminobenzoic Acid 4-biphenylamine inhibits the reaction [NAT2 protein results in increased acetylation of 4-Aminobenzoic Acid]
CTD
PMID:15627487 PMID:18842621
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nfkb1
nuclear factor kappa B subunit 1
affects expression
ISO
4-Aminobenzoic Acid affects the expression of NFKB1 mRNA
CTD
PMID:20385217
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO EXP
4-Aminobenzoic Acid promotes the reaction [SLC22A7 protein results in increased export of Orotic Acid]
CTD
PMID:22981274
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Tnf
tumor necrosis factor
affects expression
ISO
4-Aminobenzoic Acid affects the expression of TNF mRNA
CTD
PMID:20385217
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Bmp6
bone morphogenetic protein 6
increases expression
ISO
Aminosalicylic Acid results in increased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Ereg
epiregulin
increases expression
ISO
Aminosalicylic Acid results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Il24
interleukin 24
increases expression
ISO
Aminosalicylic Acid results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
Aminosalicylic Acid results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Nat1
N-acetyltransferase 1
increases acetylation
ISO
NAT1 protein results in increased acetylation of Aminosalicylic Acid
CTD
PMID:15627487 PMID:16003948
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
G
Nat2
N-acetyltransferase 2
multiple interactions
ISO
[Peroxynitrous Acid results in decreased activity of NAT2 protein] which results in decreased acetylation of Aminosalicylic Acid
CTD
PMID:19248797
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Aminosalicylic Acid results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Aminosalicylic Acid results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
ISO
Aminosalicylic Acid results in increased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
anthranilic acid results in increased expression of AKR1B10 mRNA
CTD
PMID:26198647
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases activity
ISO
anthranilic acid analog results in decreased activity of AKR1C1 protein
CTD
PMID:19007763
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Ido1
indoleamine 2,3-dioxygenase 1
decreases abundance
ISO
IDO1 gene mutant form results in decreased abundance of anthranilic acid
CTD
PMID:32871117
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
G
Ifng
interferon gamma
multiple interactions
ISO
anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein]; anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein]
CTD
PMID:15799959
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il12a
interleukin 12A
multiple interactions
ISO
anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein]
CTD
PMID:15799959
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il12b
interleukin 12B
multiple interactions
ISO
anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein]
CTD
PMID:15799959
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il18
interleukin 18
multiple interactions
ISO
anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein]
CTD
PMID:15799959
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Ins1
insulin 1
multiple interactions
EXP
anthranilic acid analog inhibits the reaction [Streptozocin results in decreased expression of INS1 protein]
CTD
PMID:28625491
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Map2k1
mitogen activated protein kinase kinase 1
decreases activity
ISO
anthranilic acid results in decreased activity of MAP2K1 protein
CTD
PMID:18393446
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases activity
ISO
anthranilic acid results in increased activity of NFE2L2 protein
CTD
PMID:30114225
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
multiple interactions
ISO
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN1 protein
CTD
PMID:22864521
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
multiple interactions
ISO
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN11 protein
CTD
PMID:22864521
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
multiple interactions
ISO
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN2 protein
CTD
PMID:22864521
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
G
Ptpn6
protein tyrosine phosphatase, non-receptor type 6
multiple interactions
ISO
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN6 protein
CTD
PMID:22864521
NCBI chr 4:157,526,034...157,550,783
Ensembl chr 4:157,526,035...157,550,984
G
Ptpn9
protein tyrosine phosphatase, non-receptor type 9
multiple interactions
ISO
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN9 protein
CTD
PMID:22864521
NCBI chr 8:57,391,290...57,472,352
Ensembl chr 8:57,391,259...57,470,952
G
Tdo2
tryptophan 2,3-dioxygenase
decreases abundance
ISO
TDO2 gene mutant form results in decreased abundance of anthranilic acid
CTD
PMID:32871117
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
G
Ar
androgen receptor
affects binding
EXP
butamben binds to AR protein
CTD
PMID:14565775
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Med1
mediator complex subunit 1
multiple interactions
ISO
butamben promotes the reaction [NR1I2.L protein binds to MED1 protein]; butamben promotes the reaction [NR1I2.S protein binds to MED1 protein]
CTD
PMID:12198127
NCBI chr10:83,145,538...83,189,260
Ensembl chr10:83,145,568...83,189,299
G
Ncoa1
nuclear receptor coactivator 1
multiple interactions
ISO
butamben promotes the reaction [NR1I2.L protein binds to NCOA1 protein]; butamben promotes the reaction [NR1I2.S protein binds to NCOA1 protein]
CTD
PMID:12198127
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions
ISO
butamben promotes the reaction [NR1I2.L protein binds to NCOA2 protein]
CTD
PMID:12198127
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Ncoa3
nuclear receptor coactivator 3
multiple interactions
ISO
butamben promotes the reaction [NR1I2.L protein binds to NCOA3 protein]
CTD
PMID:12198127
NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation multiple interactions
ISO
Calcimycin results in increased phosphorylation of AKT1 protein Cyclosporine inhibits the reaction [Calcimycin results in increased phosphorylation of AKT1 protein]
CTD
PMID:10679475
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alox5
arachidonate 5-lipoxygenase
multiple interactions increases activity increases expression
ISO EXP
1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] affects the localization of ALOX5 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of ALOX5 protein; [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Platelet Activating Factor]; bisindolylmaleimide I inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein]; bolinaquinone inhibits the reaction [Calcimycin results in increased activity of ALOX5 protein]; Calcimycin results in increased activity of and results in increased localization of ALOX5 protein; Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein; Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; SB 203580 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein]; tert-Butyl Alcohol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; U 0126 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein] Calcimycin results in increased expression of ALOX5 mRNA; Calcimycin results in increased expression of ALOX5 protein [[A 78773 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [[CMI 392 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [[zileuton co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene B4; [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene C4; [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Leukotriene B4]; Calcimycin results in increased activity of and results in increased localization of ALOX5 protein; Calcimycin results in increased localization of and results in increased activity of ALOX5 protein; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 mRNA]; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 protein]; Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]
CTD
PMID:7665580 PMID:8387780 PMID:9445378 PMID:10779545 PMID:11529688 PMID:11698504 PMID:12604694 PMID:18083043 PMID:18218859 PMID:18475477 PMID:18475545 More...
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Ano1
anoctamin 1
decreases activity
ISO
Calcimycin results in decreased activity of ANO1 protein
CTD
PMID:24478309
NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069
G
Apoe
apolipoprotein E
decreases response to substance
ISO
APOE gene mutant form results in decreased susceptibility to Calcimycin
CTD
PMID:11397713
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
Calcimycin affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of BAX mRNA] Calcimycin results in increased expression of BAX mRNA
CTD
PMID:26419736
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2l1
Bcl2-like 1
decreases response to substance
EXP
BCL2L1 gene mutant form results in decreased susceptibility to Calcimycin
CTD
PMID:10970895
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bmp2
bone morphogenetic protein 2
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP2 mRNA]
CTD
PMID:21331654
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Bmp6
bone morphogenetic protein 6
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP6 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP6 mRNA]
CTD
PMID:21331654
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Casp1
caspase 1
multiple interactions
ISO
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased activity of CASP1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased cleavage of CASP1 protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased activity of CASP1 protein]
CTD
PMID:21515303 PMID:22322153 PMID:23535185
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
increases expression multiple interactions
EXP ISO
Calcimycin results in increased expression of CASP3 protein Calcimycin inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein]
CTD
PMID:16787641 PMID:19837105 PMID:20020783
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases activity
ISO
Calcimycin results in increased activity of CASP7 protein
CTD
PMID:19139269
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
increases activity
ISO
Calcimycin results in increased activity of CASP8 protein
CTD
PMID:25410152
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity
ISO
Calcimycin results in increased activity of CASP9 protein
CTD
PMID:25410152
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl11
C-C motif chemokine ligand 11
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL11 mRNA; CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL11 mRNA]; IL5 protein promotes the reaction [CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]
CTD
PMID:12797483 PMID:21331654
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression
ISO
Calcimycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of CCL2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL2 mRNA Calcimycin results in increased expression of CCL2 mRNA
CTD
PMID:8764118 PMID:18799549 PMID:30254419
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl4
C-C motif chemokine ligand 4
increases expression multiple interactions
ISO
Calcimycin results in increased expression of CCL4 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of CCL4 mRNA]
CTD
PMID:25451590
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO EXP
CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]; IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] [Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 mRNA]; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 protein]; Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]; Masoprocol inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]
CTD
PMID:12797483 PMID:18083043
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
increases expression multiple interactions
ISO
Calcimycin results in increased expression of CCL7 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of CCL7 mRNA]
CTD
PMID:25451590
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Cd40
CD40 molecule
multiple interactions
ISO
Apigenin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; Luteolin inhibits the reaction [Calcimycin results in increased expression of CD40 protein]; Quercetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]
CTD
PMID:16601352
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd69
Cd69 molecule
multiple interactions increases expression
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein] Calcimycin results in increased expression of CD69 protein
CTD
PMID:23941771 PMID:25410152
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
G
Cdh1
cadherin 1
multiple interactions
ISO
Calcimycin promotes the reaction [Cadmium Chloride results in increased cleavage of CDH1 protein]
CTD
PMID:18791180
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Csf2
colony stimulating factor 2
multiple interactions increases secretion increases expression
ISO EXP
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]; Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] Calcimycin results in increased secretion of CSF2 protein Luteolin inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA]
CTD
PMID:1376361 PMID:9685678 PMID:17950587
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csrnp1
cysteine and serine rich nuclear protein 1
increases expression multiple interactions
ISO
Calcimycin results in increased expression of AXUD1 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA]
CTD
PMID:25451590
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
Calcimycin results in increased expression of CXCL1 mRNA
CTD
PMID:8764118
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Ddit3
DNA-damage inducible transcript 3
increases activity increases expression multiple interactions
ISO
Calcimycin results in increased activity of DDIT3 protein Calcimycin results in increased expression of DDIT3 mRNA; Calcimycin results in increased expression of DDIT3 protein parthenolide promotes the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; Quercetin inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; RELA protein inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]
CTD
PMID:11145585 PMID:11360202 PMID:19139269 PMID:19428936 PMID:27064126
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dusp1
dual specificity phosphatase 1
increases expression multiple interactions
ISO
Calcimycin results in increased expression of DUSP1 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of DUSP1 mRNA]
CTD
PMID:25451590
NCBI chr10:16,680,478...16,683,275
G
Dusp6
dual specificity phosphatase 6
increases expression multiple interactions
ISO
Calcimycin results in increased expression of DUSP6 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of DUSP6 mRNA]
CTD
PMID:25451590
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Edn1
endothelin 1
multiple interactions
EXP
[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides; NOS3 protein affects the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides]; Polyphenols inhibits the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides]
CTD
PMID:20977430
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Egr1
early growth response 1
increases expression
ISO
Calcimycin results in increased expression of EGR1 mRNA
CTD
PMID:8764118
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
increases expression multiple interactions
ISO
Calcimycin results in increased expression of EGR2 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of EGR2 mRNA]
CTD
PMID:25451590
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Egr3
early growth response 3
increases expression multiple interactions
ISO
Calcimycin results in increased expression of EGR3 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of EGR3 mRNA]
CTD
PMID:25451590
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Eif2a
eukaryotic translation initiation factor 2A
increases phosphorylation multiple interactions
ISO
Calcimycin results in increased phosphorylation of EIF2A protein Quercetin inhibits the reaction [Calcimycin results in increased phosphorylation of EIF2A protein]
CTD
PMID:19428936
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
G
Ern1
endoplasmic reticulum to nucleus signaling 1
increases expression
ISO
Calcimycin results in increased expression of ERN1 protein
CTD
PMID:19139269
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Fas
Fas cell surface death receptor
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FAS mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FAS mRNA]
CTD
PMID:21331654
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
affects expression
ISO
Calcimycin affects the expression of FASL protein Calcimycin affects the expression of FASLG protein
CTD
PMID:25410152
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fgf1
fibroblast growth factor 1
increases expression
EXP
Calcimycin results in increased expression of FGF1 protein
CTD
PMID:15264218
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Flt3
Fms related receptor tyrosine kinase 3
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FLT3 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FLT3 mRNA]
CTD
PMID:21331654
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP ISO
Luteolin inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of FOS mRNA] 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]
CTD
PMID:1932749 PMID:8764118 PMID:17950587 PMID:25451590
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO
Calcimycin results in increased expression of FOSB mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of FOSB mRNA]
CTD
PMID:8764118 PMID:25451590
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Gbp3
guanylate binding protein 3
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA]
CTD
PMID:21331654
NCBI chr 2:231,460,032...231,500,266
Ensembl chr 2:231,486,062...231,493,098
G
Gch1
GTP cyclohydrolase 1
multiple interactions
EXP
[2,4-diaminohypoxanthine results in decreased activity of GCH1 protein] which affects the susceptibility to Calcimycin; sepiapterin inhibits the reaction [[2,4-diaminohypoxanthine results in decreased activity of GCH1 protein] which affects the susceptibility to Calcimycin]
CTD
PMID:12855421
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gpx4
glutathione peroxidase 4
decreases expression
ISO
Calcimycin results in decreased expression of GPX4 protein
CTD
PMID:10432307
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Hdc
histidine decarboxylase
increases expression multiple interactions
ISO
Calcimycin results in increased expression of HDC mRNA [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein; atractylon inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]; pyeongwee-san extract inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]
CTD
PMID:17191106 PMID:27553716
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
Calcimycin inhibits the reaction [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [VEGFA protein results in increased expression of HMOX1 protein]]
CTD
PMID:12788823
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsf1
heat shock transcription factor 1
affects phosphorylation
ISO
Calcimycin affects the phosphorylation of HSF1 protein
CTD
PMID:8663271
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions increases expression
ISO
Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 mRNA]; Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 protein] Calcimycin results in increased expression of HSPA5 mRNA; Calcimycin results in increased expression of HSPA5 protein
CTD
PMID:12147617 PMID:14610226 PMID:18799549 PMID:19139269 PMID:19428936 PMID:27064126 More...
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Ifng
interferon gamma
multiple interactions
ISO
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]
CTD
PMID:1371491 PMID:14994387
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il12rb1
interleukin 12 receptor subunit beta 1
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL12RB1 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL12RB1 mRNA]
CTD
PMID:21331654
NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769
G
Il13
interleukin 13
multiple interactions increases expression
ISO EXP
[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL13 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13 mRNA; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL13 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13 mRNA] shikonin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA] Luteolin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]
CTD
PMID:12789233 PMID:17950587 PMID:21331654 PMID:25451590
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il13ra1
interleukin 13 receptor subunit alpha 1
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA]
CTD
PMID:21331654
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il18r1
interleukin 18 receptor 1
multiple interactions
ISO
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL18R1 protein
CTD
PMID:14994387
NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
G
Il1a
interleukin 1 alpha
increases expression
ISO
Calcimycin results in increased expression of IL1A mRNA
CTD
PMID:8435107
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA; [IL1B protein co-treated with Calcimycin] results in increased activity of PTGS2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL1B protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL1B protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]
CTD
PMID:15705740 PMID:17588137 PMID:18958421 PMID:21515303 PMID:22322153 PMID:23535185 PMID:24131540 PMID:30254419 More...
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]
CTD
PMID:1371491 PMID:23941771
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il3
interleukin 3
multiple interactions increases expression
ISO EXP
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]; Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein] Luteolin inhibits the reaction [Calcimycin results in increased expression of IL3 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL3 mRNA]
CTD
PMID:1376361 PMID:17950587
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il4
interleukin 4
multiple interactions increases expression affects response to substance
ISO EXP
[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL4 protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA]; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL4 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; Houttuynia cordata extract inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]; IL4 protein inhibits the reaction [Calcimycin results in increased metabolism of Leukotriene B4]; IL4 protein promotes the reaction [Calcimycin results in increased metabolism of Hydroxyeicosatetraenoic Acids metabolite]; kaempferol inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4]; Quercetin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein] Luteolin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA] IL4 protein affects the susceptibility to Calcimycin
CTD
PMID:1371491 PMID:11861792 PMID:12789233 PMID:16601352 PMID:17950587 PMID:18325701 PMID:21515303 More...
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
multiple interactions increases expression
ISO
[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; Houttuynia cordata extract inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein]; IL5 protein promotes the reaction [CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]; IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]; kaempferol inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; Quercetin inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein]
CTD
PMID:1371491 PMID:12789233 PMID:12797483 PMID:18325701
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
multiple interactions increases secretion increases expression
ISO
3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxanthyletin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; [Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL6 protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein; Calcimycin inhibits the reaction [Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; fraxetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; isopraeroside IV inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; levistolide A inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] Calcimycin results in increased secretion of IL6 protein Calcimycin results in increased expression of IL6 mRNA
CTD
PMID:11238657 PMID:12789233 PMID:17191106 PMID:17588137 PMID:18958421 PMID:19118619 PMID:19416633 PMID:19665545 PMID:21515303 PMID:22322153 PMID:23535185 PMID:24131540 PMID:30254419 PMID:30496664 More...
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhbc
inhibin subunit beta C
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of INHBC mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of INHBC mRNA]
CTD
PMID:21331654
NCBI chr 7:63,184,141...63,197,630
Ensembl chr 7:63,184,142...63,197,630
G
Irf8
interferon regulatory factor 8
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IRF8 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IRF8 mRNA]
CTD
PMID:21331654
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Itga2
integrin subunit alpha 2
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGA2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGA2 mRNA]
CTD
PMID:21331654
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itgam
integrin subunit alpha M
increases expression multiple interactions
ISO
Calcimycin results in increased expression of ITGAM protein [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGAM mRNA; Dexamethasone analog inhibits the reaction [Calcimycin results in increased expression of ITGAM protein]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGAM mRNA]; Resveratrol analog inhibits the reaction [Calcimycin results in increased expression of ITGAM protein]
CTD
PMID:8094364 PMID:18776917 PMID:21331654
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgb2
integrin subunit beta 2
increases expression
ISO
Calcimycin results in increased expression of ITGB2 protein
CTD
PMID:8094364
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO
Calcimycin results in increased expression of JUN mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of JUN mRNA]
CTD
PMID:8764118 PMID:25451590
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin analog results in increased expression of JUNB mRNA]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin results in increased expression of JUNB mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Calcimycin results in increased expression of JUNB mRNA]
CTD
PMID:1932749 PMID:8764118
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
decreases expression
ISO
Calcimycin results in decreased expression of KCNJ5 mRNA
CTD
PMID:22798349
NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
increases activity
ISO
Calcimycin results in increased activity of KCNN4 protein
CTD
PMID:17699636
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression multiple interactions
ISO
Calcimycin results in increased expression of MAP3K8 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of MAP3K8 mRNA]
CTD
PMID:25451590
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation
ISO EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein; Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein; resveratrol analog inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein] 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Calcimycin results in increased activity of MAPK1 protein]; AG 1879 inhibits the reaction [Calcimycin results in increased activity of MAPK1 protein]; Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein; Egtazic Acid inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein]; Gadolinium inhibits the reaction [Calcimycin results in increased phosphorylation of MAPK1 protein]; W 7 inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein]
CTD
PMID:11914123 PMID:18776917 PMID:19416633 PMID:19782052
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
ISO EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein; Calcimycin results in increased phosphorylation of and results in increased activity of MAPK3 protein; resveratrol analog inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein] 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Calcimycin results in increased activity of MAPK3 protein]; AG 1879 inhibits the reaction [Calcimycin results in increased activity of MAPK3 protein]; Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein; Egtazic Acid inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein]; Gadolinium inhibits the reaction [Calcimycin results in increased phosphorylation of MAPK3 protein]; W 7 inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein]
CTD
PMID:11914123 PMID:18776917 PMID:19416633 PMID:19782052
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MAPK8 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MAPK8 mRNA]
CTD
PMID:21331654
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mpo
myeloperoxidase
increases secretion multiple interactions affects activity
ISO EXP
Calcimycin results in increased secretion of MPO protein carvedilol inhibits the reaction [Calcimycin results in increased secretion of MPO protein] Calcimycin affects the activity of MPO protein
CTD
PMID:18475545 PMID:18987595
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Ms4a2
membrane spanning 4-domains A2
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MS4A2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MS4A2 mRNA]
CTD
PMID:21331654
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
G
Msr1
macrophage scavenger receptor 1
multiple interactions
ISO
Calcimycin promotes the reaction [[Hydrogen Peroxide co-treated with Vanadates] results in increased expression of MSR1 mRNA alternative form]
CTD
PMID:10837497
NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676
G
Mt1
metallothionein 1
increases expression
EXP
Calcimycin results in increased expression of MT1A mRNA
CTD
PMID:8128501
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
multiple interactions increases expression
ISO
shikonin inhibits the reaction [Calcimycin results in increased expression of MT2 mRNA]
CTD
PMID:25451590
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Naga
alpha-N-acetylgalactosaminidase
affects activity
EXP
Calcimycin affects the activity of NAGA protein
CTD
PMID:18475545
NCBI chr 7:113,846,358...113,855,430
Ensembl chr 7:113,846,374...113,855,315
G
Nfatc1
nuclear factor of activated T-cells 1
multiple interactions affects localization
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of NFATC1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [Cyclosporine results in decreased expression of NFATC1 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of NFATC1 protein; NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] Calcimycin affects the localization of NFATC1 protein
CTD
PMID:21603612 PMID:24244623 PMID:27246103
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfatc2
nuclear factor of activated T-cells 2
increases activity multiple interactions
ISO
Calcimycin results in increased activity of NFATC2 protein [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein; Cyclosporine inhibits the reaction [Calcimycin results in increased activity of NFATC2 protein]; fisetin inhibits the reaction [Calcimycin results in increased activity of NFATC2 protein]; NFATC2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein]
CTD
PMID:12789233 PMID:21603612 PMID:23941771
NCBI chr 3:157,195,970...157,328,640
Ensembl chr 3:157,198,872...157,328,325
G
Nfatc3
nuclear factor of activated T-cells 3
multiple interactions
ISO
NFATC3 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]
CTD
PMID:21603612
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
G
Nfatc4
nuclear factor of activated T-cells 4
multiple interactions
ISO
NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]
CTD
PMID:21603612
NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]
CTD
PMID:17588137 PMID:19416633 PMID:19665545 PMID:21515303 PMID:22322153 PMID:23535185 PMID:23941771 More...
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbid
NFKB inhibitor delta
increases expression multiple interactions
ISO
Calcimycin results in increased expression of NFKBID mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of NFKBID mRNA]
CTD
PMID:25451590
NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
G
Nfkbiz
NFKB inhibitor zeta
increases expression multiple interactions
ISO
Calcimycin results in increased expression of NFKBIZ mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of NFKBIZ mRNA]
CTD
PMID:25451590
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Ngf
nerve growth factor
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [Cyclosporine results in increased expression of NGF protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased expression of NGF protein
CTD
PMID:24244623
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Calcimycin]
CTD
PMID:11498454
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
increases activity increases expression multiple interactions
EXP ISO
Calcimycin results in increased activity of NOS3 protein Calcimycin results in increased expression of NOS3 mRNA Calcimycin inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA] [Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides; Nitroglycerin promotes the reaction [[Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides]; NOS3 protein affects the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides]
CTD
PMID:10625313 PMID:11796706 PMID:19837105 PMID:20020783 PMID:20977430
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
multiple interactions increases expression
ISO
NR4A1 mRNA promotes the reaction [Calcimycin results in increased expression of TNF mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A1 mRNA]
CTD
PMID:25451590
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression multiple interactions
ISO
Calcimycin results in increased expression of NR4A2 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A2 mRNA]
CTD
PMID:25451590
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
increases expression multiple interactions
ISO
Calcimycin results in increased expression of NR4A3 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A3 mRNA]
CTD
PMID:25451590
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
G
Ntf3
neurotrophin 3
increases expression
EXP
Calcimycin results in increased expression of NTF3 protein
CTD
PMID:19854260
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
G
Otc
ornithine transcarbamylase
multiple interactions
EXP
[Calcimycin co-treated with Cyclosporine] results in decreased activity of OTC protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]]; didemnins inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]]
CTD
PMID:3097147
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
G
Padi4
peptidyl arginine deiminase 4
multiple interactions
ISO
Calcimycin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of PADI4 protein]
CTD
PMID:29425503
NCBI chr 5:153,041,351...153,074,412
Ensembl chr 5:153,041,352...153,074,362
G
Plk3
polo-like kinase 3
increases expression multiple interactions
ISO
Calcimycin results in increased expression of PLK3 mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of PLK3 mRNA]
CTD
PMID:25451590
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression multiple interactions
ISO
Calcimycin results in increased expression of PPP1R15A mRNA shikonin inhibits the reaction [Calcimycin results in increased expression of PPP1R15A mRNA]
CTD
PMID:25451590
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
increases phosphorylation
ISO
Calcimycin results in increased phosphorylation of PRKAA1 protein
CTD
PMID:28298333
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
G
Prkcd
protein kinase C, delta
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein]
CTD
PMID:23941771
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prl
prolactin
multiple interactions
EXP
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]
CTD
PMID:3097147
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression
ISO
[IL1B protein co-treated with Calcimycin] results in increased activity of PTGS2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein; Calcimycin promotes the reaction [[Hydrogen Peroxide co-treated with Vanadates] results in increased expression of PTGS2 mRNA alternative form]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]] Calcimycin results in increased expression of PTGS2 mRNA; Calcimycin results in increased expression of PTGS2 protein shikonin inhibits the reaction [Calcimycin results in increased expression of PTGS2 mRNA]
CTD
PMID:9013627 PMID:10837497 PMID:15705740 PMID:19416633 PMID:19782052 PMID:25451590 More...
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptprc
protein tyrosine phosphatase, receptor type, C
affects response to substance increases response to substance increases expression
ISO
PTPRC protein affects the susceptibility to Calcimycin PTPRC protein results in increased susceptibility to Calcimycin Calcimycin results in increased expression of PTPRC protein
CTD
PMID:25410152
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
Pygl
glycogen phosphorylase L
increases activity multiple interactions
EXP
Calcimycin results in increased activity of PYGL protein Calcium deficiency inhibits the reaction [Calcimycin results in increased activity of PYGL protein]
CTD
PMID:6430282
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Rcan1
regulator of calcineurin 1
increases expression
ISO
Calcimycin results in increased expression of RCAN1 protein
CTD
PMID:12927602
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
G
Rela
RELA proto-oncogene, NF-kB subunit
increases response to substance multiple interactions
ISO
RELA gene mutant form results in increased susceptibility to Calcimycin [Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; RELA protein inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]
CTD
PMID:11360202 PMID:17588137 PMID:18958421 PMID:19416633 PMID:19665545 PMID:21515303 PMID:22322153 PMID:23535185 More...
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Sell
selectin L
decreases expression multiple interactions
ISO
Calcimycin results in decreased expression of SELL protein [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of SELL mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of SELL mRNA]; resveratrol analog inhibits the reaction [Calcimycin results in decreased expression of SELL protein]
CTD
PMID:18776917 PMID:21331654
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
increases expression
ISO
Calcimycin results in increased expression of SELP protein
CTD
PMID:24466103
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Sirt1
sirtuin 1
affects response to substance
EXP
SIRT1 protein affects the susceptibility to Calcimycin
CTD
PMID:23422569
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sp1
Sp1 transcription factor
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of SP1 protein
CTD
PMID:24244623
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Sptan1
spectrin, alpha, non-erythrocytic 1
increases cleavage multiple interactions
ISO
Calcimycin results in increased cleavage of SPTAN1 protein rosiglitazone inhibits the reaction [Calcimycin results in increased cleavage of SPTAN1 protein]
CTD
PMID:19226370
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
increases phosphorylation
ISO
Calcimycin results in increased phosphorylation of SRC protein
CTD
PMID:19782052
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Tagap
T-cell activation RhoGTPase activating protein
multiple interactions increases expression
ISO
shikonin inhibits the reaction [Calcimycin results in increased expression of TAGAP mRNA]
CTD
PMID:25451590
NCBI chr 1:47,170,725...47,179,705
Ensembl chr 1:47,170,725...47,179,792
G
Tat
tyrosine aminotransferase
multiple interactions
EXP
Calcimycin promotes the reaction [Dexamethasone results in increased activity of TAT protein]; Sphingosine inhibits the reaction [Calcimycin promotes the reaction [Dexamethasone results in increased activity of TAT protein]]
CTD
PMID:9398635
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
Calcimycin results in increased expression of TGFB1 mRNA
CTD
PMID:8148055
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO EXP
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of and results in increased expression of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein; Calcimycin results in increased expression of and results in increased secretion of TNF protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Doxycycline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; fraxetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; isopraeroside IV inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of and results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; prolinedithiocarbamate inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] Calcimycin results in increased expression of TNF mRNA Luteolin inhibits the reaction [Calcimycin results in increased expression of TNF mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of TNF mRNA] Calcimycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein]; NR4A1 mRNA promotes the reaction [Calcimycin results in increased expression of TNF mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of TNF mRNA]
CTD
PMID:1371491 PMID:16134060 PMID:17588137 PMID:17950587 PMID:18799549 PMID:18958421 PMID:19118619 PMID:19416633 PMID:19665545 PMID:21515303 PMID:22322153 PMID:23426871 PMID:23535185 PMID:24131540 PMID:25451590 PMID:30254419 PMID:30496664 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC3 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]
CTD
PMID:21603612
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO
[[Air Pollutants results in increased abundance of Particulate Matter] which co-treated with Calcimycin] affects the expression of TP53 mRNA Calcimycin results in increased expression of TP53 mRNA
CTD
PMID:26419736
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tslp
thymic stromal lymphopoietin
multiple interactions
ISO
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein]
CTD
PMID:24131540
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
decreases expression
ISO
Calcimycin results in decreased expression of UHRF1 mRNA; Calcimycin results in decreased expression of UHRF1 protein
CTD
PMID:15964557
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
G
Vegfa
vascular endothelial growth factor A
multiple interactions increases secretion increases expression
ISO
Calcimycin inhibits the reaction [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [VEGFA protein results in increased expression of HMOX1 protein]] Calcimycin results in increased secretion of VEGFA protein Calcimycin results in increased expression of VEGFA mRNA
CTD
PMID:9743532 PMID:12147617 PMID:12788823
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xbp1
X-box binding protein 1
increases splicing multiple interactions
ISO
Calcimycin results in increased splicing of XBP1 mRNA Quercetin inhibits the reaction [Calcimycin results in increased splicing of XBP1 mRNA]
CTD
PMID:19428936
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Zfp36
zinc finger protein 36
multiple interactions increases expression
ISO
shikonin inhibits the reaction [Calcimycin results in increased expression of ZFP36 mRNA]
CTD
PMID:25451590
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Adam17
ADAM metallopeptidase domain 17
increases response to substance
ISO
ADAM17 results in increased susceptibility to fenamic acid
CTD
PMID:12147693
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases activity
ISO
fenamic acid analog results in decreased activity of AKR1C1 protein
CTD
PMID:19010312
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
decreases activity
ISO
fenamic acid analog results in decreased activity of AKR1C2 protein
CTD
PMID:19010312
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases activity
ISO
fenamic acid analog results in decreased activity of AKR1C3 protein
CTD
PMID:19010312
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Aqp3
aquaporin 3 (Gill blood group)
multiple interactions
ISO
fenamic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA]
CTD
PMID:12542607
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Cftr
CF transmembrane conductance regulator
multiple interactions decreases activity
ISO EXP
fenamic acid inhibits the reaction [[[Colforsin co-treated with Genistein] results in increased activity of CFTR protein] which results in increased transport of Iodides]; fenamic acid inhibits the reaction [Colforsin results in increased activity of CFTR protein] fenamic acid results in decreased activity of CFTR protein
CTD
PMID:14502435 PMID:14668136 PMID:15020588 PMID:15277574 PMID:15857825 PMID:15921678 PMID:15986093 PMID:16038730 PMID:18230692 More...
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Havcr1
hepatitis A virus cellular receptor 1
increases expression
EXP
fenamic acid results in increased expression of HAVCR1 mRNA
CTD
PMID:23142791
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Krt14
keratin 14
increases expression
EXP
fenamic acid results in increased expression of KRT14 mRNA
CTD
PMID:23142791
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
G
Lmcd1
LIM and cysteine-rich domains 1
increases expression
EXP
fenamic acid results in increased expression of LMCD1 mRNA
CTD
PMID:23558518
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
G
Mir210
microRNA 210
affects expression
EXP
fenamic acid affects the expression of MIR210
CTD
PMID:30169741
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mir34c
microRNA 34c
increases expression
EXP
fenamic acid results in increased expression of MIR34C
CTD
PMID:33367795
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
G
Tgfb2
transforming growth factor, beta 2
increases expression
EXP
fenamic acid results in increased expression of TGFB2 mRNA
CTD
PMID:23558518
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Tnf
tumor necrosis factor
multiple interactions
ISO
fenamic acid inhibits the reaction [TNF protein results in increased transport of Chlorides]
CTD
PMID:10783394
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vip
vasoactive intestinal peptide
multiple interactions
ISO
fenamic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA]
CTD
PMID:12542607
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Adam17
ADAM metallopeptidase domain 17
increases response to substance
ISO
ADAM17 results in increased susceptibility to Flufenamic Acid
CTD
PMID:12147693
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases activity multiple interactions
ISO
Flufenamic Acid results in decreased activity of AKR1C1 protein Flufenamic Acid inhibits the reaction [AKR1C1 protein affects the susceptibility to Oxaliplatin]; Flufenamic Acid inhibits the reaction [AKR1C1 protein results in increased metabolism of Dihydrotestosterone]
CTD
PMID:8573067 PMID:12604236 PMID:14672942 PMID:23933386
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
multiple interactions decreases activity
ISO
Flufenamic Acid inhibits the reaction [AKR1C2 protein results in increased metabolism of Dihydrotestosterone] Flufenamic Acid results in decreased activity of AKR1C2 protein
CTD
PMID:8573067 PMID:12604236 PMID:14672942
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
affects binding multiple interactions decreases activity
ISO
Flufenamic Acid binds to AKR1C3 protein Flufenamic Acid inhibits the reaction [AKR1C3 protein affects the susceptibility to oxaliplatin]; Flufenamic Acid inhibits the reaction [AKR1C3 protein results in increased metabolism of Dihydrotestosterone] Flufenamic Acid results in decreased activity of AKR1C3 protein
CTD
PMID:12604236 PMID:14672942 PMID:14996743 PMID:23933386
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Ar
androgen receptor
multiple interactions decreases expression
ISO
Flufenamic Acid analog binds to and results in decreased activity of AR protein; Flufenamic Acid binds to and results in decreased activity of AR protein Flufenamic Acid results in decreased expression of AR mRNA; Flufenamic Acid results in decreased expression of AR protein
CTD
PMID:10537180 PMID:19645433
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Asic5
acid sensing ion channel subunit family member 5
multiple interactions
ISO
Flufenamic Acid binds to and results in increased activity of ASIC5 protein
CTD
PMID:21828194
NCBI chr 2:167,307,984...167,336,812
Ensembl chr 2:167,307,984...167,336,812
G
Bad
BCL2-associated agonist of cell death
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAD protein]
CTD
PMID:27957685
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein]
CTD
PMID:27957685
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Best1
bestrophin 1
decreases activity
ISO
Flufenamic Acid results in decreased activity of BEST1 protein
CTD
PMID:19828819
NCBI chr 1:206,629,340...206,646,085
Ensembl chr 1:206,629,500...206,646,063
G
Bid
BH3 interacting domain death agonist
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BID protein]
CTD
PMID:27957685
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Casp3
caspase 3
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form]
CTD
PMID:27957685
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casr
calcium-sensing receptor
multiple interactions
ISO
Flufenamic Acid promotes the reaction [CASR protein results in increased uptake of Calcium]
CTD
PMID:21562303
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
G
Cftr
CF transmembrane conductance regulator
decreases activity
ISO
Flufenamic Acid results in decreased activity of CFTR protein
CTD
PMID:15277574
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Cga
glycoprotein hormones, alpha polypeptide
multiple interactions
EXP
[Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of CGA mRNA
CTD
PMID:8404651
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
G
Chrm1
cholinergic receptor, muscarinic 1
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [[Carbachol results in increased activity of CHRM1 protein] which results in increased abundance of Calcium]
CTD
PMID:18316702
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Dhrs11
dehydrogenase/reductase 11
decreases activity
ISO
Flufenamic Acid results in decreased activity of DHRS11 protein
CTD
PMID:30926317
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
EXP
[Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of FSHB mRNA
CTD
PMID:8404651
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Grm1
glutamate metabotropic receptor 1
multiple interactions
EXP
Flufenamic Acid inhibits the reaction [3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein]; Flufenamic Acid inhibits the reaction [[3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein] which results in increased abundance of Calcium]
CTD
PMID:14622174
NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A protein]
CTD
PMID:10866999
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il6
interleukin 6
increases expression multiple interactions
EXP ISO
Flufenamic Acid results in increased expression of IL6 mRNA Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD
PMID:15135310 PMID:24849676
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions
ISO
E 4031 inhibits the reaction [Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium]]; Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium]
CTD
PMID:12359267
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnk10
potassium two pore domain channel subfamily K member 10
multiple interactions
ISO
Flufenamic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695
G
Kcnk2
potassium two pore domain channel subfamily K member 2
multiple interactions
ISO
Flufenamic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kcnk4
potassium two pore domain channel subfamily K member 4
multiple interactions
ISO
Flufenamic Acid promotes the reaction [KCNK4 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr 1:204,117,941...204,129,494
Ensembl chr 1:204,114,572...204,125,925
G
Kiss1
KiSS-1 metastasis-suppressor
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [[KISS1 protein results in increased activity of KISS1R protein] which results in increased abundance of Calcium]
CTD
PMID:18948403
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
G
Kiss1r
KISS1 receptor
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [[KISS1 protein results in increased activity of KISS1R protein] which results in increased abundance of Calcium]
CTD
PMID:18948403
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
G
Ldlr
low density lipoprotein receptor
multiple interactions increases expression
ISO
Flufenamic Acid inhibits the reaction [Cyclosporine inhibits the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]]; Flufenamic Acid promotes the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]; Flufenamic Acid promotes the reaction [Cholesterol, LDL binds to LDLR protein] Flufenamic Acid results in increased expression of LDLR mRNA; Flufenamic Acid results in increased expression of LDLR protein
CTD
PMID:10395027
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lep
leptin
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [LEP protein results in increased transport of Calcium]
CTD
PMID:20107083
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
[Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of LHB mRNA
CTD
PMID:8404651
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Nkx3-1
NK3 homeobox 1
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]
CTD
PMID:10537180
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nos2
nitric oxide synthase 2
multiple interactions increases expression
ISO EXP
Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] Flufenamic Acid results in increased expression of NOS2 mRNA
CTD
PMID:10866999 PMID:15135310
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Panx1
Pannexin 1
decreases activity
ISO
Flufenamic Acid results in decreased activity of PANX1 protein
CTD
PMID:19023039
NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:11,850,730...11,889,774
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
ISO
Flufenamic Acid binds to and results in increased activity of PPARA protein
CTD
PMID:9013583
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases activity
ISO
[Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; Flufenamic Acid binds to and results in increased activity of PPARG protein
CTD
PMID:9013583 PMID:10866999
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression
ISO
[Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] Flufenamic Acid results in increased expression of PTGS2 mRNA; Flufenamic Acid results in increased expression of PTGS2 protein
CTD
PMID:10866999
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Sell
selectin L
decreases expression
ISO
Flufenamic Acid results in decreased expression of SELL protein
CTD
PMID:12147693
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Slc6a11
solute carrier family 6 member 11
multiple interactions
ISO
Flufenamic Acid inhibits the reaction [SLC6A11 protein results in increased uptake of gamma-Aminobutyric Acid]
CTD
PMID:15981712
NCBI chr 4:147,297,972...147,413,319
Ensembl chr 4:147,297,969...147,413,443
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO EXP
Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] Flufenamic Acid results in increased expression of TNF mRNA
CTD
PMID:10866999 PMID:15135310
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
multiple interactions increases activity
ISO EXP
[Flufenamic Acid results in increased activity of TRPC6 protein] which results in increased uptake of Calcium Flufenamic Acid inhibits the reaction [1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [TRPC6 protein results in increased uptake of Calcium]]; Flufenamic Acid inhibits the reaction [1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [TRPC6 protein results in increased uptake of Manganese]]
CTD
PMID:11535132 PMID:14551041 PMID:21562303
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
multiple interactions
EXP
Flufenamic Acid inhibits the reaction [Adenosine Diphosphate Ribose promotes the reaction [TRPM2 protein results in increased transport of Calcium]]
CTD
PMID:21900507
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
G
Trpm4
transient receptor potential cation channel, subfamily M, member 4
decreases activity
ISO EXP
Flufenamic Acid results in decreased activity of TRPM4 protein
CTD
PMID:16966582 PMID:17188667
NCBI chr 1:95,781,805...95,812,095
Ensembl chr 1:95,782,000...95,812,532
G
A2m
alpha-2-macroglobulin
increases expression
EXP
Glafenine results in increased expression of A2M mRNA
CTD
PMID:24136188
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Aadac
arylacetamide deacetylase
decreases expression
EXP
Glafenine results in decreased expression of AADAC mRNA
CTD
PMID:24136188
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
G
Aamdc
adipogenesis associated, Mth938 domain containing
decreases expression
EXP
Glafenine results in decreased expression of AAMDC mRNA
CTD
PMID:24136188
NCBI chr 1:151,861,990...151,893,621
Ensembl chr 1:151,845,255...151,892,398
G
Abat
4-aminobutyrate aminotransferase
decreases expression
EXP
Glafenine results in decreased expression of ABAT mRNA
CTD
PMID:24136188
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
EXP
Glafenine results in increased expression of ABCA1 mRNA
CTD
PMID:24136188
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression
EXP
Glafenine results in decreased expression of ABCB11 mRNA
CTD
PMID:24136188
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression
EXP
Glafenine results in decreased expression of ABCB1 mRNA
CTD
PMID:24136188
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression
EXP
Glafenine results in decreased expression of ABCC2 mRNA
CTD
PMID:24136188
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcd3
ATP binding cassette subfamily D member 3
decreases expression
EXP
Glafenine results in decreased expression of ABCD3 mRNA
CTD
PMID:24136188
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
G
Abcg5
ATP binding cassette subfamily G member 5
decreases expression
EXP
Glafenine results in decreased expression of ABCG5 mRNA
CTD
PMID:24136188
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abhd1
abhydrolase domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of ABHD1 mRNA
CTD
PMID:24136188
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
G
Abhd14b
abhydrolase domain containing 14b
decreases expression
EXP
Glafenine results in decreased expression of ABHD14B mRNA
CTD
PMID:24136188
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
G
Abhd2
abhydrolase domain containing 2, acylglycerol lipase
increases expression
EXP
Glafenine results in increased expression of ABHD2 mRNA
CTD
PMID:24136188
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
G
Abhd6
abhydrolase domain containing 6, acylglycerol lipase
decreases expression
EXP
Glafenine results in decreased expression of ABHD6 mRNA
CTD
PMID:24136188
NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985
G
Abi1
abl-interactor 1
decreases expression
EXP
Glafenine results in decreased expression of ABI1 mRNA
CTD
PMID:24136188
NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792
G
Abraxas2
abraxas 2, BRISC complex subunit
decreases expression
EXP
Glafenine results in decreased expression of ABRAXAS2 mRNA
CTD
PMID:24136188
NCBI chr 1:187,647,078...187,672,660
Ensembl chr 1:187,647,067...187,672,655
G
Abtb1
ankyrin repeat and BTB domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of ABTB1 mRNA
CTD
PMID:24136188
NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:121,299,304...121,305,620
G
Abtb2
ankyrin repeat and BTB domain containing 2
decreases expression
EXP
Glafenine results in decreased expression of ABTB2 mRNA
CTD
PMID:24136188
NCBI chr 3:89,954,726...90,108,549
Ensembl chr 3:89,954,713...90,108,548
G
Abtb3
ankyrin repeat and BTB domain containing 3
decreases expression
EXP
Glafenine results in decreased expression of ABTB3 mRNA
CTD
PMID:24136188
NCBI chr 7:18,035,151...18,310,718
Ensembl chr 7:18,036,083...18,310,834
G
Acaa1a
acetyl-CoA acyltransferase 1A
decreases expression
EXP
Glafenine results in decreased expression of ACAA1 mRNA
CTD
PMID:24136188
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
G
Acaca
acetyl-CoA carboxylase alpha
increases expression
EXP
Glafenine results in increased expression of ACACA mRNA
CTD
PMID:24136188
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acad10
acyl-CoA dehydrogenase family, member 10
decreases expression
EXP
Glafenine results in decreased expression of ACAD10 mRNA
CTD
PMID:24136188
NCBI chr12:34,901,211...34,943,973
Ensembl chr12:34,901,219...34,982,521
G
Acad11
acyl-CoA dehydrogenase family, member 11
decreases expression
EXP
Glafenine results in decreased expression of ACAD11 mRNA
CTD
PMID:24136188
NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560
G
Acad9
acyl-CoA dehydrogenase family, member 9
decreases expression
EXP
Glafenine results in decreased expression of ACAD9 mRNA
CTD
PMID:24136188
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
G
Acadm
acyl-CoA dehydrogenase medium chain
decreases expression
EXP
Glafenine results in decreased expression of ACADM mRNA
CTD
PMID:24136188
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
G
Acads
acyl-CoA dehydrogenase short chain
decreases expression
EXP
Glafenine results in decreased expression of ACADS mRNA
CTD
PMID:24136188
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
G
Acbd5
acyl-CoA binding domain containing 5
decreases expression
EXP
Glafenine results in decreased expression of ACBD5 mRNA
CTD
PMID:24136188
NCBI chr17:85,206,178...85,248,909
Ensembl chr17:85,206,303...85,248,215
G
Acer2
alkaline ceramidase 2
increases expression
EXP
Glafenine results in increased expression of ACER2 mRNA
CTD
PMID:24136188
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
G
Ackr3
atypical chemokine receptor 3
increases expression
EXP
Glafenine results in increased expression of ACKR3 mRNA
CTD
PMID:24136188
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Acot12
acyl-CoA thioesterase 12
decreases expression
EXP
Glafenine results in decreased expression of ACOT12 mRNA
CTD
PMID:24136188
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
G
Acot2
acyl-CoA thioesterase 2
decreases expression
EXP
Glafenine results in decreased expression of ACOT2 mRNA
CTD
PMID:24136188
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
G
Acot4
acyl-CoA thioesterase 4
decreases expression
EXP
Glafenine results in decreased expression of ACOT4 mRNA
CTD
PMID:24136188
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
G
Acox1
acyl-CoA oxidase 1
decreases expression
EXP
Glafenine results in decreased expression of ACOX1 mRNA
CTD
PMID:24136188
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
EXP
Glafenine results in decreased expression of ACSL1 mRNA
CTD
PMID:24136188
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
decreases expression
EXP
Glafenine results in decreased expression of ACSM2A mRNA
CTD
PMID:24136188
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
G
Acss2
acyl-CoA synthetase short-chain family member 2
decreases expression
EXP
Glafenine results in decreased expression of ACSS2 mRNA
CTD
PMID:24136188
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
G
Actg1
actin, gamma 1
increases expression
EXP
Glafenine results in increased expression of ACTG1 mRNA
CTD
PMID:24136188
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Adck5
aarF domain containing kinase 5
decreases expression
EXP
Glafenine results in decreased expression of ADCK5 mRNA
CTD
PMID:24136188
NCBI chr 7:108,301,623...108,319,439
Ensembl chr 7:108,301,415...108,319,436
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
decreases expression
EXP
Glafenine results in decreased expression of ADH4 mRNA
CTD
PMID:24136188
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
G
Adhfe1
alcohol dehydrogenase, iron containing, 1
decreases expression
EXP
Glafenine results in decreased expression of ADHFE1 mRNA
CTD
PMID:24136188
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
G
Adipor2
adiponectin receptor 2
decreases expression
EXP
Glafenine results in decreased expression of ADIPOR2 mRNA
CTD
PMID:24136188
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adk
adenosine kinase
decreases expression
EXP
Glafenine results in decreased expression of ADK mRNA
CTD
PMID:24136188
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Adss1
adenylosuccinate synthase 1
decreases expression
EXP
Glafenine results in decreased expression of ADSS1 mRNA
CTD
PMID:24136188
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
G
Adss2
adenylosuccinate synthase 2
decreases expression
EXP
Glafenine results in decreased expression of ADSS2 mRNA
CTD
PMID:24136188
NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604
G
Adtrp
androgen-dependent TFPI-regulating protein
decreases expression
EXP
Glafenine results in decreased expression of ADTRP mRNA
CTD
PMID:24136188
NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826
G
Afm
afamin
decreases expression
EXP
Glafenine results in decreased expression of AFM mRNA
CTD
PMID:24136188
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
G
Afmid
arylformamidase
decreases expression
EXP
Glafenine results in decreased expression of AFMID mRNA
CTD
PMID:24136188
NCBI chr10:103,046,129...103,061,718
Ensembl chr10:103,046,180...103,061,718
G
Agmat
agmatinase
decreases expression
EXP
Glafenine results in decreased expression of AGMAT mRNA
CTD
PMID:24136188
NCBI chr 5:154,043,665...154,074,278
Ensembl chr 5:154,060,151...154,074,276
G
Agmo
alkylglycerol monooxygenase
decreases expression
EXP
Glafenine results in decreased expression of AGMO mRNA
CTD
PMID:24136188
NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623
G
Ahcy
adenosylhomocysteinase
decreases expression
EXP
Glafenine results in decreased expression of AHCY mRNA
CTD
PMID:24136188
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
G
Aimp2
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
increases expression
EXP
Glafenine results in increased expression of AIMP2 mRNA
CTD
PMID:24136188
NCBI chr12:10,701,194...10,710,772
Ensembl chr12:10,701,194...10,710,769
G
Ak3
adenylate kinase 3
decreases expression
EXP
Glafenine results in decreased expression of AK3 mRNA
CTD
PMID:24136188
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
G
Akr1a1
aldo-keto reductase family 1 member A1
increases expression
EXP
Glafenine results in increased expression of AKR1A1 mRNA
CTD
PMID:24136188
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases expression
EXP
Glafenine results in decreased expression of AKR1C1 mRNA
CTD
PMID:24136188
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
AKR1C3l1
aldo-keto reductase family 1 member C3-like 1
decreases expression
EXP
Glafenine results in decreased expression of AKR1C3L1 mRNA
CTD
PMID:24136188
NCBI chr17:65,847,580...65,881,488
Ensembl chr17:65,835,634...65,881,488
G
Akr1e2
aldo-keto reductase family 1, member E2
decreases expression
EXP
Glafenine results in decreased expression of AKR1E2 mRNA
CTD
PMID:24136188
NCBI chr17:65,735,909...65,750,441
Ensembl chr17:65,735,943...65,750,441
G
Akr7a2
aldo-keto reductase family 7, member A2
decreases expression
EXP
Glafenine results in decreased expression of AKR7A2 mRNA
CTD
PMID:24136188
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Akr7a3
aldo-keto reductase family 7 member A3
decreases expression
EXP
Glafenine results in decreased expression of AKR7A3 mRNA
CTD
PMID:24136188
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Alas1
5'-aminolevulinate synthase 1
decreases expression
EXP
Glafenine results in decreased expression of ALAS1 mRNA
CTD
PMID:24136188
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression
EXP
Glafenine results in decreased expression of ALDH1A1 mRNA
CTD
PMID:24136188
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
decreases expression
EXP
Glafenine results in decreased expression of ALDH1L1 mRNA
CTD
PMID:24136188
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
G
Aldh2
aldehyde dehydrogenase 2 family member
decreases expression
EXP
Glafenine results in decreased expression of ALDH2 mRNA
CTD
PMID:24136188
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
decreases expression
EXP
Glafenine results in decreased expression of ALDH3A2 mRNA
CTD
PMID:24136188
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Aldh4a1
aldehyde dehydrogenase 4 family, member A1
decreases expression
EXP
Glafenine results in decreased expression of ALDH4A1 mRNA
CTD
PMID:24136188
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
decreases expression
EXP
Glafenine results in decreased expression of ALDH5A1 mRNA
CTD
PMID:24136188
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
EXP
Glafenine results in decreased expression of ALDH6A1 mRNA
CTD
PMID:24136188
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aldh9a1
aldehyde dehydrogenase 9 family, member A1
decreases expression
EXP
Glafenine results in decreased expression of ALDH9A1 mRNA
CTD
PMID:24136188
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
EXP
Glafenine results in increased expression of ALDOA mRNA
CTD
PMID:24136188
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Alg12
ALG12, alpha-1,6-mannosyltransferase
increases expression
EXP
Glafenine results in increased expression of ALG12 mRNA
CTD
PMID:24136188
NCBI chr 7:119,895,112...119,909,488
Ensembl chr 7:119,895,120...119,909,458
G
Alg2
ALG2, alpha-1,3/1,6-mannosyltransferase
increases expression
EXP
Glafenine results in increased expression of ALG2 mRNA
CTD
PMID:24136188
NCBI chr 5:61,768,738...61,773,297
Ensembl chr 5:61,768,740...61,773,297
G
Alg3
ALG3, alpha-1,3- mannosyltransferase
increases expression
EXP
Glafenine results in increased expression of ALG3 mRNA
CTD
PMID:24136188
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
G
Amacr
alpha-methylacyl-CoA racemase
decreases expression
EXP
Glafenine results in decreased expression of AMACR mRNA
CTD
PMID:24136188
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
G
Amigo3
adhesion molecule with Ig like domain 3
increases expression
EXP
Glafenine results in increased expression of AMIGO3 mRNA
CTD
PMID:24136188
NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:108,693,060...108,744,555
G
Amy2a3
amylase 2a3
decreases expression
EXP
Glafenine results in decreased expression of AMY1A mRNA
CTD
PMID:24136188
NCBI chr 2:201,317,916...201,326,487
Ensembl chr 2:201,317,920...201,326,532
G
Ang
angiogenin
decreases expression
EXP
Glafenine results in decreased expression of ANG mRNA
CTD
PMID:24136188
NCBI chr15:24,312,711...24,323,361
G
Angptl3
angiopoietin-like 3
decreases expression
EXP
Glafenine results in decreased expression of ANGPTL3 mRNA
CTD
PMID:24136188
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Ankrd24
ankyrin repeat domain 24
increases expression
EXP
Glafenine results in increased expression of ANKRD24 mRNA
CTD
PMID:24136188
NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142
G
Ankrd46
ankyrin repeat domain 46
decreases expression
EXP
Glafenine results in decreased expression of ANKRD46 mRNA
CTD
PMID:24136188
NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132
G
Anks4b
ankyrin repeat and sterile alpha motif domain containing 4B
decreases expression
EXP
Glafenine results in decreased expression of ANKS4B mRNA
CTD
PMID:24136188
NCBI chr 1:174,534,195...174,557,798
Ensembl chr 1:174,547,473...174,557,797
G
Antxr2
ANTXR cell adhesion molecule 2
decreases expression
EXP
Glafenine results in decreased expression of ANTXR2 mRNA
CTD
PMID:24136188
NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094
G
Anxa4
annexin A4
decreases expression
EXP
Glafenine results in decreased expression of ANXA4 mRNA
CTD
PMID:24136188
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Apeg3
antisense paternally expressed gene 3
increases expression
EXP
Glafenine results in increased expression of APEG3 mRNA
CTD
PMID:24136188
NCBI chr 1:67,121,402...67,122,333
Ensembl chr 1:67,121,900...67,122,181 Ensembl chr 1:67,121,900...67,122,181
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases expression
EXP
Glafenine results in increased expression of APEX1 mRNA
CTD
PMID:24136188
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Apmap
adipocyte plasma membrane associated protein
decreases expression
EXP
Glafenine results in decreased expression of APMAP mRNA
CTD
PMID:24136188
NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341
G
Apoa2
apolipoprotein A2
decreases expression
EXP
Glafenine results in decreased expression of APOA2 mRNA
CTD
PMID:24136188
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
G
Apol7b-ps1
apolipoprotein L7b, pseudogene 1
decreases expression
EXP
Glafenine results in decreased expression of APOL7B mRNA
CTD
PMID:24136188
NCBI chr 7:109,156,746...109,175,642
G
Appbp2
amyloid beta precursor protein binding protein 2
decreases expression
EXP
Glafenine results in decreased expression of APPBP2 mRNA
CTD
PMID:24136188
NCBI chr10:70,057,774...70,099,877
Ensembl chr10:70,057,774...70,099,835
G
Aprt
adenine phosphoribosyl transferase
increases expression
EXP
Glafenine results in increased expression of APRT mRNA
CTD
PMID:24136188
NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
G
Arf4
ADP-ribosylation factor 4
increases expression
EXP
Glafenine results in increased expression of ARF4 mRNA
CTD
PMID:24136188
NCBI chr16:1,896,692...1,913,267
Ensembl chr16:1,896,546...1,913,261
G
Arfgap3
ADP-ribosylation factor GTPase activating protein 3
increases expression
EXP
Glafenine results in increased expression of ARFGAP3 mRNA
CTD
PMID:24136188
NCBI chr 7:114,432,873...114,479,206
Ensembl chr 7:114,432,873...114,479,208
G
Arfgef1
ADP ribosylation factor guanine nucleotide exchange factor 1
decreases expression
EXP
Glafenine results in decreased expression of ARFGEF1 mRNA
CTD
PMID:24136188
NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326
G
Arfip2
ADP-ribosylation factor interacting protein 2
increases expression
EXP
Glafenine results in increased expression of ARFIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:159,974,255...159,980,398
Ensembl chr 1:159,974,201...159,980,336
G
Arhgap1
Rho GTPase activating protein 1
increases expression
EXP
Glafenine results in increased expression of ARHGAP1 mRNA
CTD
PMID:24136188
NCBI chr 3:77,621,377...77,643,400
Ensembl chr 3:77,620,655...77,643,396
G
Arhgap18
Rho GTPase activating protein 18
decreases expression
EXP
Glafenine results in decreased expression of ARHGAP18 mRNA
CTD
PMID:24136188
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
G
Arhgap24
Rho GTPase activating protein 24
decreases expression
EXP
Glafenine results in decreased expression of ARHGAP24 mRNA
CTD
PMID:24136188
NCBI chr14:6,800,624...7,183,877
Ensembl chr14:6,800,631...7,183,823
G
Arl6ip1
ADP-ribosylation factor like GTPase 6 interacting protein 1
decreases expression
EXP
Glafenine results in decreased expression of ARL6IP1 mRNA
CTD
PMID:24136188
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
G
Arl6ip4
ADP-ribosylation factor like GTPase 6 interacting protein 4
increases expression
EXP
Glafenine results in increased expression of ARL6IP4 mRNA
CTD
PMID:24136188
NCBI chr12:32,479,623...32,481,768
Ensembl chr12:32,479,625...32,481,799
G
Armc9
armadillo repeat containing 9
increases expression
EXP
Glafenine results in increased expression of ARMC9 mRNA
CTD
PMID:24136188
NCBI chr 9:86,802,791...86,928,611
Ensembl chr 9:86,802,868...86,928,860
G
Armcx3
armadillo repeat containing, X-linked 3
increases expression
EXP
Glafenine results in increased expression of ARMCX3 mRNA
CTD
PMID:24136188
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
G
Arpc1b
actin related protein 2/3 complex, subunit 1B
increases expression
EXP
Glafenine results in increased expression of ARPC1B mRNA
CTD
PMID:24136188
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
G
Arpc5l
actin related protein 2/3 complex, subunit 5-like
increases expression
EXP
Glafenine results in increased expression of ARPC5L mRNA
CTD
PMID:24136188
NCBI chr 3:22,758,710...22,767,520
Ensembl chr 3:22,759,876...22,767,538 Ensembl chr 9:22,759,876...22,767,538
G
Asl
argininosuccinate lyase
decreases expression
EXP
Glafenine results in decreased expression of ASL mRNA
CTD
PMID:24136188
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
G
Ass1
argininosuccinate synthase 1
decreases expression
EXP
Glafenine results in decreased expression of ASS1 mRNA
CTD
PMID:24136188
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atf4
activating transcription factor 4
increases expression
EXP
Glafenine results in increased expression of ATF4 mRNA
CTD
PMID:24136188
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atg13
autophagy related 13
increases expression
EXP
Glafenine results in increased expression of ATG13 mRNA
CTD
PMID:24136188
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
G
Atg16l2
autophagy related 16-like 2
increases expression
EXP
Glafenine results in increased expression of ATG16L2 mRNA
CTD
PMID:24136188
NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420
G
Atg2b
autophagy related 2B
decreases expression
EXP
Glafenine results in decreased expression of ATG2B mRNA
CTD
PMID:24136188
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
G
Atl2
atlastin GTPase 2
decreases expression
EXP
Glafenine results in decreased expression of ATL2 mRNA
CTD
PMID:24136188
NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421
G
Atosa
atos homolog A
decreases expression
EXP
Glafenine results in decreased expression of ATOSA mRNA
CTD
PMID:24136188
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
G
Atp11a
ATPase phospholipid transporting 11A
decreases expression
EXP
Glafenine results in decreased expression of ATP11A mRNA
CTD
PMID:24136188
NCBI chr16:76,657,752...76,767,640
Ensembl chr16:76,657,752...76,767,640
G
Atp11c
ATPase phospholipid transporting 11C
decreases expression
EXP
Glafenine results in decreased expression of ATP11C mRNA
CTD
PMID:24136188
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
decreases expression
EXP
Glafenine results in decreased expression of ATP1B1 mRNA
CTD
PMID:24136188
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
increases expression
EXP
Glafenine results in increased expression of ATP2A2 mRNA
CTD
PMID:24136188
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Atp5mc1
ATP synthase membrane subunit c locus 1
increases expression
EXP
Glafenine results in increased expression of ATP5MC1 mRNA
CTD
PMID:24136188
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
G
Atrn
attractin
decreases expression
EXP
Glafenine results in decreased expression of ATRN mRNA
CTD
PMID:24136188
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
G
Atxn2
ataxin 2
decreases expression
EXP
Glafenine results in decreased expression of ATXN2 mRNA
CTD
PMID:24136188
NCBI chr12:34,754,132...34,851,175
Ensembl chr12:34,754,137...34,851,479
G
Aurkaip1
aurora kinase A interacting protein 1
increases expression
EXP
Glafenine results in increased expression of AURKAIP1 mRNA
CTD
PMID:24136188
NCBI chr 5:166,435,177...166,436,888
Ensembl chr 5:166,417,508...166,436,882
G
B2m
beta-2 microglobulin
decreases expression
EXP
Glafenine results in decreased expression of B2M mRNA
CTD
PMID:24136188
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
B4galt1
beta-1,4-galactosyltransferase 1
increases expression
EXP
Glafenine results in increased expression of B4GALT1 mRNA
CTD
PMID:24136188
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
G
B4gat1
beta-1,4-glucuronyltransferase 1
decreases expression
EXP
Glafenine results in decreased expression of B4GAT1 mRNA
CTD
PMID:24136188
NCBI chr 1:202,343,268...202,345,490
Ensembl chr 1:202,343,240...202,346,065
G
Baat
bile acid CoA:amino acid N-acyltransferase
decreases expression
EXP
Glafenine results in decreased expression of BAAT mRNA
CTD
PMID:24136188
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
G
Babam1
BRISC and BRCA1 A complex member 1
increases expression
EXP
Glafenine results in increased expression of BABAM1 mRNA
CTD
PMID:24136188
NCBI chr16:18,068,830...18,074,938
Ensembl chr16:18,068,884...18,074,923
G
Basp1
brain abundant, membrane attached signal protein 1
increases expression
EXP
Glafenine results in increased expression of BASP1 mRNA
CTD
PMID:24136188
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
G
Bbln
bublin coiled coil protein
increases expression
EXP
Glafenine results in increased expression of BBLN mRNA
CTD
PMID:24136188
NCBI chr 3:15,674,577...15,677,322
Ensembl chr 3:15,674,580...15,677,374
G
Bbox1
gamma-butyrobetaine hydroxylase 1
decreases expression
EXP
Glafenine results in decreased expression of BBOX1 mRNA
CTD
PMID:24136188
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
G
Bbs2
Bardet-Biedl syndrome 2
decreases expression
EXP
Glafenine results in decreased expression of BBS2 mRNA
CTD
PMID:24136188
NCBI chr19:10,909,653...10,944,998
Ensembl chr19:10,909,619...10,944,993
G
Bcl3
BCL3, transcription coactivator
increases expression
EXP
Glafenine results in increased expression of BCL3 mRNA
CTD
PMID:24136188
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
increases expression
EXP
Glafenine results in increased expression of BET1L mRNA
CTD
PMID:24136188
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
G
Bhlhe40
basic helix-loop-helix family, member e40
increases expression
EXP
Glafenine results in increased expression of BHLHE40 mRNA
CTD
PMID:24136188
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Bhmt
betaine-homocysteine S-methyltransferase
decreases expression
EXP
Glafenine results in decreased expression of BHMT mRNA
CTD
PMID:24136188
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
Bhmt2
betaine-homocysteine S-methyltransferase 2
decreases expression
EXP
Glafenine results in decreased expression of BHMT2 mRNA
CTD
PMID:24136188
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
G
Bloc1s5
biogenesis of lysosomal organelles complex 1 subunit 5
decreases expression
EXP
Glafenine results in decreased expression of BLOC1S5 mRNA
CTD
PMID:24136188
NCBI chr17:26,171,965...26,197,276
Ensembl chr17:26,172,018...26,197,251
G
Blvrb
biliverdin reductase B
decreases expression
EXP
Glafenine results in decreased expression of BLVRB mRNA
CTD
PMID:24136188
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bnip1
BCL2 interacting protein 1
increases expression
EXP
Glafenine results in increased expression of BNIP1 mRNA
CTD
PMID:24136188
NCBI chr10:16,386,876...16,399,124
Ensembl chr10:16,386,841...16,399,157
G
Bnip3l
BCL2 interacting protein 3 like
decreases expression
EXP
Glafenine results in decreased expression of BNIP3L mRNA
CTD
PMID:24136188
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
G
Bola2-ps4
bolA family member 2, pseudogene 4
increases expression
EXP
Glafenine results in increased expression of BOLA2-PS4 mRNA
CTD
PMID:24136188
NCBI chr 3:153,272,435...153,272,781
G
Bola3
bolA family member 3
increases expression
EXP
Glafenine results in increased expression of BOLA3 mRNA
CTD
PMID:24136188
NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:115,853,350...115,862,797
G
Bop1
BOP1 ribosomal biogenesis factor
increases expression
EXP
Glafenine results in increased expression of BOP1 mRNA
CTD
PMID:24136188
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
G
Borcs7
BLOC-1 related complex subunit 7
increases expression
EXP
Glafenine results in increased expression of BORCS7 mRNA
CTD
PMID:24136188
NCBI chr 1:245,564,347...245,578,182
Ensembl chr 1:245,564,369...245,579,343
G
Bphl
biphenyl hydrolase like
decreases expression
EXP
Glafenine results in decreased expression of BPHL mRNA
CTD
PMID:24136188
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
G
Brd3
bromodomain containing 3
decreases expression
EXP
Glafenine results in decreased expression of BRD3 mRNA
CTD
PMID:24136188
NCBI chr 3:10,773,163...10,829,675
Ensembl chr 3:10,775,272...10,829,577
G
Brix1
biogenesis of ribosomes BRX1
increases expression
EXP
Glafenine results in increased expression of BRIX1 mRNA
CTD
PMID:24136188
NCBI chr 2:59,450,608...59,461,486
Ensembl chr 2:59,450,614...59,461,495
G
Btbd1
BTB domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of BTBD1 mRNA
CTD
PMID:24136188
NCBI chr 1:135,734,549...135,773,067
Ensembl chr 1:135,734,589...135,771,981
G
Btbd6
BTB domain containing 6
decreases expression
EXP
Glafenine results in decreased expression of BTBD6 mRNA
CTD
PMID:24136188
NCBI chr 6:132,058,094...132,060,603
Ensembl chr 6:132,058,096...132,060,587
G
Btg2
BTG anti-proliferation factor 2
increases expression
EXP
Glafenine results in increased expression of BTG2 mRNA
CTD
PMID:24136188
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btg3
BTG anti-proliferation factor 3
increases expression
EXP
Glafenine results in increased expression of BTG3 mRNA
CTD
PMID:24136188
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
G
Bysl
bystin-like
increases expression
EXP
Glafenine results in increased expression of BYSL mRNA
CTD
PMID:24136188
NCBI chr 9:13,382,806...13,392,557
Ensembl chr 9:13,382,557...13,394,339
G
C10h17orf58
similar to human chromosome 17 open reading frame 58
increases expression
EXP
Glafenine results in increased expression of C10H17ORF58 mRNA
CTD
PMID:24136188
NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602
G
C15h14orf119
similar to human chromosome 14 open reading frame 119
increases expression
EXP
Glafenine results in increased expression of C15H14ORF119 mRNA
CTD
PMID:24136188
NCBI chr15:28,146,368...28,151,422
Ensembl chr15:28,146,333...28,155,180
G
C18h18orf32
similar to human chromosome 18 open reading frame 32
increases expression
EXP
Glafenine results in increased expression of C18H18ORF32 mRNA
CTD
PMID:24136188
NCBI chr18:68,586,278...68,594,851
Ensembl chr18:68,586,211...68,596,787
G
C1qbp
complement C1q binding protein
increases expression
EXP
Glafenine results in increased expression of C1QBP mRNA
CTD
PMID:24136188
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
G
C4bpb
complement component 4 binding protein, beta
increases expression
EXP
Glafenine results in increased expression of C4BPB mRNA
CTD
PMID:24136188
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
G
C5
complement C5
increases expression
EXP
Glafenine results in increased expression of C5 mRNA
CTD
PMID:24136188
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C5h1orf122
similar to human chromosome 1 open reading frame 122
increases expression
EXP
Glafenine results in increased expression of C5H1ORF122 mRNA
CTD
PMID:24136188
NCBI chr 5:137,109,093...137,110,130
Ensembl chr 5:137,108,633...137,110,929
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
decreases expression
EXP
Glafenine results in decreased expression of C8H11ORF54 mRNA
CTD
PMID:24136188
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
G
C9
complement C9
increases expression
EXP
Glafenine results in increased expression of C9 mRNA
CTD
PMID:24136188
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
increases expression
EXP
Glafenine results in increased expression of CAD mRNA
CTD
PMID:24136188
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
G
Calm1
calmodulin 1
increases expression
EXP
Glafenine results in increased expression of CALM1 mRNA
CTD
PMID:24136188
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
G
Calr
calreticulin
increases expression
EXP
Glafenine results in increased expression of CALR mRNA
CTD
PMID:24136188
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Calu
calumenin
increases expression
EXP
Glafenine results in increased expression of CALU mRNA
CTD
PMID:24136188
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Caprin1
cell cycle associated protein 1
decreases expression
EXP
Glafenine results in decreased expression of CAPRIN1 mRNA
CTD
PMID:24136188
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
G
Car14
carbonic anhydrase 14
decreases expression
EXP
Glafenine results in decreased expression of CAR14 mRNA
CTD
PMID:24136188
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
G
Car3
carbonic anhydrase 3
decreases expression
EXP
Glafenine results in decreased expression of CAR3 mRNA
CTD
PMID:24136188
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Car5a
carbonic anhydrase 5A
decreases expression
EXP
Glafenine results in decreased expression of CAR5A mRNA
CTD
PMID:24136188
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
G
Car8
carbonic anhydrase 8
increases expression
EXP
Glafenine results in increased expression of CAR8 mRNA
CTD
PMID:24136188
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
EXP
Glafenine results in increased expression of CARS1 mRNA
CTD
PMID:24136188
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Cars2
cysteinyl-tRNA synthetase 2, mitochondrial
decreases expression
EXP
Glafenine results in decreased expression of CARS2 mRNA
CTD
PMID:24136188
NCBI chr16:77,945,468...77,987,163
Ensembl chr16:77,950,008...77,987,772
G
Cat
catalase
decreases expression
EXP
Glafenine results in decreased expression of CAT mRNA
CTD
PMID:24136188
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav2
caveolin 2
increases expression
EXP
Glafenine results in increased expression of CAV2 mRNA
CTD
PMID:24136188
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
G
Cbr4
carbonyl reductase 4
decreases expression
EXP
Glafenine results in decreased expression of CBR4 mRNA
CTD
PMID:24136188
NCBI chr16:28,629,928...28,684,230
Ensembl chr16:28,617,224...28,645,712
G
Ccdc125
coiled-coil domain containing 125
increases expression
EXP
Glafenine results in increased expression of CCDC125 mRNA
CTD
PMID:24136188
NCBI chr 2:31,809,120...31,835,538
Ensembl chr 2:31,809,228...31,850,152
G
Ccdc134
coiled-coil domain containing 134
increases expression
EXP
Glafenine results in increased expression of CCDC134 mRNA
CTD
PMID:24136188
NCBI chr 7:113,644,557...113,659,050
Ensembl chr 7:113,644,639...113,659,050
G
Ccdc167
coiled-coil domain containing 167
increases expression
EXP
Glafenine results in increased expression of CCDC167 mRNA
CTD
PMID:24136188
NCBI chr20:7,763,927...7,782,090
Ensembl chr20:7,751,782...7,781,613
G
Ccdc28a
coiled-coil domain containing 28A
decreases expression
EXP
Glafenine results in decreased expression of CCDC28A mRNA
CTD
PMID:24136188
NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003
G
Ccdc86
coiled-coil domain containing 86
increases expression
EXP
Glafenine results in increased expression of CCDC86 mRNA
CTD
PMID:24136188
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
G
Ccng2
cyclin G2
decreases expression
EXP
Glafenine results in decreased expression of CCNG2 mRNA
CTD
PMID:24136188
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Ccni
cyclin I
decreases expression
EXP
Glafenine results in decreased expression of CCNI mRNA
CTD
PMID:24136188
NCBI chr14:14,879,698...14,902,510
Ensembl chr14:14,879,717...14,902,510
G
Cd2bp2
Cd2 (cytoplasmic tail) binding protein 2
increases expression
EXP
Glafenine results in increased expression of CD2BP2 mRNA
CTD
PMID:24136188
NCBI chr 1:181,809,399...181,815,269
Ensembl chr 1:181,809,406...181,813,448
G
Cd48
Cd48 molecule
increases expression
EXP
Glafenine results in increased expression of CD48 mRNA
CTD
PMID:24136188
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
G
Cd59b
CD59b molecule
decreases expression
EXP
Glafenine results in decreased expression of CD59 mRNA
CTD
PMID:24136188
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
G
Cdadc1
cytidine and dCMP deaminase domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of CDADC1 mRNA
CTD
PMID:24136188
NCBI chr15:33,726,590...33,755,611
Ensembl chr15:33,723,435...33,755,576
G
Cdc42se1
CDC42 small effector 1
increases expression
EXP
Glafenine results in increased expression of CDC42SE1 mRNA
CTD
PMID:24136188
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
G
Cdc5l
cell division cycle 5-like
decreases expression
EXP
Glafenine results in decreased expression of CDC5L mRNA
CTD
PMID:24136188
NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450
G
Cdh2
cadherin 2
decreases expression
EXP
Glafenine results in decreased expression of CDH2 mRNA
CTD
PMID:24136188
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cdip1
cell death-inducing p53 target 1
decreases expression
EXP
Glafenine results in decreased expression of CDIP1 mRNA
CTD
PMID:24136188
NCBI chr10:10,773,538...10,796,979
Ensembl chr10:10,774,705...10,796,980
G
Cdk2ap1
cyclin-dependent kinase 2 associated protein 1
increases expression
EXP
Glafenine results in increased expression of CDK2AP1 mRNA
CTD
PMID:24136188
NCBI chr12:32,249,752...32,258,483
Ensembl chr12:32,249,747...32,258,479
G
Cdk2ap2
cyclin-dependent kinase 2 associated protein 2
increases expression
EXP
Glafenine results in increased expression of CDK2AP2 mRNA
CTD
PMID:24136188
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
G
Cdk4
cyclin-dependent kinase 4
increases expression
EXP
Glafenine results in increased expression of CDK4 mRNA
CTD
PMID:24136188
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
EXP
Glafenine results in increased expression of CDKN1A mRNA
CTD
PMID:24136188
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
EXP
Glafenine results in decreased expression of CDKN1B mRNA
CTD
PMID:24136188
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP
Glafenine results in decreased expression of CDKN3 mRNA
CTD
PMID:24136188
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cdo1
cysteine dioxygenase type 1
decreases expression
EXP
Glafenine results in decreased expression of CDO1 mRNA
CTD
PMID:24136188
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
G
Ceacam1
CEA cell adhesion molecule 1
decreases expression
EXP
Glafenine results in decreased expression of CEACAM1 mRNA
CTD
PMID:24136188
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
G
Cebpd
CCAAT/enhancer binding protein delta
increases expression
EXP
Glafenine results in increased expression of CEBPD mRNA
CTD
PMID:24136188
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
G
Cemip2
cell migration inducing hyaluronidase 2
increases expression
EXP
Glafenine results in increased expression of CEMIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760
G
Cept1
choline/ethanolamine phosphotransferase 1
decreases expression
EXP
Glafenine results in decreased expression of CEPT1 mRNA
CTD
PMID:24136188
NCBI chr 2:193,994,220...194,036,141
Ensembl chr 2:193,993,447...194,035,578
G
Ces1d
carboxylesterase 1D
decreases expression
EXP
Glafenine results in decreased expression of CES1D mRNA
CTD
PMID:24136188
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Chac2
ChaC glutathione specific gamma-glutamylcyclotransferase 2
decreases expression
EXP
Glafenine results in decreased expression of CHAC2 mRNA
CTD
PMID:24136188
NCBI chr14:104,720,754...104,728,305
Ensembl chr14:104,720,758...104,728,301
G
Chchd6
coiled-coil-helix-coiled-coil-helix domain containing 6
increases expression
EXP
Glafenine results in increased expression of CHCHD6 mRNA
CTD
PMID:24136188
NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216
G
Chid1
chitinase domain containing 1
increases expression
EXP
Glafenine results in increased expression of CHID1 mRNA
CTD
PMID:24136188
NCBI chr 1:196,594,357...196,629,700
Ensembl chr 1:196,587,509...196,629,606
G
Chmp4c
charged multivesicular body protein 4C
decreases expression
EXP
Glafenine results in decreased expression of CHMP4C mRNA
CTD
PMID:24136188
NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668
G
Chpf2
chondroitin polymerizing factor 2
increases expression
EXP
Glafenine results in increased expression of CHPF2 mRNA
CTD
PMID:24136188
NCBI chr 4:10,578,470...10,585,940
Ensembl chr 4:10,580,462...10,585,916
G
Cic
capicua transcriptional repressor
increases expression
EXP
Glafenine results in increased expression of CIC mRNA
CTD
PMID:24136188
NCBI chr 1:80,853,920...80,880,537
Ensembl chr 1:80,853,920...80,880,532
G
Cinp
cyclin-dependent kinase 2-interacting protein
increases expression
EXP
Glafenine results in increased expression of CINP mRNA
CTD
PMID:24136188
NCBI chr 6:129,878,618...129,899,575
Ensembl chr 6:129,885,570...129,899,480
G
Cisd2
CDGSH iron sulfur domain 2
increases expression
EXP
Glafenine results in increased expression of CISD2 mRNA
CTD
PMID:24136188
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
G
Cks1b
CDC28 protein kinase regulatory subunit 1B
increases expression
EXP
Glafenine results in increased expression of CKS1B mRNA
CTD
PMID:24136188
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
G
Clcn4
chloride voltage-gated channel 4
decreases expression
EXP
Glafenine results in decreased expression of CLCN4 mRNA
CTD
PMID:24136188
NCBI chr X:23,729,194...23,795,391
Ensembl chr X:23,729,338...23,793,238
G
Clic1
chloride intracellular channel 1
increases expression
EXP
Glafenine results in increased expression of CLIC1 mRNA
CTD
PMID:24136188
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
G
Clpx
caseinolytic mitochondrial matrix peptidase chaperone subunit X
decreases expression
EXP
Glafenine results in decreased expression of CLPX mRNA
CTD
PMID:24136188
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
G
Cmbl
carboxymethylenebutenolidase homolog
decreases expression
EXP
Glafenine results in decreased expression of CMBL mRNA
CTD
PMID:24136188
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cmtr1
cap methyltransferase 1
decreases expression
EXP
Glafenine results in decreased expression of CMTR1 mRNA
CTD
PMID:24136188
NCBI chr20:7,722,729...7,782,579
Ensembl chr20:7,709,713...7,766,302
G
Cnn2
calponin 2
increases expression
EXP
Glafenine results in increased expression of CNN2 mRNA
CTD
PMID:24136188
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
G
Cnppd1
cyclin Pas1/PHO80 domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of CNPPD1 mRNA
CTD
PMID:24136188
NCBI chr 9:76,633,475...76,640,164
Ensembl chr 9:76,633,477...76,640,188
G
Cnpy2
canopy FGF signaling regulator 2
increases expression
EXP
Glafenine results in increased expression of CNPY2 mRNA
CTD
PMID:24136188
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
G
Cnpy3
canopy FGF signaling regulator 3
increases expression
EXP
Glafenine results in increased expression of CNPY3 mRNA
CTD
PMID:24136188
NCBI chr 9:14,233,478...14,247,847
Ensembl chr 9:14,233,428...14,247,831
G
Coasy
Coenzyme A synthase
decreases expression
EXP
Glafenine results in decreased expression of COASY mRNA
CTD
PMID:24136188
NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841
G
Cog3
component of oligomeric golgi complex 3
increases expression
EXP
Glafenine results in increased expression of COG3 mRNA
CTD
PMID:24136188
NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570
G
Cog4
component of oligomeric golgi complex 4
decreases expression
EXP
Glafenine results in decreased expression of COG4 mRNA
CTD
PMID:24136188
NCBI chr19:38,820,478...38,854,803
Ensembl chr19:38,820,501...38,854,796
G
Col18a1
collagen type XVIII alpha 1 chain
increases expression
EXP
Glafenine results in increased expression of COL18A1 mRNA
CTD
PMID:24136188
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col4a1
collagen type IV alpha 1 chain
increases expression
EXP
Glafenine results in increased expression of COL4A1 mRNA
CTD
PMID:24136188
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
G
Copa
COPI coat complex subunit alpha
increases expression
EXP
Glafenine results in increased expression of COPA mRNA
CTD
PMID:24136188
NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874
G
Cope
COPI coat complex subunit epsilon
increases expression
EXP
Glafenine results in increased expression of COPE mRNA
CTD
PMID:24136188
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
G
Copg1
COPI coat complex subunit gamma 1
increases expression
EXP
Glafenine results in increased expression of COPG1 mRNA
CTD
PMID:24136188
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
G
Copg2
COPI coat complex subunit gamma 2
decreases expression
EXP
Glafenine results in decreased expression of COPG2 mRNA
CTD
PMID:24136188
NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618
G
Copz1
COPI coat complex subunit zeta 1
increases expression
EXP
Glafenine results in increased expression of COPZ1 mRNA
CTD
PMID:24136188
NCBI chr 7:134,409,523...134,435,661
Ensembl chr 7:134,409,799...134,435,662
G
Copz2
COPI coat complex subunit zeta 2
increases expression
EXP
Glafenine results in increased expression of COPZ2 mRNA
CTD
PMID:24136188
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
G
Coq10a
coenzyme Q10A
decreases expression
EXP
Glafenine results in decreased expression of COQ10A mRNA
CTD
PMID:24136188
NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161
G
Coq10b
coenzyme Q10B
increases expression
EXP
Glafenine results in increased expression of COQ10B mRNA
CTD
PMID:24136188
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
G
Coq8a
coenzyme Q8A
decreases expression
EXP
Glafenine results in decreased expression of COQ8A mRNA
CTD
PMID:24136188
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
G
Cotl1
coactosin-like F-actin binding protein 1
increases expression
EXP
Glafenine results in increased expression of COTL1 mRNA
CTD
PMID:24136188
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
G
Cox5a
cytochrome c oxidase subunit 5A
decreases expression
EXP
Glafenine results in decreased expression of COX5A mRNA
CTD
PMID:24136188
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
G
Cox5b
cytochrome c oxidase subunit 5B
increases expression
EXP
Glafenine results in increased expression of COX5B mRNA
CTD
PMID:24136188
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
G
Cp
ceruloplasmin
increases expression
EXP
Glafenine results in increased expression of CP mRNA
CTD
PMID:24136188
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpne3
copine 3
decreases expression
EXP
Glafenine results in decreased expression of CPNE3 mRNA
CTD
PMID:24136188
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
G
Cpne8
copine 8
increases expression
EXP
Glafenine results in increased expression of CPNE8 mRNA
CTD
PMID:24136188
NCBI chr 7:121,615,293...121,789,507
Ensembl chr 7:121,615,294...121,790,377
G
Cpped1
calcineurin-like phosphoesterase domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of CPPED1 mRNA
CTD
PMID:24136188
NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054
G
Cpq
carboxypeptidase Q
decreases expression
EXP
Glafenine results in decreased expression of PGCP mRNA
CTD
PMID:24136188
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
G
Cps1
carbamoyl-phosphate synthase 1
decreases expression
EXP
Glafenine results in decreased expression of CPS1 mRNA
CTD
PMID:24136188
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Cpt2
carnitine palmitoyltransferase 2
decreases expression
EXP
Glafenine results in decreased expression of CPT2 mRNA
CTD
PMID:24136188
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Crat
carnitine O-acetyltransferase
decreases expression
EXP
Glafenine results in decreased expression of CRAT mRNA
CTD
PMID:24136188
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
G
Crbn
cereblon
decreases expression
EXP
Glafenine results in decreased expression of CRBN mRNA
CTD
PMID:24136188
NCBI chr 4:139,701,154...139,719,949
Ensembl chr 4:139,701,094...139,719,938
G
Creb3l3
cAMP responsive element binding protein 3-like 3
decreases expression
EXP
Glafenine results in decreased expression of CREB3L3 mRNA
CTD
PMID:24136188
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Crebzf
CREB/ATF bZIP transcription factor
decreases expression
EXP
Glafenine results in decreased expression of CREBZF mRNA
CTD
PMID:24136188
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
G
Creld2
cysteine-rich with EGF-like domains 2
increases expression
EXP
Glafenine results in increased expression of CRELD2 mRNA
CTD
PMID:24136188
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
G
Crem
cAMP responsive element modulator
decreases expression
EXP
Glafenine results in decreased expression of CREM mRNA
CTD
PMID:24136188
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Crls1
cardiolipin synthase 1
decreases expression
EXP
Glafenine results in decreased expression of CRLS1 mRNA
CTD
PMID:24136188
NCBI chr 3:120,119,822...120,138,674
Ensembl chr 3:120,119,852...120,138,655
G
Crot
carnitine O-octanoyltransferase
decreases expression
EXP
Glafenine results in decreased expression of CROT mRNA
CTD
PMID:24136188
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
G
Crybg2
crystallin beta-gamma domain containing 2
decreases expression
EXP
Glafenine results in decreased expression of CRYBG2 mRNA
CTD
PMID:24136188
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
G
Cryl1
crystallin, lambda 1
decreases expression
EXP
Glafenine results in decreased expression of CRYL1 mRNA
CTD
PMID:24136188
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
G
Crym
crystallin, mu
decreases expression
EXP
Glafenine results in decreased expression of CRYM mRNA
CTD
PMID:24136188
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
G
Cryz
crystallin zeta
decreases expression
EXP
Glafenine results in decreased expression of CRYZ mRNA
CTD
PMID:24136188
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
G
Csf1
colony stimulating factor 1
increases expression
EXP
Glafenine results in increased expression of CSF1 mRNA
CTD
PMID:24136188
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Ctbs
chitobiase
decreases expression
EXP
Glafenine results in decreased expression of CTBS mRNA
CTD
PMID:24136188
NCBI chr 2:235,340,520...235,355,091
Ensembl chr 2:235,340,547...235,355,091
G
Cth
cystathionine gamma-lyase
decreases expression
EXP
Glafenine results in decreased expression of CTH mRNA
CTD
PMID:24136188
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctnna1
catenin alpha 1
decreases expression
EXP
Glafenine results in decreased expression of CTNNA1 mRNA
CTD
PMID:24136188
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
G
Ctps1
CTP synthase 1
increases expression
EXP
Glafenine results in increased expression of CTPS1 mRNA
CTD
PMID:24136188
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
G
Ctsa
cathepsin A
decreases expression
EXP
Glafenine results in decreased expression of CTSA mRNA
CTD
PMID:24136188
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
G
Ctsf
cathepsin F
decreases expression
EXP
Glafenine results in decreased expression of CTSF mRNA
CTD
PMID:24136188
NCBI chr 1:202,152,777...202,158,525
Ensembl chr 1:202,152,728...202,158,525
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
EXP
Glafenine results in increased expression of CXCL1 mRNA
CTD
PMID:24136188
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
EXP
Glafenine results in decreased expression of CXCL12 mRNA
CTD
PMID:24136188
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl9
C-X-C motif chemokine ligand 9
decreases expression
EXP
Glafenine results in decreased expression of CXCL9 mRNA
CTD
PMID:24136188
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyb5r3
cytochrome b5 reductase 3
decreases expression
EXP
Glafenine results in decreased expression of CYB5R3 mRNA
CTD
PMID:24136188
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP17A1 mRNA
CTD
PMID:24136188
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
ISO
Glafenine results in decreased activity of CYP1A1 protein
CTD
PMID:33814510
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Glafenine results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP27A1 mRNA
CTD
PMID:24136188
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP2A1 mRNA
CTD
PMID:24136188
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
G
Cyp2a2
cytochrome P450, family 2, subfamily a, polypeptide 2
decreases expression
EXP
Glafenine results in decreased expression of CYP2A2 mRNA
CTD
PMID:24136188
NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP2B1 mRNA
CTD
PMID:24136188
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases expression
EXP
Glafenine results in decreased expression of CYP2C11 mRNA
CTD
PMID:24136188
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2d1
cytochrome P450, family 2, subfamily d, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP2D1 mRNA
CTD
PMID:24136188
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
G
Cyp2d2
cytochrome P450, family 2, subfamily d, polypeptide 2
decreases expression
EXP
Glafenine results in decreased expression of CYP2D2 mRNA
CTD
PMID:24136188
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
G
Cyp2d3
cytochrome P450, family 2, subfamily d, polypeptide 3
decreases expression
EXP
Glafenine results in decreased expression of CYP2D3 mRNA
CTD
PMID:24136188
NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases expression
EXP
Glafenine results in decreased expression of CYP2D4 mRNA
CTD
PMID:24136188
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP2E1 mRNA
CTD
PMID:24136188
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2j3
cytochrome P450, family 2, subfamily j, polypeptide 3
decreases expression
EXP
Glafenine results in decreased expression of CYP2J3 mRNA
CTD
PMID:24136188
NCBI chr 5:111,219,921...111,244,987
Ensembl chr 5:111,178,703...111,244,794
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
decreases expression
EXP
Glafenine results in decreased expression of CYP2J4 mRNA
CTD
PMID:24136188
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
G
Cyp2t1
cytochrome P450, family 2, subfamily t, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP2T1 mRNA
CTD
PMID:24136188
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
G
Cyp39a1
cytochrome P450, family 39, subfamily a, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP39A1 mRNA
CTD
PMID:24136188
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
decreases expression
EXP
Glafenine results in decreased expression of CYP3A18 mRNA
CTD
PMID:24136188
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases expression
EXP
Glafenine results in decreased expression of CYP3A2 mRNA
CTD
PMID:24136188
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP3A23-3A1 mRNA
CTD
PMID:24136188
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP4A1 mRNA
CTD
PMID:24136188
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Cyp4f1
cytochrome P450, family 4, subfamily f, polypeptide 1
decreases expression
EXP
Glafenine results in decreased expression of CYP4F1 mRNA
CTD
PMID:24136188
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
G
Cyp4f4
cytochrome P450, family 4, subfamily f, polypeptide 4
decreases expression
EXP
Glafenine results in decreased expression of CYP4F4 mRNA
CTD
PMID:24136188
NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506
G
Dad1
defender against cell death 1
increases expression
EXP
Glafenine results in increased expression of DAD1 mRNA
CTD
PMID:24136188
NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347
G
Dao
D-amino-acid oxidase
decreases expression
EXP
Glafenine results in decreased expression of DAO mRNA
CTD
PMID:24136188
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
G
Dap
death-associated protein
increases expression
EXP
Glafenine results in increased expression of DAP mRNA
CTD
PMID:24136188
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
G
Dcaf11
DDB1 and CUL4 associated factor 11
decreases expression
EXP
Glafenine results in decreased expression of DCAF11 mRNA
CTD
PMID:24136188
NCBI chr15:29,046,744...29,057,450
Ensembl chr15:29,046,826...29,057,669
G
Dcaf6
DDB1 and CUL4 associated factor 6
decreases expression
EXP
Glafenine results in decreased expression of DCAF6 mRNA
CTD
PMID:24136188
NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512
G
Dcun1d4
defective in cullin neddylation 1 domain containing 4
decreases expression
EXP
Glafenine results in decreased expression of DCUN1D4 mRNA
CTD
PMID:24136188
NCBI chr14:34,652,723...34,733,122
Ensembl chr14:34,652,723...34,733,207
G
Dda1
DET1 and DDB1 associated 1
increases expression
EXP
Glafenine results in increased expression of DDA1 mRNA
CTD
PMID:24136188
NCBI chr16:18,156,310...18,163,938
Ensembl chr16:18,156,386...18,163,937
G
Ddc
dopa decarboxylase
decreases expression
EXP
Glafenine results in decreased expression of DDC mRNA
CTD
PMID:24136188
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Glafenine results in increased expression of DDIT3 mRNA
CTD
PMID:24136188
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddost
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
increases expression
EXP
Glafenine results in increased expression of DDOST mRNA
CTD
PMID:24136188
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
G
Ddx39a
DExD-box helicase 39A
increases expression
EXP
Glafenine results in increased expression of DDX39A mRNA
CTD
PMID:24136188
NCBI chr19:24,418,743...24,427,422
Ensembl chr19:24,418,114...24,426,954
G
Ddx39b
DExD-box helicase 39B
increases expression
EXP
Glafenine results in increased expression of DDX39B mRNA
CTD
PMID:24136188
NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996
G
Ddx49
DEAD-box helicase 49
increases expression
EXP
Glafenine results in increased expression of DDX49 mRNA
CTD
PMID:24136188
NCBI chr16:19,125,388...19,133,042
Ensembl chr16:19,125,384...19,133,616
G
Decr2
2,4-dienoyl-CoA reductase 2
decreases expression
EXP
Glafenine results in decreased expression of DECR2 mRNA
CTD
PMID:24136188
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
G
Dek
DEK proto-oncogene
decreases expression
EXP
Glafenine results in decreased expression of DEK mRNA
CTD
PMID:24136188
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
G
Dennd6a
DENN domain containing 6A
decreases expression
EXP
Glafenine results in decreased expression of DENND6A mRNA
CTD
PMID:24136188
NCBI chr16:1,837,019...1,885,420
Ensembl chr16:1,837,059...1,885,420
G
Depdc7
DEP domain containing 7
decreases expression
EXP
Glafenine results in decreased expression of DEPDC7 mRNA
CTD
PMID:24136188
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
G
Dera
deoxyribose-phosphate aldolase
decreases expression
EXP
Glafenine results in decreased expression of DERA mRNA
CTD
PMID:24136188
NCBI chr 4:170,663,689...170,742,469
Ensembl chr 4:170,663,665...170,758,865
G
Derl1
derlin 1
increases expression
EXP
Glafenine results in increased expression of DERL1 mRNA
CTD
PMID:24136188
NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145
G
Desi2
desumoylating isopeptidase 2
increases expression
EXP
Glafenine results in increased expression of DESI2 mRNA
CTD
PMID:24136188
NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416
G
Dhcr24
24-dehydrocholesterol reductase
increases expression
EXP
Glafenine results in increased expression of DHCR24 mRNA
CTD
PMID:24136188
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dhodh
dihydroorotate dehydrogenase (quinone)
increases expression
EXP
Glafenine results in increased expression of DHODH mRNA
CTD
PMID:24136188
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
G
Dhrs3
dehydrogenase/reductase 3
decreases expression
EXP
Glafenine results in decreased expression of DHRS3 mRNA
CTD
PMID:24136188
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Dhrs7b
dehydrogenase/reductase 7B
increases expression
EXP
Glafenine results in increased expression of DHRS7B mRNA
CTD
PMID:24136188
NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076
G
Dhtkd1
dehydrogenase E1 and transketolase domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of DHTKD1 mRNA
CTD
PMID:24136188
NCBI chr17:72,355,201...72,406,725
Ensembl chr17:72,355,201...72,406,723
G
Dmbt1
deleted in malignant brain tumors 1
increases expression
EXP
Glafenine results in increased expression of DMBT1 mRNA
CTD
PMID:24136188
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
G
Dmgdh
dimethylglycine dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of DMGDH mRNA
CTD
PMID:24136188
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
G
Dnaaf9
dynein axonemal assembly factor 9
decreases expression
EXP
Glafenine results in decreased expression of DNAAF9 mRNA
CTD
PMID:24136188
NCBI chr 3:117,918,047...118,052,641
Ensembl chr 3:117,921,620...118,052,630
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
increases expression
EXP
Glafenine results in increased expression of DNAJB11 mRNA
CTD
PMID:24136188
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
EXP
Glafenine results in increased expression of DNAJB9 mRNA
CTD
PMID:24136188
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
G
Dnajc15
DnaJ heat shock protein family (Hsp40) member C15
increases expression
EXP
Glafenine results in increased expression of DNAJC15 mRNA
CTD
PMID:24136188
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
increases expression
EXP
Glafenine results in increased expression of DNAJC3 mRNA
CTD
PMID:24136188
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
G
Dnlz
DNL-type zinc finger
increases expression
EXP
Glafenine results in increased expression of DNLZ mRNA
CTD
PMID:24136188
NCBI chr 3:9,169,948...9,171,727
Ensembl chr 3:9,169,793...9,180,551
G
Dock9
dedicator of cytokinesis 9
decreases expression
EXP
Glafenine results in decreased expression of DOCK9 mRNA
CTD
PMID:24136188
NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153
G
Dpagt1
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1
increases expression
EXP
Glafenine results in increased expression of DPAGT1 mRNA
CTD
PMID:24136188
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
G
Dph1
diphthamide biosynthesis 1
increases expression
EXP
Glafenine results in increased expression of DPH1 mRNA
CTD
PMID:24136188
NCBI chr10:60,028,081...60,039,764
Ensembl chr10:60,026,048...60,039,850
G
Dph3
diphthamide biosynthesis 3
increases expression
EXP
Glafenine results in increased expression of DPH3 mRNA
CTD
PMID:24136188
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
G
Dph5
diphthamide biosynthesis 5
increases expression
EXP
Glafenine results in increased expression of DPH5 mRNA
CTD
PMID:24136188
NCBI chr 2:203,804,620...203,858,196
Ensembl chr 2:203,804,936...203,840,433
G
Dpm3
dolichyl-phosphate mannosyltransferase subunit 3, regulatory
increases expression
EXP
Glafenine results in increased expression of DPM3 mRNA
CTD
PMID:24136188
NCBI chr 2:174,676,532...174,677,047
Ensembl chr 2:174,676,363...174,677,668 Ensembl chr15:174,676,363...174,677,668
G
Dpp4
dipeptidylpeptidase 4
decreases expression
EXP
Glafenine results in decreased expression of DPP4 mRNA
CTD
PMID:24136188
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Dpyd
dihydropyrimidine dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of DPYD mRNA
CTD
PMID:24136188
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dpys
dihydropyrimidinase
decreases expression
EXP
Glafenine results in decreased expression of DPYS mRNA
CTD
PMID:24136188
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
G
Dram2
DNA damage regulated autophagy modulator 2
decreases expression
EXP
Glafenine results in decreased expression of DRAM2 mRNA
CTD
PMID:24136188
NCBI chr 2:194,035,624...194,064,415
Ensembl chr 2:194,035,818...194,063,403
G
Drap1
Dr1 associated protein 1
increases expression
EXP
Glafenine results in increased expression of DRAP1 mRNA
CTD
PMID:24136188
NCBI chr 1:202,731,775...202,734,468
Ensembl chr 1:202,731,788...202,734,425
G
Dsc2
desmocollin 2
increases expression
EXP
Glafenine results in increased expression of DSC2 mRNA
CTD
PMID:24136188
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
G
Dsp
desmoplakin
decreases expression
EXP
Glafenine results in decreased expression of DSP mRNA
CTD
PMID:24136188
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
G
Dusp11
dual specificity phosphatase 11
increases expression
EXP
Glafenine results in increased expression of DUSP11 mRNA
CTD
PMID:24136188
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
G
Dynll1
dynein light chain LC8-type 1
increases expression
EXP
Glafenine results in increased expression of DYNLL1 mRNA
CTD
PMID:24136188
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Dynlt1
dynein light chain Tctex-type 1
increases expression
EXP
Glafenine results in increased expression of DYNLT1 mRNA
CTD
PMID:24136188
NCBI chr 1:46,887,017...46,893,956
Ensembl chr 1:46,887,017...46,893,881
G
Dynlt3
dynein light chain Tctex-type 3
decreases expression
EXP
Glafenine results in decreased expression of DYNLT3 mRNA
CTD
PMID:24136188
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
G
Dyrk2
dual specificity tyrosine phosphorylation regulated kinase 2
decreases expression
EXP
Glafenine results in decreased expression of DYRK2 mRNA
CTD
PMID:24136188
NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106
G
Ebna1bp2
EBNA1 binding protein 2
increases expression
EXP
Glafenine results in increased expression of EBNA1BP2 mRNA
CTD
PMID:24136188
NCBI chr 5:132,148,164...132,152,730
Ensembl chr 5:132,148,143...132,153,267
G
Echdc3
enoyl CoA hydratase domain containing 3
decreases expression
EXP
Glafenine results in decreased expression of ECHDC3 mRNA
CTD
PMID:24136188
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
G
Eci2
enoyl-CoA delta isomerase 2
decreases expression
EXP
Glafenine results in decreased expression of ECI2 mRNA
CTD
PMID:24136188
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
EXP
Glafenine results in increased expression of EDEM1 mRNA
CTD
PMID:24136188
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
G
Edem2
ER degradation enhancing alpha-mannosidase like protein 2
increases expression
EXP
Glafenine results in increased expression of EDEM2 mRNA
CTD
PMID:24136188
NCBI chr 3:144,201,604...144,227,423
Ensembl chr 3:144,201,605...144,227,485
G
Eef1b2
eukaryotic translation elongation factor 1 beta 2
increases expression
EXP
Glafenine results in increased expression of EEF1B2 mRNA
CTD
PMID:24136188
NCBI chr 9:64,580,163...64,582,737
Ensembl chr 9:64,579,893...64,582,737
G
Eef1g
eukaryotic translation elongation factor 1 gamma
increases expression
EXP
Glafenine results in increased expression of EEF1G mRNA
CTD
PMID:24136188
NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
G
Eepd1
endonuclease/exonuclease/phosphatase family domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of EEPD1 mRNA
CTD
PMID:24136188
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
G
Efr3a
EFR3 homolog A
decreases expression
EXP
Glafenine results in decreased expression of EFR3A mRNA
CTD
PMID:24136188
NCBI chr 7:97,552,677...97,633,369
Ensembl chr 7:97,552,677...97,633,369
G
Egf
epidermal growth factor
decreases expression
EXP
Glafenine results in decreased expression of EGF mRNA
CTD
PMID:24136188
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfl7
EGF-like-domain, multiple 7
increases expression
EXP
Glafenine results in increased expression of EGFL7 mRNA
CTD
PMID:24136188
NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879
G
Egfr
epidermal growth factor receptor
decreases expression
EXP
Glafenine results in decreased expression of EGFR mRNA
CTD
PMID:24136188
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of EHHADH mRNA
CTD
PMID:24136188
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Ei24
EI24, autophagy associated transmembrane protein
decreases expression
EXP
Glafenine results in decreased expression of EI24 mRNA
CTD
PMID:24136188
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
G
Eif1ad
eukaryotic translation initiation factor 1A domain containing
increases expression
EXP
Glafenine results in increased expression of EIF1AD mRNA
CTD
PMID:24136188
NCBI chr 1:202,674,362...202,679,662
Ensembl chr 1:202,674,185...202,679,658
G
Eif2ak1
eukaryotic translation initiation factor 2 alpha kinase 1
decreases expression
EXP
Glafenine results in decreased expression of EIF2AK1 mRNA
CTD
PMID:24136188
NCBI chr12:10,710,771...10,744,597
Ensembl chr12:10,705,874...10,744,573
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases expression
EXP
Glafenine results in increased expression of EIF2S1 mRNA
CTD
PMID:24136188
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Eif2s3
eukaryotic translation initiation factor 2 subunit gamma
decreases expression
EXP
Glafenine results in decreased expression of EIF2S3X mRNA
CTD
PMID:24136188
NCBI chr X:58,916,513...58,939,923
Ensembl chr X:58,917,490...58,940,686
G
Eif3b
eukaryotic translation initiation factor 3, subunit B
increases expression
EXP
Glafenine results in increased expression of EIF3B mRNA
CTD
PMID:24136188
NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886
G
Eif3i
eukaryotic translation initiation factor 3, subunit I
increases expression
EXP
Glafenine results in increased expression of EIF3I mRNA
CTD
PMID:24136188
NCBI chr 5:141,935,135...141,942,589
Ensembl chr 5:141,935,044...141,942,676
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
EXP
Glafenine results in increased expression of EIF4A1 mRNA
CTD
PMID:24136188
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
G
Eif4a2
eukaryotic translation initiation factor 4A2
decreases expression
EXP
Glafenine results in decreased expression of EIF4A2 mRNA
CTD
PMID:24136188
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
G
Eif4b
eukaryotic translation initiation factor 4B
decreases expression
EXP
Glafenine results in decreased expression of EIF4B mRNA
CTD
PMID:24136188
NCBI chr 7:133,206,637...133,228,436
G
Eif4g1
eukaryotic translation initiation factor 4 gamma 1
increases expression
EXP
Glafenine results in increased expression of EIF4G1 mRNA
CTD
PMID:24136188
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
G
Eif5a
eukaryotic translation initiation factor 5A
increases expression
EXP
Glafenine results in increased expression of EIF5A mRNA
CTD
PMID:24136188
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
G
Eif6
eukaryotic translation initiation factor 6
increases expression
EXP
Glafenine results in increased expression of EIF6 mRNA
CTD
PMID:24136188
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Eipr1
EARP complex and GARP complex interacting protein 1
increases expression
EXP
Glafenine results in increased expression of EIPR1 mRNA
CTD
PMID:24136188
NCBI chr 6:45,388,451...45,502,089
Ensembl chr 6:45,388,376...45,502,083
G
Ell3
elongation factor for RNA polymerase II 3
increases expression
EXP
Glafenine results in increased expression of ELL3 mRNA
CTD
PMID:24136188
NCBI chr 3:108,413,035...108,417,181
Ensembl chr 3:108,410,448...108,417,132
G
Elob
elongin B
increases expression
EXP
Glafenine results in increased expression of ELOB mRNA
CTD
PMID:24136188
NCBI chr10:12,848,830...12,853,897
Ensembl chr10:12,848,827...12,853,635
G
Elof1
elongation factor 1
increases expression
EXP
Glafenine results in increased expression of ELOF1 mRNA
CTD
PMID:24136188
NCBI chr 8:20,645,336...20,650,888
Ensembl chr 8:20,645,336...20,650,579
G
Elovl6
ELOVL fatty acid elongase 6
increases expression
EXP
Glafenine results in increased expression of ELOVL6 mRNA
CTD
PMID:24136188
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Emc6
ER membrane protein complex subunit 6
increases expression
EXP
Glafenine results in increased expression of EMC6 mRNA
CTD
PMID:24136188
NCBI chr10:57,794,072...57,795,671
Ensembl chr10:57,793,685...57,796,217
G
Emilin1
elastin microfibril interfacer 1
increases expression
EXP
Glafenine results in increased expression of EMILIN1 mRNA
CTD
PMID:24136188
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
G
Enc1
ectodermal-neural cortex 1
increases expression
EXP
Glafenine results in increased expression of ENC1 mRNA
CTD
PMID:24136188
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Eng
endoglin
increases expression
EXP
Glafenine results in increased expression of ENG mRNA
CTD
PMID:24136188
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Enpep
glutamyl aminopeptidase
decreases expression
EXP
Glafenine results in decreased expression of ENPEP mRNA
CTD
PMID:24136188
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
decreases expression
EXP
Glafenine results in decreased expression of ENPP2 mRNA
CTD
PMID:24136188
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Enpp3
ectonucleotide pyrophosphatase/phosphodiesterase 3
decreases expression
EXP
Glafenine results in decreased expression of ENPP3 mRNA
CTD
PMID:24136188
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
G
Eola2
endothelium and lymphocyte associated ASCH domain 2
increases expression
EXP
Glafenine results in increased expression of EOLA2 mRNA
CTD
PMID:24136188
NCBI chr X:149,064,015...149,068,627
Ensembl chr X:149,064,041...149,068,627
G
Ephx1
epoxide hydrolase 1
decreases expression
EXP
Glafenine results in decreased expression of EPHX1 mRNA
CTD
PMID:24136188
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
increases expression
EXP
Glafenine results in increased expression of EPRS1 mRNA
CTD
PMID:24136188
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Eps8l2
EPS8-like 2
decreases expression
EXP
Glafenine results in decreased expression of EPS8L2 mRNA
CTD
PMID:24136188
NCBI chr 1:196,446,260...196,471,544
Ensembl chr 1:196,446,287...196,471,541
G
Erg28
ergosterol biosynthesis 28 homolog
increases expression
EXP
Glafenine results in increased expression of ERG28 mRNA
CTD
PMID:24136188
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
G
Erh
ERH, mRNA splicing and mitosis factor
increases expression
EXP
Glafenine results in increased expression of ERH mRNA
CTD
PMID:24136188
NCBI chr 6:100,280,933...100,291,200
Ensembl chr 6:100,280,930...100,291,210
G
Erp29
endoplasmic reticulum protein 29
increases expression
EXP
Glafenine results in increased expression of ERP29 mRNA
CTD
PMID:24136188
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
G
Erp44
endoplasmic reticulum protein 44
increases expression
EXP
Glafenine results in increased expression of ERP44 mRNA
CTD
PMID:24136188
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
G
Esam
endothelial cell adhesion molecule
increases expression
EXP
Glafenine results in increased expression of ESAM mRNA
CTD
PMID:24136188
NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215
G
Etfdh
electron transfer flavoprotein dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of ETFDH mRNA
CTD
PMID:24136188
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
G
Ethe1
ETHE1, persulfide dioxygenase
decreases expression
EXP
Glafenine results in decreased expression of ETHE1 mRNA
CTD
PMID:24136188
NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052
G
Faah
fatty acid amide hydrolase
decreases expression
EXP
Glafenine results in decreased expression of FAAH mRNA
CTD
PMID:24136188
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
G
Fabp4
fatty acid binding protein 4
increases expression
EXP
Glafenine results in increased expression of FABP4 mRNA
CTD
PMID:24136188
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fabp5
fatty acid binding protein 5
increases expression
EXP
Glafenine results in increased expression of FABP5 mRNA
CTD
PMID:24136188
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
G
Fads1
fatty acid desaturase 1
decreases expression
EXP
Glafenine results in decreased expression of FADS1 mRNA
CTD
PMID:24136188
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
G
Fads2
fatty acid desaturase 2
decreases expression
EXP
Glafenine results in decreased expression of FADS2 mRNA
CTD
PMID:24136188
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Fam114a1
family with sequence similarity 114, member A1
increases expression
EXP
Glafenine results in increased expression of FAM114A1 mRNA
CTD
PMID:24136188
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
G
Fam117b
family with sequence similarity 117, member B
decreases expression
EXP
Glafenine results in decreased expression of FAM117B mRNA
CTD
PMID:24136188
NCBI chr 9:61,340,284...61,418,531
Ensembl chr 9:61,340,249...61,408,483
G
Fam167b
family with sequence similarity 167, member B
increases expression
EXP
Glafenine results in increased expression of FAM167B mRNA
CTD
PMID:24136188
NCBI chr 5:141,920,695...141,922,342
Ensembl chr 5:141,920,695...141,922,340
G
Fam210a
family with sequence similarity 210, member A
decreases expression
EXP
Glafenine results in decreased expression of FAM210A mRNA
CTD
PMID:24136188
NCBI chr18:61,846,447...61,886,123
Ensembl chr18:61,852,907...61,886,171
G
Fam210b
family with sequence similarity 210, member B
decreases expression
EXP
Glafenine results in decreased expression of FAM210B mRNA
CTD
PMID:24136188
NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397
G
Fam241b
family with sequence similarity 241 member B
decreases expression
EXP
Glafenine results in decreased expression of FAM241B mRNA
CTD
PMID:24136188
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
G
Fam3c
FAM3 metabolism regulating signaling molecule C
increases expression
EXP
Glafenine results in increased expression of FAM3C mRNA
CTD
PMID:24136188
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
G
Farsb
phenylalanyl-tRNA synthetase subunit beta
increases expression
EXP
Glafenine results in increased expression of FARSB mRNA
CTD
PMID:24136188
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
G
Fasn
fatty acid synthase
increases expression
EXP
Glafenine results in increased expression of FASN mRNA
CTD
PMID:24136188
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fastk
Fas-activated serine/threonine kinase
increases expression
EXP
Glafenine results in increased expression of FASTK mRNA
CTD
PMID:24136188
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
G
Fbl
fibrillarin
increases expression
EXP
Glafenine results in increased expression of FBL mRNA
CTD
PMID:24136188
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
G
Fbxo3
F-box protein 3
decreases expression
EXP
Glafenine results in decreased expression of FBXO3 mRNA
CTD
PMID:24136188
NCBI chr 3:90,417,262...90,449,557
Ensembl chr 3:90,417,297...90,449,557
G
Fbxo7
F-box protein 7
decreases expression
EXP
Glafenine results in decreased expression of FBXO7 mRNA
CTD
PMID:24136188
NCBI chr 7:17,809,224...17,837,549
Ensembl chr 7:17,809,231...17,837,530
G
Fcf1
Fcf1 rRNA-processing protein
increases expression
EXP
Glafenine results in increased expression of NOMO1 mRNA
CTD
PMID:24136188
NCBI chr 6:104,617,780...104,629,643
Ensembl chr 6:104,617,770...104,629,643
G
Fcgr2b
Fc gamma receptor 2B
increases expression
EXP
Glafenine results in increased expression of FCGR2B mRNA
CTD
PMID:24136188
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fchsd2
FCH and double SH3 domains 2
decreases expression
EXP
Glafenine results in decreased expression of FCHSD2 mRNA
CTD
PMID:24136188
NCBI chr 1:155,444,471...155,685,350
Ensembl chr 1:155,444,460...155,685,539
G
Fdps
farnesyl diphosphate synthase
increases expression
EXP
Glafenine results in increased expression of FDPS mRNA
CTD
PMID:24136188
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fdx1
ferredoxin 1
decreases expression
EXP
Glafenine results in decreased expression of FDX1 mRNA
CTD
PMID:24136188
NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414
G
Fdxr
ferredoxin reductase
decreases expression
EXP
Glafenine results in decreased expression of FDXR mRNA
CTD
PMID:24136188
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Fech
ferrochelatase
decreases expression
EXP
Glafenine results in decreased expression of FECH mRNA
CTD
PMID:24136188
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
G
Fermt2
FERM domain containing kindlin 2
decreases expression
EXP
Glafenine results in decreased expression of FERMT2 mRNA
CTD
PMID:24136188
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
G
Fga
fibrinogen alpha chain
increases expression
EXP
Glafenine results in increased expression of FGA mRNA
CTD
PMID:24136188
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgl1
fibrinogen-like 1
increases expression
EXP
Glafenine results in increased expression of FGL1 mRNA
CTD
PMID:24136188
NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093
G
Fis1
fission, mitochondrial 1
increases expression
EXP
Glafenine results in increased expression of FIS1 mRNA
CTD
PMID:24136188
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
G
Fitm2
fat storage-inducing transmembrane protein 2
decreases expression
EXP
Glafenine results in decreased expression of FITM2 mRNA
CTD
PMID:24136188
NCBI chr 3:152,141,346...152,147,858
Ensembl chr 3:152,141,346...152,147,858
G
Fkbp11
FKBP prolyl isomerase 11
increases expression
EXP
Glafenine results in increased expression of FKBP11 mRNA
CTD
PMID:24136188
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
G
Fkbp5
FKBP prolyl isomerase 5
increases expression
EXP
Glafenine results in increased expression of FKBP5 mRNA
CTD
PMID:24136188
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
G
Flad1
flavin adenine dinucleotide synthetase 1
increases expression
EXP
Glafenine results in increased expression of FLAD1 mRNA
CTD
PMID:24136188
NCBI chr 2:174,819,451...174,828,921
Ensembl chr 2:174,819,453...174,828,977
G
Flcn
folliculin
decreases expression
EXP
Glafenine results in decreased expression of FLCN mRNA
CTD
PMID:24136188
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
G
Flna
filamin A
increases expression
EXP
Glafenine results in increased expression of FLNA mRNA
CTD
PMID:24136188
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
EXP
Glafenine results in decreased expression of FMO1 mRNA
CTD
PMID:24136188
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
decreases expression
EXP
Glafenine results in decreased expression of FMO3 mRNA
CTD
PMID:24136188
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Fn1
fibronectin 1
increases expression
EXP
Glafenine results in increased expression of FN1 mRNA
CTD
PMID:24136188
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fn3krp
fructosamine-3-kinase-related protein
decreases expression
EXP
Glafenine results in decreased expression of FN3KRP mRNA
CTD
PMID:24136188
NCBI chr10:106,688,413...106,697,137
Ensembl chr10:106,688,439...106,697,134
G
Fndc3b
fibronectin type III domain containing 3B
increases expression
EXP
Glafenine results in increased expression of FNDC3B mRNA
CTD
PMID:24136188
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
G
Foxa2
forkhead box A2
decreases expression
EXP
Glafenine results in decreased expression of FOXA2 mRNA
CTD
PMID:24136188
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Foxa3
forkhead box A3
increases expression
EXP
Glafenine results in increased expression of FOXA3 mRNA
CTD
PMID:24136188
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
G
Foxn3
forkhead box N3
decreases expression
EXP
Glafenine results in decreased expression of FOXN3 mRNA
CTD
PMID:24136188
NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
G
Fpgs
folylpolyglutamate synthase
increases expression
EXP
Glafenine results in increased expression of FPGS mRNA
CTD
PMID:24136188
NCBI chr 3:15,972,800...15,993,592
Ensembl chr 3:15,972,800...15,993,563
G
Ftcd
formimidoyltransferase cyclodeaminase
decreases expression
EXP
Glafenine results in decreased expression of FTCD mRNA
CTD
PMID:24136188
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
G
Ftsj3
FtsJ RNA 2'-O-methyltransferase 3
increases expression
EXP
Glafenine results in increased expression of FTSJ3 mRNA
CTD
PMID:24136188
NCBI chr10:91,180,945...91,187,389
Ensembl chr10:91,180,696...91,187,397
G
Fuca2
alpha-L-fucosidase 2
decreases expression
EXP
Glafenine results in decreased expression of FUCA2 mRNA
CTD
PMID:24136188
NCBI chr 1:7,885,986...7,900,777
Ensembl chr 1:7,885,918...7,900,776
G
Fundc2
FUN14 domain containing 2
increases expression
EXP
Glafenine results in increased expression of FUNDC2 mRNA
CTD
PMID:24136188
NCBI chr18:128,473...138,232
Ensembl chr18:132,248...138,345
G
Fus
Fus RNA binding protein
increases expression
EXP
Glafenine results in increased expression of FUS mRNA
CTD
PMID:24136188
NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
G
Fut8
fucosyltransferase 8
increases expression
EXP
Glafenine results in increased expression of FUT8 mRNA
CTD
PMID:24136188
NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677
G
Fxr1
FMR1 autosomal homolog 1
decreases expression
EXP
Glafenine results in decreased expression of FXR1 mRNA
CTD
PMID:24136188
NCBI chr 2:116,884,167...116,937,590
Ensembl chr 2:116,884,248...116,937,590
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
EXP
Glafenine results in decreased expression of FYCO1 mRNA
CTD
PMID:24136188
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
G
Fzd8
frizzled class receptor 8
decreases expression
EXP
Glafenine results in decreased expression of FZD8 mRNA
CTD
PMID:24136188
NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Glafenine results in decreased expression of G6PC1 mRNA
CTD
PMID:24136188
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
EXP
Glafenine results in increased expression of G6PD mRNA
CTD
PMID:24136188
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gab1
GRB2-associated binding protein 1
decreases expression
EXP
Glafenine results in decreased expression of GAB1 mRNA
CTD
PMID:24136188
NCBI chr19:27,131,262...27,239,236
Ensembl chr19:27,131,262...27,239,236
G
Gabarapl1
GABA type A receptor associated protein like 1
decreases expression
EXP
Glafenine results in decreased expression of GABARAPL1 mRNA
CTD
PMID:24136188
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
G
Gabarapl2
GABA type A receptor associated protein like 2
decreases expression
EXP
Glafenine results in decreased expression of GABARAPL2 mRNA
CTD
PMID:24136188
NCBI chr19:39,910,572...39,921,408
Ensembl chr19:39,910,534...39,924,628 Ensembl chr 8:39,910,534...39,924,628
G
Gale
UDP-galactose-4-epimerase
increases expression
EXP
Glafenine results in increased expression of GALE mRNA
CTD
PMID:24136188
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Galk2
galactokinase 2
decreases expression
EXP
Glafenine results in decreased expression of GALK2 mRNA
CTD
PMID:24136188
NCBI chr 3:113,110,057...113,243,014
Ensembl chr 3:113,110,030...113,233,306
G
Galm
galactose mutarotase
decreases expression
EXP
Glafenine results in decreased expression of GALM mRNA
CTD
PMID:24136188
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
G
Galnt11
polypeptide N-acetylgalactosaminyltransferase 11
decreases expression
EXP
Glafenine results in decreased expression of GALNT11 mRNA
CTD
PMID:24136188
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
EXP
Glafenine results in increased expression of GAPDH mRNA
CTD
PMID:24136188
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gar1
GAR1 ribonucleoprotein
increases expression
EXP
Glafenine results in increased expression of GAR1 mRNA
CTD
PMID:24136188
NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524
G
Gas5
growth arrest specific 5
increases expression
EXP
Glafenine results in increased expression of GAS5 mRNA
CTD
PMID:24136188
NCBI chr13:73,303,611...73,306,932
G
Gas6
growth arrest specific 6
increases expression
EXP
Glafenine results in increased expression of GAS6 mRNA
CTD
PMID:24136188
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
G
Gbe1
1,4-alpha-glucan branching enzyme 1
decreases expression
EXP
Glafenine results in decreased expression of GBE1 mRNA
CTD
PMID:24136188
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
G
Gcdh
glutaryl-CoA dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of GCDH mRNA
CTD
PMID:24136188
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
G
Gck
glucokinase
increases expression
EXP
Glafenine results in increased expression of GCK mRNA
CTD
PMID:24136188
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
G
Gckr
glucokinase regulator
decreases expression
EXP
Glafenine results in decreased expression of GCKR mRNA
CTD
PMID:24136188
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
G
Gclm
glutamate cysteine ligase, modifier subunit
decreases expression
EXP
Glafenine results in decreased expression of GCLM mRNA
CTD
PMID:24136188
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gcnt2
glucosaminyl (N-acetyl) transferase 2
increases expression
EXP
Glafenine results in increased expression of GCNT2 mRNA
CTD
PMID:24136188
NCBI chr17:23,796,859...23,901,625
Ensembl chr17:23,796,859...23,901,611
G
Gda
guanine deaminase
increases expression
EXP
Glafenine results in increased expression of GDA mRNA
CTD
PMID:24136188
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Get4
guided entry of tail-anchored proteins factor 4
increases expression
EXP
Glafenine results in increased expression of GET4 mRNA
CTD
PMID:24136188
NCBI chr12:15,377,009...15,394,238
Ensembl chr12:15,377,009...15,394,053
G
Gga2
golgi associated, gamma adaptin ear containing, ARF binding protein 2
decreases expression
EXP
Glafenine results in decreased expression of GGA2 mRNA
CTD
PMID:24136188
NCBI chr 1:176,552,046...176,585,332
Ensembl chr 1:176,552,046...176,585,361
G
Ggct
gamma-glutamyl cyclotransferase
increases expression
EXP
Glafenine results in increased expression of GGCT mRNA
CTD
PMID:24136188
NCBI chr 4:84,122,921...84,129,327
Ensembl chr 4:84,123,118...84,129,277
G
Ggcx
gamma-glutamyl carboxylase
increases expression
EXP
Glafenine results in increased expression of GGCX mRNA
CTD
PMID:24136188
NCBI chr 4:104,469,737...104,485,631
Ensembl chr 4:104,469,765...104,487,063
G
Ghr
growth hormone receptor
decreases expression
EXP
Glafenine results in decreased expression of GHR mRNA
CTD
PMID:24136188
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Gja1
gap junction protein, alpha 1
increases expression
EXP
Glafenine results in increased expression of GJA1 mRNA
CTD
PMID:24136188
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gk
glycerol kinase
decreases expression
EXP
Glafenine results in decreased expression of GK mRNA
CTD
PMID:24136188
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
G
Glb1
galactosidase, beta 1
decreases expression
EXP
Glafenine results in decreased expression of GLB1 mRNA
CTD
PMID:24136188
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Gls2
glutaminase 2
decreases expression
EXP
Glafenine results in decreased expression of GLS2 mRNA
CTD
PMID:24136188
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
G
Glt8d1
glycosyltransferase 8 domain containing 1
increases expression
EXP
Glafenine results in increased expression of GLT8D1 mRNA
CTD
PMID:24136188
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
G
Glud1
glutamate dehydrogenase 1
decreases expression
EXP
Glafenine results in decreased expression of GLUD1 mRNA
CTD
PMID:24136188
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
G
Glyat
glycine-N-acyltransferase
decreases expression
EXP
Glafenine results in decreased expression of GLYAT mRNA
CTD
PMID:24136188
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
G
Glyr1
glyoxylate reductase 1 homolog
decreases expression
EXP
Glafenine results in decreased expression of GLYR1 mRNA
CTD
PMID:24136188
NCBI chr10:10,532,036...10,567,639
Ensembl chr10:10,532,154...10,567,637
G
Gmcl1
germ cell-less 1, spermatogenesis associated
decreases expression
EXP
Glafenine results in decreased expression of GMCL1 mRNA
CTD
PMID:24136188
NCBI chr 4:119,140,598...119,179,891
Ensembl chr 4:119,140,598...119,179,881
G
Gmfg
glia maturation factor, gamma
increases expression
EXP
Glafenine results in increased expression of GMFG mRNA
CTD
PMID:24136188
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
G
Gmppa
GDP-mannose pyrophosphorylase A
increases expression
EXP
Glafenine results in increased expression of GMPPA mRNA
CTD
PMID:24136188
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
G
Gmppb
GDP-mannose pyrophosphorylase B
increases expression
EXP
Glafenine results in increased expression of GMPPB mRNA
CTD
PMID:24136188
NCBI chr 8:108,737,429...108,740,437
Ensembl chr 8:108,693,060...108,767,286
G
Gnai2
G protein subunit alpha i2
increases expression
EXP
Glafenine results in increased expression of GNAI2 mRNA
CTD
PMID:24136188
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnat1
G protein subunit alpha transducin 1
increases expression
EXP
Glafenine results in increased expression of GNAT1 mRNA
CTD
PMID:24136188
NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671
G
Gnmt
glycine N-methyltransferase
decreases expression
EXP
Glafenine results in decreased expression of GNMT mRNA
CTD
PMID:24136188
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
G
Gns
glucosamine (N-acetyl)-6-sulfatase
decreases expression
EXP
Glafenine results in decreased expression of GNS mRNA
CTD
PMID:24136188
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
G
Gosr2
golgi SNAP receptor complex member 2
increases expression
EXP
Glafenine results in increased expression of GOSR2 mRNA
CTD
PMID:24136188
NCBI chr10:88,585,291...88,605,642
Ensembl chr10:88,586,299...88,605,625
G
Gpat4
glycerol-3-phosphate acyltransferase 4
decreases expression
EXP
Glafenine results in decreased expression of GPAT4 mRNA
CTD
PMID:24136188
NCBI chr16:68,819,031...68,852,903
Ensembl chr16:68,819,079...68,852,901
G
Gpbp1l1
GC-rich promoter binding protein 1-like 1
decreases expression
EXP
Glafenine results in decreased expression of GPBP1L1 mRNA
CTD
PMID:24136188
NCBI chr 5:130,009,768...130,050,636
Ensembl chr 5:130,023,137...130,050,459
G
Gphn
gephyrin
decreases expression
EXP
Glafenine results in decreased expression of GPHN mRNA
CTD
PMID:24136188
NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
G
Gpkow
G patch domain and KOW motifs
increases expression
EXP
Glafenine results in increased expression of GPKOW mRNA
CTD
PMID:24136188
NCBI chr X:14,791,601...14,806,384
Ensembl chr X:14,791,610...14,806,384
G
Gpld1
glycosylphosphatidylinositol specific phospholipase D1
decreases expression
EXP
Glafenine results in decreased expression of GPLD1 mRNA
CTD
PMID:24136188
NCBI chr17:40,084,427...40,132,035
Ensembl chr17:40,084,617...40,126,939
G
Gpr108
G protein-coupled receptor 108
increases expression
EXP
Glafenine results in increased expression of GPR108 mRNA
CTD
PMID:24136188
NCBI chr 9:2,120,740...2,131,771
Ensembl chr 9:2,120,744...2,132,572
G
Gpr146
G protein-coupled receptor 146
increases expression
EXP
Glafenine results in increased expression of GPR146 mRNA
CTD
PMID:24136188
NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
G
Gpt
glutamic--pyruvic transaminase
decreases expression
EXP
Glafenine results in decreased expression of GPT mRNA
CTD
PMID:24136188
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpt2
glutamic--pyruvic transaminase 2
decreases expression
EXP
Glafenine results in decreased expression of GPT2 mRNA
CTD
PMID:24136188
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
G
Gpx1
glutathione peroxidase 1
decreases expression
EXP
Glafenine results in decreased expression of GPX1 mRNA
CTD
PMID:24136188
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Grsf1
G-rich RNA sequence binding factor 1
decreases expression
EXP
Glafenine results in decreased expression of GRSF1 mRNA
CTD
PMID:24136188
NCBI chr14:19,412,944...19,429,364
Ensembl chr14:19,412,156...19,429,362
G
Gsap
gamma-secretase activating protein
increases expression
EXP
Glafenine results in increased expression of GSAP mRNA
CTD
PMID:24136188
NCBI chr 4:13,813,046...13,907,875
Ensembl chr 4:13,813,046...13,907,814
G
Gsdmd
gasdermin D
decreases expression
EXP
Glafenine results in decreased expression of GSDMD mRNA
CTD
PMID:24136188
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
G
Gss
glutathione synthetase
increases expression
EXP
Glafenine results in increased expression of GSS mRNA
CTD
PMID:24136188
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
G
Gsta3
glutathione S-transferase alpha 3
decreases expression
EXP
Glafenine results in decreased expression of GSTA3 mRNA
CTD
PMID:24136188
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gstp3
glutathione S-transferase pi 3
decreases expression
EXP
Glafenine results in decreased expression of GSTP3 mRNA
CTD
PMID:24136188
NCBI chr 1:201,355,682...201,358,216
Ensembl chr 1:201,355,682...201,358,330
G
Gstt2
glutathione S-transferase theta 2
decreases expression
EXP
Glafenine results in decreased expression of GSTT2 mRNA
CTD
PMID:24136188
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
G
Gstz1
glutathione S-transferase zeta 1
decreases expression
EXP
Glafenine results in decreased expression of GSTZ1 mRNA
CTD
PMID:24136188
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
G
Gtf2f1
general transcription factor IIF subunit 1
increases expression
EXP
Glafenine results in increased expression of GTF2F1 mRNA
CTD
PMID:24136188
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
G
Gtf2i
general transcription factor II I
decreases expression
EXP
Glafenine results in decreased expression of GTF2I mRNA
CTD
PMID:24136188
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
G
Gucd1
guanylyl cyclase domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of GUCD1 mRNA
CTD
PMID:24136188
NCBI chr20:13,145,617...13,156,330
Ensembl chr20:13,146,076...13,156,328
G
Gucy1a1
guanylate cyclase 1 soluble subunit alpha 1
decreases expression
EXP
Glafenine results in decreased expression of GUCY1A1 mRNA
CTD
PMID:24136188
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
G
Gusb
glucuronidase, beta
decreases expression
EXP
Glafenine results in decreased expression of GUSB mRNA
CTD
PMID:24136188
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
Hacl1
2-hydroxyacyl-CoA lyase 1
decreases expression
EXP
Glafenine results in decreased expression of HACL1 mRNA
CTD
PMID:24136188
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of HADH mRNA
CTD
PMID:24136188
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hal
histidine ammonia lyase
decreases expression
EXP
Glafenine results in decreased expression of HAL mRNA
CTD
PMID:24136188
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
G
Hdac2
histone deacetylase 2
decreases expression
EXP
Glafenine results in decreased expression of HDAC2 mRNA
CTD
PMID:24136188
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Hdhd2
haloacid dehalogenase-like hydrolase domain containing 2
increases expression
EXP
Glafenine results in increased expression of HDHD2 mRNA
CTD
PMID:24136188
NCBI chr18:70,488,315...70,526,471
Ensembl chr18:70,474,926...70,526,470
G
Hdlbp
high density lipoprotein binding protein
increases expression
EXP
Glafenine results in increased expression of HDLBP mRNA
CTD
PMID:24136188
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
G
Heca
hdc homolog, cell cycle regulator
decreases expression
EXP
Glafenine results in decreased expression of HECA mRNA
CTD
PMID:24136188
NCBI chr 1:12,525,445...12,575,358
Ensembl chr 1:12,525,135...12,576,427
G
Hectd1
HECT domain E3 ubiquitin protein ligase 1
decreases expression
EXP
Glafenine results in decreased expression of HECTD1 mRNA
CTD
PMID:24136188
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
G
Hells
helicase, lymphoid specific
decreases expression
EXP
Glafenine results in decreased expression of HELLS mRNA
CTD
PMID:24136188
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Hes6
hes family bHLH transcription factor 6
decreases expression
EXP
Glafenine results in decreased expression of HES6 mRNA
CTD
PMID:24136188
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
G
Hexa
hexosaminidase subunit alpha
decreases expression
EXP
Glafenine results in decreased expression of HEXA mRNA
CTD
PMID:24136188
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
G
Hexb
hexosaminidase subunit beta
decreases expression
EXP
Glafenine results in decreased expression of HEXB mRNA
CTD
PMID:24136188
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
G
Hexim1
HEXIM P-TEFb complex subunit 1
decreases expression
EXP
Glafenine results in decreased expression of HEXIM1 mRNA
CTD
PMID:24136188
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189
G
Hgd
homogentisate 1, 2-dioxygenase
decreases expression
EXP
Glafenine results in decreased expression of HGD mRNA
CTD
PMID:24136188
NCBI chr11:63,086,750...63,138,325
Ensembl chr11:63,086,752...63,138,323
G
Hibadh
3-hydroxyisobutyrate dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of HIBADH mRNA
CTD
PMID:24136188
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
G
Hibch
3-hydroxyisobutyryl-CoA hydrolase
decreases expression
EXP
Glafenine results in decreased expression of HIBCH mRNA
CTD
PMID:24136188
NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
G
Higd1a
HIG1 hypoxia inducible domain family, member 1A
increases expression
EXP
Glafenine results in increased expression of HIGD1A mRNA
CTD
PMID:24136188
NCBI chr 8:121,514,152...121,523,382
Ensembl chr 8:121,514,156...121,523,443
G
Hint2
histidine triad nucleotide binding protein 2
increases expression
EXP
Glafenine results in increased expression of HINT2 mRNA
CTD
PMID:24136188
NCBI chr 5:57,904,613...57,906,868
Ensembl chr 5:57,904,614...57,907,097
G
Hint3
histidine triad nucleotide binding protein 3
decreases expression
EXP
Glafenine results in decreased expression of HINT3 mRNA
CTD
PMID:24136188
NCBI chr 1:27,035,936...27,045,799
Ensembl chr 1:27,035,905...27,047,721
G
Hipk2
homeodomain interacting protein kinase 2
decreases expression
EXP
Glafenine results in decreased expression of HIPK2 mRNA
CTD
PMID:24136188
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
G
Hm13
histocompatibility minor 13
increases expression
EXP
Glafenine results in increased expression of HM13 mRNA
CTD
PMID:24136188
NCBI chr 3:141,145,792...141,183,557
Ensembl chr 3:141,145,782...141,184,703
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
EXP
Glafenine results in increased expression of HMGCR mRNA
CTD
PMID:24136188
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
Glafenine results in decreased expression of HMGCS2 mRNA
CTD
PMID:24136188
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hmgn3
high mobility group nucleosomal binding domain 3
increases expression
EXP
Glafenine results in increased expression of HMGN3 mRNA
CTD
PMID:24136188
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
EXP
Glafenine results in increased expression of HNRNPA1 mRNA
CTD
PMID:24136188
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
increases expression
EXP
Glafenine results in increased expression of HNRNPA2B1 mRNA
CTD
PMID:24136188
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hoga1
4-hydroxy-2-oxoglutarate aldolase 1
decreases expression
EXP
Glafenine results in decreased expression of HOGA1 mRNA
CTD
PMID:24136188
NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:240,857,126...240,884,568
G
Hras
HRas proto-oncogene, GTPase
increases expression
EXP
Glafenine results in increased expression of HRAS mRNA
CTD
PMID:24136188
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
decreases expression
EXP
Glafenine results in decreased expression of HSD17B10 mRNA
CTD
PMID:24136188
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
G
Hsd17b11
hydroxysteroid (17-beta) dehydrogenase 11
decreases expression
EXP
Glafenine results in decreased expression of HSD17B11 mRNA
CTD
PMID:24136188
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
EXP
Glafenine results in decreased expression of HSD17B2 mRNA
CTD
PMID:24136188
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
decreases expression
EXP
Glafenine results in decreased expression of HSD17B4 mRNA
CTD
PMID:24136188
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
increases expression
EXP
Glafenine results in increased expression of HSD17B7 mRNA
CTD
PMID:24136188
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
G
Hsd3b7
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
decreases expression
EXP
Glafenine results in decreased expression of HSD3B7 mRNA
CTD
PMID:24136188
NCBI chr 1:182,412,216...182,415,447
Ensembl chr 1:182,412,151...182,415,442
G
Hsdl2
hydroxysteroid dehydrogenase like 2
decreases expression
EXP
Glafenine results in decreased expression of HSDL2 mRNA
CTD
PMID:24136188
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
G
Hsf2
heat shock transcription factor 2
decreases expression
EXP
Glafenine results in decreased expression of HSF2 mRNA
CTD
PMID:24136188
NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174
G
Hsp90b1
heat shock protein 90 beta family member 1
increases expression
EXP
Glafenine results in increased expression of HSP90B1 mRNA
CTD
PMID:24136188
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
G
Hspa13
heat shock protein family A (Hsp70) member 13
increases expression
EXP
Glafenine results in increased expression of HSPA13 mRNA
CTD
PMID:24136188
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
Glafenine results in increased expression of HSPA5 mRNA
CTD
PMID:24136188
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hyal2
hyaluronidase 2
increases expression
EXP
Glafenine results in increased expression of HYAL2 mRNA
CTD
PMID:24136188
NCBI chr 8:108,241,895...108,246,853
Ensembl chr 8:108,243,133...108,246,850
G
Hykk
hydroxylysine kinase
decreases expression
EXP
Glafenine results in decreased expression of HYKK mRNA
CTD
PMID:24136188
NCBI chr 8:55,315,919...55,339,720
Ensembl chr 8:55,315,969...55,337,339
G
Hyls1
HYLS1, centriolar and ciliogenesis associated
decreases expression
EXP
Glafenine results in decreased expression of HYLS1 mRNA
CTD
PMID:24136188
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
G
Hyou1
hypoxia up-regulated 1
increases expression
EXP
Glafenine results in increased expression of HYOU1 mRNA
CTD
PMID:24136188
NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186
G
Hypk
Huntingtin interacting protein K
increases expression
EXP
Glafenine results in increased expression of HYPK mRNA
CTD
PMID:24136188
NCBI chr 3:108,434,997...108,436,370
Ensembl chr 3:108,432,539...108,436,370
G
Iars2
isoleucyl-tRNA synthetase 2, mitochondrial
decreases expression
EXP
Glafenine results in decreased expression of IARS2 mRNA
CTD
PMID:24136188
NCBI chr13:96,831,484...96,865,518
Ensembl chr13:96,831,484...96,865,501
G
Icam1
intercellular adhesion molecule 1
increases expression
EXP
Glafenine results in increased expression of ICAM1 mRNA
CTD
PMID:24136188
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id2
inhibitor of DNA binding 2
decreases expression
EXP
Glafenine results in decreased expression of ID2 mRNA
CTD
PMID:24136188
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Id4
inhibitor of DNA binding 4
decreases expression
EXP
Glafenine results in decreased expression of ID4 mRNA
CTD
PMID:24136188
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
G
Ier3
immediate early response 3
increases expression
EXP
Glafenine results in increased expression of IER3 mRNA
CTD
PMID:24136188
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ier5
immediate early response 5
increases expression
EXP
Glafenine results in increased expression of IER5 mRNA
CTD
PMID:24136188
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
G
Ifitm1
interferon induced transmembrane protein 1
increases expression
EXP
Glafenine results in increased expression of IFITM1 mRNA
CTD
PMID:24136188
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm2
interferon induced transmembrane protein 2
increases expression
EXP
Glafenine results in increased expression of IFITM2 mRNA
CTD
PMID:24136188
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
EXP
Glafenine results in increased expression of IFITM3 mRNA
CTD
PMID:24136188
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifnar2
interferon alpha and beta receptor subunit 2
increases expression
EXP
Glafenine results in increased expression of IFNAR2 mRNA
CTD
PMID:24136188
NCBI chr11:30,613,576...30,645,958
Ensembl chr11:30,613,767...30,668,124
G
Ift20
intraflagellar transport 20
increases expression
EXP
Glafenine results in increased expression of IFT20 mRNA
CTD
PMID:24136188
NCBI chr10:63,432,597...63,438,125
Ensembl chr10:63,432,633...63,438,124
G
Iftap
intraflagellar transport associated protein
decreases expression
EXP
Glafenine results in decreased expression of IFTAP mRNA
CTD
PMID:24136188
NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
decreases expression
EXP
Glafenine results in decreased expression of IGFALS mRNA
CTD
PMID:24136188
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression
EXP
Glafenine results in decreased expression of IGFBP3 mRNA
CTD
PMID:24136188
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Il1b
interleukin 1 beta
increases expression
EXP
Glafenine results in increased expression of IL1B
CTD
PMID:24136188
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
increases expression
EXP
Glafenine results in increased expression of IL1RN mRNA
CTD
PMID:24136188
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
increases expression
EXP
Glafenine results in increased expression of IL6
CTD
PMID:24136188
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Imp3
IMP U3 small nucleolar ribonucleoprotein 3
increases expression
EXP
Glafenine results in increased expression of IMP3 mRNA
CTD
PMID:24136188
NCBI chr 8:57,339,528...57,340,416
Ensembl chr 8:57,339,496...57,340,414
G
Impa1
inositol monophosphatase 1
decreases expression
EXP
Glafenine results in decreased expression of IMPA1 mRNA
CTD
PMID:24136188
NCBI chr 2:91,462,781...91,484,057
Ensembl chr 2:91,462,799...91,484,313
G
Ing1
inhibitor of growth family, member 1
decreases expression
EXP
Glafenine results in decreased expression of ING1 mRNA
CTD
PMID:24136188
NCBI chr16:77,937,276...77,945,320
Ensembl chr16:77,937,279...77,946,264
G
Inmt
indolethylamine N-methyltransferase
decreases expression
EXP
Glafenine results in decreased expression of INMT mRNA
CTD
PMID:24136188
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
G
Insig2
insulin induced gene 2
decreases expression
EXP
Glafenine results in decreased expression of INSIG2 mRNA
CTD
PMID:24136188
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Ipo4
importin 4
increases expression
EXP
Glafenine results in increased expression of IPO4 mRNA
CTD
PMID:24136188
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
G
Irak1
interleukin-1 receptor-associated kinase 1
increases expression
EXP
Glafenine results in increased expression of IRAK1 mRNA
CTD
PMID:24136188
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
G
Irak3
interleukin-1 receptor-associated kinase 3
increases expression
EXP
Glafenine results in increased expression of IRAK3 mRNA
CTD
PMID:24136188
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
G
Irf6
interferon regulatory factor 6
decreases expression
EXP
Glafenine results in decreased expression of IRF6 mRNA
CTD
PMID:24136188
NCBI chr13:104,672,179...104,691,386
Ensembl chr13:104,672,179...104,691,386
G
Isoc1
isochorismatase domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of ISOC1 mRNA
CTD
PMID:24136188
NCBI chr18:52,158,790...52,179,206
Ensembl chr18:52,158,790...52,178,703
G
Isyna1
inositol-3-phosphate synthase 1
increases expression
EXP
Glafenine results in increased expression of ISYNA1 mRNA
CTD
PMID:24136188
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
G
Itgb1bp1
integrin subunit beta 1 binding protein 1
increases expression
EXP
Glafenine results in increased expression of ITGB1BP1 mRNA
CTD
PMID:24136188
NCBI chr 6:40,820,693...40,836,074
Ensembl chr 6:40,821,339...40,836,037
G
Itpa
inosine triphosphatase
increases expression
EXP
Glafenine results in increased expression of ITPA mRNA
CTD
PMID:24136188
NCBI chr 3:117,885,464...117,897,247
Ensembl chr 3:117,885,099...117,897,249
G
Iyd
iodotyrosine deiodinase
decreases expression
EXP
Glafenine results in decreased expression of IYD mRNA
CTD
PMID:24136188
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Jam2
junctional adhesion molecule 2
increases expression
EXP
Glafenine results in increased expression of JAM2 mRNA
CTD
PMID:24136188
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
G
Jmjd1c
jumonji domain containing 1C
decreases expression
EXP
Glafenine results in decreased expression of JMJD1C mRNA
CTD
PMID:24136188
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
G
Jmjd6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
increases expression
EXP
Glafenine results in increased expression of JMJD6 mRNA
CTD
PMID:24136188
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
G
Josd2
Josephin domain containing 2
increases expression
EXP
Glafenine results in increased expression of JOSD2 mRNA
CTD
PMID:24136188
NCBI chr 1:94,960,867...94,964,751
Ensembl chr 1:94,961,107...94,964,749
G
Jpt2
Jupiter microtubule associated homolog 2
increases expression
EXP
Glafenine results in increased expression of JPT2 mRNA
CTD
PMID:24136188
NCBI chr10:13,963,135...13,983,212
Ensembl chr10:13,963,137...13,983,170
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Glafenine results in increased expression of JUNB mRNA
CTD
PMID:24136188
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kank1
KN motif and ankyrin repeat domains 1
decreases expression
EXP
Glafenine results in decreased expression of KANK1 mRNA
CTD
PMID:24136188
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
G
Kat2b
lysine acetyltransferase 2B
decreases expression
EXP
Glafenine results in decreased expression of KAT2B mRNA
CTD
PMID:24136188
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
increases expression
EXP
Glafenine results in increased expression of KCNJ8 mRNA
CTD
PMID:24136188
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
G
Kctd2
potassium channel tetramerization domain containing 2
decreases expression
EXP
Glafenine results in decreased expression of KCTD2 mRNA
CTD
PMID:24136188
NCBI chr10:100,663,013...100,674,756
Ensembl chr10:100,662,884...100,674,336
G
Kctd6
potassium channel tetramerization domain containing 6
decreases expression
EXP
Glafenine results in decreased expression of KCTD6 mRNA
CTD
PMID:24136188
NCBI chr15:16,695,297...16,712,460
Ensembl chr15:16,695,297...16,698,699
G
Kctd9
potassium channel tetramerization domain containing 9
decreases expression
EXP
Glafenine results in decreased expression of KCTD9 mRNA
CTD
PMID:24136188
NCBI chr15:41,942,165...41,969,862
Ensembl chr15:41,942,381...41,969,862
G
Kdelr2
KDEL endoplasmic reticulum protein retention receptor 2
increases expression
EXP
Glafenine results in increased expression of KDELR2 mRNA
CTD
PMID:24136188
NCBI chr12:11,138,820...11,157,117
Ensembl chr12:11,138,820...11,157,153
G
Kdm1b
lysine demethylase 1B
decreases expression
EXP
Glafenine results in decreased expression of KDM1B mRNA
CTD
PMID:24136188
NCBI chr17:17,602,961...17,643,865
Ensembl chr17:17,602,961...17,643,800
G
Kdr
kinase insert domain receptor
decreases expression
EXP
Glafenine results in decreased expression of KDR mRNA
CTD
PMID:24136188
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Khk
ketohexokinase
decreases expression
EXP
Glafenine results in decreased expression of KHK mRNA
CTD
PMID:24136188
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
G
Klc4
kinesin light chain 4
decreases expression
EXP
Glafenine results in decreased expression of KLC4 mRNA
CTD
PMID:24136188
NCBI chr 9:14,337,164...14,351,075
Ensembl chr 9:14,337,534...14,351,066
G
Klf3
KLF transcription factor 3
decreases expression
EXP
Glafenine results in decreased expression of KLF3 mRNA
CTD
PMID:24136188
NCBI chr14:43,474,767...43,505,801
Ensembl chr14:43,474,767...43,497,209
G
Klhl25
kelch-like family member 25
decreases expression
EXP
Glafenine results in decreased expression of KLHL25 mRNA
CTD
PMID:24136188
NCBI chr 1:129,724,894...129,750,142
Ensembl chr 1:129,722,026...129,750,227
G
Klhl7
kelch-like family member 7
decreases expression
EXP
Glafenine results in decreased expression of KLHL7 mRNA
CTD
PMID:24136188
NCBI chr 4:11,006,366...11,055,399
Ensembl chr 4:11,006,375...11,055,541
G
Kng1
kininogen 1
increases expression
EXP
Glafenine results in increased expression of KNG1 mRNA
CTD
PMID:24136188
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Kpna2
karyopherin subunit alpha 2
decreases expression
EXP
Glafenine results in decreased expression of KPNA2 mRNA
CTD
PMID:24136188
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Krt18
keratin 18
increases expression
EXP
Glafenine results in increased expression of KRT18 mRNA
CTD
PMID:24136188
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Krtcap2
keratinocyte associated protein 2
increases expression
EXP
Glafenine results in increased expression of KRTCAP2 mRNA
CTD
PMID:24136188
NCBI chr 2:174,654,409...174,658,405
Ensembl chr 2:174,654,219...174,658,405
G
Kyat1
kynurenine aminotransferase 1
increases expression
EXP
Glafenine results in increased expression of KYAT1 mRNA
CTD
PMID:24136188
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
G
Kyat3
kynurenine aminotransferase 3
decreases expression
EXP
Glafenine results in decreased expression of KYAT3 mRNA
CTD
PMID:24136188
NCBI chr 2:231,701,881...231,747,462
Ensembl chr 2:231,701,963...231,747,227
G
Kynu
kynureninase
decreases expression
EXP
Glafenine results in decreased expression of KYNU mRNA
CTD
PMID:24136188
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
L2hgdh
L-2-hydroxyglutarate dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of L2HGDH mRNA
CTD
PMID:24136188
NCBI chr 6:88,164,429...88,205,585
Ensembl chr 6:88,164,440...88,205,578
G
Lactb2
lactamase, beta 2
decreases expression
EXP
Glafenine results in decreased expression of LACTB2 mRNA
CTD
PMID:24136188
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
G
Lage3
L antigen family, member 3
increases expression
EXP
Glafenine results in increased expression of LAGE3 mRNA
CTD
PMID:24136188
NCBI chr X:152,138,209...152,139,632
Ensembl chr X:152,138,218...152,139,632
G
Lamtor3
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
increases expression
EXP
Glafenine results in increased expression of LAMTOR3 mRNA
CTD
PMID:24136188
NCBI chr 2:226,411,389...226,423,612
Ensembl chr 2:226,411,400...226,423,607
G
Larp1b
La ribonucleoprotein 1B
decreases expression
EXP
Glafenine results in decreased expression of LARP1B mRNA
CTD
PMID:24136188
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
G
Lbp
lipopolysaccharide binding protein
increases expression
EXP
Glafenine results in increased expression of LBP mRNA
CTD
PMID:24136188
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lcn2
lipocalin 2
increases expression
EXP
Glafenine results in increased expression of LCN2 mRNA
CTD
PMID:24136188
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Ldaf1
lipid droplet assembly factor 1
decreases expression
EXP
Glafenine results in decreased expression of LDAF1 mRNA
CTD
PMID:24136188
NCBI chr 1:174,484,438...174,503,037
Ensembl chr 1:174,484,447...174,503,036
G
Ldhd
lactate dehydrogenase D
decreases expression
EXP
Glafenine results in decreased expression of LDHD mRNA
CTD
PMID:24136188
NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
G
Lenep
lens epithelial protein
increases expression
EXP
Glafenine results in increased expression of LENEP mRNA
CTD
PMID:24136188
NCBI chr 2:174,819,439...174,820,127
Ensembl chr 2:174,819,459...174,820,127
G
Lgals3
galectin 3
increases expression
EXP
Glafenine results in increased expression of LGALS3 mRNA
CTD
PMID:24136188
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lgals8
galectin 8
decreases expression
EXP
Glafenine results in decreased expression of LGALS8 mRNA
CTD
PMID:24136188
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
G
Lhpp
phospholysine phosphohistidine inorganic pyrophosphate phosphatase
decreases expression
EXP
Glafenine results in decreased expression of LHPP mRNA
CTD
PMID:24136188
NCBI chr 1:187,403,390...187,494,577
Ensembl chr 1:187,403,433...187,494,578
G
Lias
lipoic acid synthetase
decreases expression
EXP
Glafenine results in decreased expression of LIAS mRNA
CTD
PMID:24136188
NCBI chr14:42,876,699...42,893,824
Ensembl chr14:42,876,699...42,893,783
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
increases expression
EXP
Glafenine results in increased expression of LIN7A mRNA
CTD
PMID:24136188
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
G
Lipa
lipase A, lysosomal acid type
decreases expression
EXP
Glafenine results in decreased expression of LIPA mRNA
CTD
PMID:24136188
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
G
Lipc
lipase C, hepatic type
decreases expression
EXP
Glafenine results in decreased expression of LIPC mRNA
CTD
PMID:24136188
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
G
Lman1
lectin, mannose-binding, 1
increases expression
EXP
Glafenine results in increased expression of LMAN1 mRNA
CTD
PMID:24136188
NCBI chr18:59,508,996...59,530,873
Ensembl chr18:59,508,996...59,530,851
G
Lmo4
LIM domain only 4
increases expression
EXP
Glafenine results in increased expression of STIMATE mRNA
CTD
PMID:24136188
NCBI chr 2:233,264,180...233,280,881
Ensembl chr 2:233,264,182...233,280,880
G
Lnx2
ligand of numb-protein X 2
decreases expression
EXP
Glafenine results in decreased expression of LNX2 mRNA
CTD
PMID:24136188
NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494
G
Lonp2
lon peptidase 2, peroxisomal
decreases expression
EXP
Glafenine results in decreased expression of LONP2 mRNA
CTD
PMID:24136188
NCBI chr19:20,407,475...20,498,985
Ensembl chr19:20,407,477...20,499,014
G
Lpar6
lysophosphatidic acid receptor 6
decreases expression
EXP
Glafenine results in decreased expression of LPAR6 mRNA
CTD
PMID:24136188
NCBI chr15:48,416,548...48,418,357
Ensembl chr15:48,416,544...48,422,331
G
Lpgat1
lysophosphatidylglycerol acyltransferase 1
decreases expression
EXP
Glafenine results in decreased expression of LPGAT1 mRNA
CTD
PMID:24136188
NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333
G
Lrat
lecithin retinol acyltransferase
decreases expression
EXP
Glafenine results in decreased expression of LRAT mRNA
CTD
PMID:24136188
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
increases expression
EXP
Glafenine results in increased expression of LRG1 mRNA
CTD
PMID:24136188
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
G
Lrrc40
leucine rich repeat containing 40
decreases expression
EXP
Glafenine results in decreased expression of LRRC40 mRNA
CTD
PMID:24136188
NCBI chr 2:247,101,518...247,131,061
Ensembl chr 2:247,101,500...247,131,059
G
Lrrc59
leucine rich repeat containing 59
increases expression
EXP
Glafenine results in increased expression of LRRC59 mRNA
CTD
PMID:24136188
NCBI chr10:79,572,295...79,586,953
Ensembl chr10:79,572,317...79,602,533
G
Lrrc8d
leucine rich repeat containing 8 VRAC subunit D
decreases expression
EXP
Glafenine results in decreased expression of LRRC8D mRNA
CTD
PMID:24136188
NCBI chr14:4,029,971...4,134,922
Ensembl chr14:4,029,473...4,135,877
G
Lsm4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
increases expression
EXP
Glafenine results in increased expression of LSM4 mRNA
CTD
PMID:24136188
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
G
Lsm8
LSM8 homolog, U6 small nuclear RNA associated
increases expression
EXP
Glafenine results in increased expression of LSM8 mRNA
CTD
PMID:24136188
NCBI chr 4:47,306,259...47,312,125
Ensembl chr 4:47,306,295...47,314,293
G
Ltb
lymphotoxin beta
increases expression
EXP
Glafenine results in increased expression of LTB mRNA
CTD
PMID:24136188
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Ltn1
listerin E3 ubiquitin protein ligase 1
decreases expression
EXP
Glafenine results in decreased expression of LTN1 mRNA
CTD
PMID:24136188
NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886
G
Lurap1l
leucine rich adaptor protein 1-like
increases expression
EXP
Glafenine results in increased expression of LURAP1L mRNA
CTD
PMID:24136188
NCBI chr 5:95,362,005...95,409,439
Ensembl chr 5:95,362,005...95,409,438
G
Lypla1
lysophospholipase 1
decreases expression
EXP
Glafenine results in decreased expression of LYPLA1 mRNA
CTD
PMID:24136188
NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746
G
Lyplal1
lysophospholipase-like 1
decreases expression
EXP
Glafenine results in decreased expression of LYPLAL1 mRNA
CTD
PMID:24136188
NCBI chr13:97,626,568...97,657,901
Ensembl chr13:97,626,451...97,657,867
G
Lysmd2
LysM domain containing 2
increases expression
EXP
Glafenine results in increased expression of LYSMD2 mRNA
CTD
PMID:24136188
NCBI chr 8:76,378,984...76,394,396
Ensembl chr 8:76,379,219...76,394,654
G
Lyz2
lysozyme 2
increases expression
EXP
Glafenine results in increased expression of LYZ2 mRNA
CTD
PMID:24136188
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Macrod1
mono-ADP ribosylhydrolase 1
decreases expression
EXP
Glafenine results in decreased expression of MACROD1 mRNA
CTD
PMID:24136188
NCBI chr 1:204,246,238...204,387,027
Ensembl chr 1:204,246,166...204,389,716
G
Maea
macrophage erythroblast attacher, E3 ubiquitin ligase
decreases expression
EXP
Glafenine results in decreased expression of MAEA mRNA
CTD
PMID:24136188
NCBI chr14:77,357,261...77,390,683
Ensembl chr14:77,357,264...77,390,671
G
Mafb
MAF bZIP transcription factor B
decreases expression
EXP
Glafenine results in decreased expression of MAFB mRNA
CTD
PMID:24136188
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Magoh
mago homolog, exon junction complex subunit
increases expression
EXP
Glafenine results in increased expression of MAGOH mRNA
CTD
PMID:24136188
NCBI chr 5:122,639,268...122,646,650
Ensembl chr 5:122,639,308...122,646,617
G
Man1b1
mannosidase, alpha, class 1B, member 1
increases expression
EXP
Glafenine results in increased expression of MAN1B1 mRNA
CTD
PMID:24136188
NCBI chr 3:8,143,877...8,165,007
Ensembl chr 3:8,143,381...8,165,006
G
Man2b1
mannosidase, alpha, class 2B, member 1
decreases expression
EXP
Glafenine results in decreased expression of MAN2B1 mRNA
CTD
PMID:24136188
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
increases expression
EXP
Glafenine results in increased expression of MANF mRNA
CTD
PMID:24136188
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
G
Maob
monoamine oxidase B
decreases expression
EXP
Glafenine results in decreased expression of MAOB mRNA
CTD
PMID:24136188
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
EXP
Glafenine results in increased expression of MAP1LC3B mRNA
CTD
PMID:24136188
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map2k3
mitogen activated protein kinase kinase 3
decreases expression
EXP
Glafenine results in decreased expression of MAP2K3 mRNA
CTD
PMID:24136188
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map4k3
mitogen-activated protein kinase kinase kinase kinase 3
decreases expression
EXP
Glafenine results in decreased expression of MAP4K3 mRNA
CTD
PMID:24136188
NCBI chr 6:14,276,623...14,446,321
Ensembl chr 6:14,277,121...14,446,334
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
EXP
Glafenine results in increased expression of MAPK8IP3 mRNA
CTD
PMID:24136188
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
G
Mapkapk5
MAPK activated protein kinase 5
increases expression
EXP
Glafenine results in increased expression of MAPKAPK5 mRNA
CTD
PMID:24136188
NCBI chr12:34,993,520...35,013,059
Ensembl chr12:34,994,092...35,013,052
G
Mapre1
microtubule-associated protein, RP/EB family, member 1
increases expression
EXP
Glafenine results in increased expression of MAPRE1 mRNA
CTD
PMID:24136188
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
G
Marchf2
membrane associated ring-CH-type finger 2
decreases expression
EXP
Glafenine results in decreased expression of MARCHF2 mRNA
CTD
PMID:24136188
NCBI chr 7:14,480,605...14,507,821
Ensembl chr 7:14,481,761...14,507,794
G
Marchf6
membrane associated ring-CH-type finger 6
decreases expression
EXP
Glafenine results in decreased expression of MARCHF6 mRNA
CTD
PMID:24136188
NCBI chr 2:82,455,686...82,532,917
Ensembl chr 2:82,455,689...82,532,910
G
Mbd3
methyl-CpG binding domain protein 3
increases expression
EXP
Glafenine results in increased expression of MBD3 mRNA
CTD
PMID:24136188
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
G
Mbl2
mannose binding lectin 2
decreases expression
EXP
Glafenine results in decreased expression of MBL2 mRNA
CTD
PMID:24136188
NCBI chr 1:228,016,439...228,024,736
G
Mbnl2
muscleblind-like splicing regulator 2
decreases expression
EXP
Glafenine results in decreased expression of MBNL2 mRNA
CTD
PMID:24136188
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mccc2
methylcrotonyl-CoA carboxylase subunit 2
decreases expression
EXP
Glafenine results in decreased expression of MCCC2 mRNA
CTD
PMID:24136188
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
G
Mcts2
MCTS family member 2
increases expression
EXP
Glafenine results in increased expression of MCTS2 mRNA
CTD
PMID:24136188
NCBI chr 3:141,163,330...141,164,108
G
Mdp1
magnesium-dependent phosphatase 1
decreases expression
EXP
Glafenine results in decreased expression of MDP1 mRNA
CTD
PMID:24136188
NCBI chr15:29,148,994...29,151,868
Ensembl chr15:29,148,994...29,151,905
G
Me1
malic enzyme 1
decreases expression
EXP
Glafenine results in decreased expression of ME1 mRNA
CTD
PMID:24136188
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Med15
mediator complex subunit 15
increases expression
EXP
Glafenine results in increased expression of MED15 mRNA
CTD
PMID:24136188
NCBI chr11:83,280,722...83,356,006
Ensembl chr11:83,280,762...83,355,362
G
Med29
mediator complex subunit 29
increases expression
EXP
Glafenine results in increased expression of MED29 mRNA
CTD
PMID:24136188
NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365
G
Mfn2
mitofusin 2
decreases expression
EXP
Glafenine results in decreased expression of MFN2 mRNA
CTD
PMID:24136188
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mfsd4b2l1
major facilitator superfamily domain containing 4B2 like 1
decreases expression
EXP
Glafenine results in decreased expression of MFSD4B2L1 mRNA
CTD
PMID:24136188
NCBI chr20:43,436,857...43,450,064
Ensembl chr20:43,436,857...43,450,064
G
Mgll
monoglyceride lipase
decreases expression
EXP
Glafenine results in decreased expression of MGLL mRNA
CTD
PMID:24136188
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mgmt
O-6-methylguanine-DNA methyltransferase
decreases expression
EXP
Glafenine results in decreased expression of MGMT mRNA
CTD
PMID:24136188
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mgst3
microsomal glutathione S-transferase 3
decreases expression
EXP
Glafenine results in decreased expression of MGST3 mRNA
CTD
PMID:24136188
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
G
Mia3
MIA SH3 domain ER export factor 3
decreases expression
EXP
Glafenine results in decreased expression of MIA3 mRNA
CTD
PMID:24136188
NCBI chr13:94,970,421...95,012,071
Ensembl chr13:94,970,424...95,011,972
G
Micu2
mitochondrial calcium uptake 2
decreases expression
EXP
Glafenine results in decreased expression of MICU2 mRNA
CTD
PMID:24136188
NCBI chr15:32,064,872...32,146,874
Ensembl chr15:32,064,875...32,147,094
G
Midn
midnolin
increases expression
EXP
Glafenine results in increased expression of MIDN mRNA
CTD
PMID:24136188
NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
G
Miox
myo-inositol oxygenase
increases expression
EXP
Glafenine results in increased expression of MIOX mRNA
CTD
PMID:24136188
NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537
G
Mipep
mitochondrial intermediate peptidase
decreases expression
EXP
Glafenine results in decreased expression of MIPEP mRNA
CTD
PMID:24136188
NCBI chr15:34,926,198...35,051,722
Ensembl chr15:34,926,207...35,051,727
G
Mkln1
muskelin 1
decreases expression
EXP
Glafenine results in decreased expression of MKLN1 mRNA
CTD
PMID:24136188
NCBI chr 4:59,815,912...60,124,047
Ensembl chr 4:60,002,464...60,123,993
G
Mlec
malectin
increases expression
EXP
Glafenine results in increased expression of MLEC mRNA
CTD
PMID:24136188
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708
G
Mmut
methylmalonyl-CoA mutase
decreases expression
EXP
Glafenine results in decreased expression of MMUT mRNA
CTD
PMID:24136188
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
G
Morf4l2
mortality factor 4 like 2
increases expression
EXP
Glafenine results in increased expression of MORF4L2 mRNA
CTD
PMID:24136188
NCBI chr X:100,082,562...100,093,658
Ensembl chr X:100,082,404...100,093,728
G
Mospd2
motile sperm domain containing 2
decreases expression
EXP
Glafenine results in decreased expression of MOSPD2 mRNA
CTD
PMID:24136188
NCBI chr X:29,420,485...29,472,099
Ensembl chr X:29,420,586...29,462,398
G
Mospd3
motile sperm domain containing 3
increases expression
EXP
Glafenine results in increased expression of MOSPD3 mRNA
CTD
PMID:24136188
NCBI chr12:19,095,203...19,100,303
Ensembl chr12:19,095,242...19,099,477
G
Mpdz
multiple PDZ domain crumbs cell polarity complex component
decreases expression
EXP
Glafenine results in decreased expression of MPDZ mRNA
CTD
PMID:24136188
NCBI chr 5:95,766,112...95,920,531
Ensembl chr 5:95,766,118...95,920,499
G
Mphosph6
M phase phosphoprotein 6
increases expression
EXP
Glafenine results in increased expression of MPHOSPH6 mRNA
CTD
PMID:24136188
NCBI chr19:45,860,152...45,870,117
Ensembl chr19:45,860,154...45,870,170
G
Mppe1
metallophosphoesterase 1
decreases expression
EXP
Glafenine results in decreased expression of MPPE1 mRNA
CTD
PMID:24136188
NCBI chr18:60,763,418...60,781,553
Ensembl chr18:60,763,419...60,781,553
G
Mro
maestro
decreases expression
EXP
Glafenine results in decreased expression of MRO mRNA
CTD
PMID:24136188
NCBI chr18:67,450,186...67,467,593
Ensembl chr18:67,450,595...67,467,044
G
Mrpl12
mitochondrial ribosomal protein L12
increases expression
EXP
Glafenine results in increased expression of MRPL12 mRNA
CTD
PMID:24136188
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
G
Mrpl17
mitochondrial ribosomal protein L17
increases expression
EXP
Glafenine results in increased expression of MRPL17 mRNA
CTD
PMID:24136188
NCBI chr 1:160,162,181...160,163,870
Ensembl chr 1:160,158,807...160,163,815
G
Mrpl41
mitochondrial ribosomal protein L41
increases expression
EXP
Glafenine results in increased expression of MRPL41 mRNA
CTD
PMID:24136188
NCBI chr 3:7,780,658...7,781,576
Ensembl chr 3:7,779,143...7,782,818
G
Mrpl54
mitochondrial ribosomal protein L54
increases expression
EXP
Glafenine results in increased expression of MRPL54 mRNA
CTD
PMID:24136188
NCBI chr 7:8,452,801...8,455,321
Ensembl chr 7:8,452,716...8,455,321
G
Mrpl55
mitochondrial ribosomal protein L55
increases expression
EXP
Glafenine results in increased expression of MRPL55 mRNA
CTD
PMID:24136188
NCBI chr10:43,988,676...43,991,841
Ensembl chr10:43,988,683...43,991,841
G
Mrps16
mitochondrial ribosomal protein S16
increases expression
EXP
Glafenine results in increased expression of MRPS16 mRNA
CTD
PMID:24136188
NCBI chr15:3,918,621...3,921,024
Ensembl chr15:3,918,615...3,921,656
G
Mrps18b
mitochondrial ribosomal protein S18B
increases expression
EXP
Glafenine results in increased expression of MRPS18B mRNA
CTD
PMID:24136188
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
G
Mrps18c
mitochondrial ribosomal protein S18C
increases expression
EXP
Glafenine results in increased expression of MRPS18C mRNA
CTD
PMID:24136188
NCBI chr14:8,812,301...8,818,538
Ensembl chr14:8,791,330...8,818,516
G
Mrps2
mitochondrial ribosomal protein S2
increases expression
EXP
Glafenine results in increased expression of MRPS2 mRNA
CTD
PMID:24136188
NCBI chr 3:11,803,044...11,806,341
Ensembl chr 3:11,801,310...11,806,313
G
Mrps21
mitochondrial ribosomal protein S21
increases expression
EXP
Glafenine results in increased expression of MRPS21 mRNA
CTD
PMID:24136188
NCBI chr 2:183,406,791...183,414,413
Ensembl chr 2:183,406,792...183,414,372
G
Mrps27
mitochondrial ribosomal protein S27
increases expression
EXP
Glafenine results in increased expression of MRPS27 mRNA
CTD
PMID:24136188
NCBI chr 2:30,740,007...30,808,577
Ensembl chr 2:30,740,033...30,808,577
G
Mrps34
mitochondrial ribosomal protein S34
increases expression
EXP
Glafenine results in increased expression of MRPS34 mRNA
CTD
PMID:24136188
NCBI chr10:13,916,024...13,917,155
Ensembl chr10:13,916,026...13,918,406
G
Mrps7
mitochondrial ribosomal protein S7
increases expression
EXP
Glafenine results in increased expression of MRPS7 mRNA
CTD
PMID:24136188
NCBI chr10:100,843,691...100,846,838
Ensembl chr10:100,843,356...100,847,129
G
Mrto4
MRT4 homolog, ribosome maturation factor
increases expression
EXP
Glafenine results in increased expression of MRTO4 mRNA
CTD
PMID:24136188
NCBI chr 5:151,601,780...151,608,533
Ensembl chr 5:151,601,780...151,608,287
G
Msantd4
Myb/SANT DNA binding domain containing 4 with coiled-coils
decreases expression
EXP
Glafenine results in decreased expression of MSANTD4 mRNA
CTD
PMID:24136188
NCBI chr 8:1,516,979...1,527,587
Ensembl chr 8:1,516,979...1,527,587
G
Msn
moesin
increases expression
EXP
Glafenine results in increased expression of MSN mRNA
CTD
PMID:24136188
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Mt1
metallothionein 1
decreases expression
EXP
Glafenine results in decreased expression of MT1A mRNA
CTD
PMID:24136188
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
increases expression
EXP
Glafenine results in increased expression of MT2A mRNA
CTD
PMID:24136188
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtarc1
mitochondrial amidoxime reducing component 1
decreases expression
EXP
Glafenine results in decreased expression of MTARC1 mRNA
CTD
PMID:24136188
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
G
Mtarc2
mitochondrial amidoxime reducing component 2
decreases expression
EXP
Glafenine results in decreased expression of MTARC2 mRNA
CTD
PMID:24136188
NCBI chr13:96,362,810...96,397,284
G
Mthfd1
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1
decreases expression
EXP
Glafenine results in decreased expression of MTHFD1 mRNA
CTD
PMID:24136188
NCBI chr 6:94,977,862...95,045,375
Ensembl chr 6:94,977,862...95,045,372
G
Mthfs
methenyltetrahydrofolate synthetase
decreases expression
EXP
Glafenine results in decreased expression of MTHFS mRNA
CTD
PMID:24136188
NCBI chr 8:89,729,498...89,801,998
Ensembl chr 8:89,729,508...89,799,089
G
Mtmr10
myotubularin related protein 10
decreases expression
EXP
Glafenine results in decreased expression of MTMR10 mRNA
CTD
PMID:24136188
NCBI chr 1:117,859,355...117,910,839
Ensembl chr 1:117,859,267...117,910,849
G
Mtx1
Metaxin 1
increases expression
EXP
Glafenine results in increased expression of MTX1 mRNA
CTD
PMID:24136188
NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:174,615,461...174,620,982
G
Mvk
mevalonate kinase
increases expression
EXP
Glafenine results in increased expression of MVK mRNA
CTD
PMID:24136188
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
G
Mxi1
MAX interactor 1, dimerization protein
decreases expression
EXP
Glafenine results in decreased expression of MXI1 mRNA
CTD
PMID:24136188
NCBI chr 1:252,323,915...252,383,682
Ensembl chr 1:252,323,303...252,383,681
G
Myadm
myeloid-associated differentiation marker
increases expression
EXP
Glafenine results in increased expression of MYADM mRNA
CTD
PMID:24136188
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
G
Mybbp1a
MYB binding protein 1a
increases expression
EXP
Glafenine results in increased expression of MYBBP1A mRNA
CTD
PMID:24136188
NCBI chr10:57,056,897...57,067,258
Ensembl chr10:57,056,874...57,067,255
G
Mydgf
myeloid-derived growth factor
increases expression
EXP
Glafenine results in increased expression of MYDGF mRNA
CTD
PMID:24136188
NCBI chr 9:999,659...1,008,804
Ensembl chr 9:1,000,722...1,008,822
G
Myh9
myosin, heavy chain 9
increases expression
EXP
Glafenine results in increased expression of MYH9 mRNA
CTD
PMID:24136188
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
G
Myl6
myosin light chain 6
increases expression
EXP
Glafenine results in increased expression of MYL6 mRNA
CTD
PMID:24136188
NCBI chr 7:910,764...914,062
Ensembl chr 7:910,774...933,791
G
Mylk
myosin light chain kinase
decreases expression
EXP
Glafenine results in decreased expression of MYLK mRNA
CTD
PMID:24136188
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
G
Myo18a
myosin XVIIIa
increases expression
EXP
Glafenine results in increased expression of MYO18A mRNA
CTD
PMID:24136188
NCBI chr10:62,654,218...62,755,465
Ensembl chr10:62,654,281...62,755,468
G
Myo1d
myosin ID
decreases expression
EXP
Glafenine results in decreased expression of MYO1D mRNA
CTD
PMID:24136188
NCBI chr10:65,489,153...65,765,812
Ensembl chr10:65,489,154...65,766,349
G
Myo1g
myosin IG
increases expression
EXP
Glafenine results in increased expression of MYO1G mRNA
CTD
PMID:24136188
NCBI chr14:81,386,701...81,401,843
Ensembl chr14:81,386,701...81,401,843
G
Naa10
N(alpha)-acetyltransferase 10, NatA catalytic subunit
increases expression
EXP
Glafenine results in increased expression of NAA10 mRNA
CTD
PMID:24136188
NCBI chr X:151,656,056...151,661,304
Ensembl chr X:151,656,056...151,661,252
G
Naa35
N(alpha)-acetyltransferase 35, NatC auxiliary subunit
decreases expression
EXP
Glafenine results in decreased expression of NAA35 mRNA
CTD
PMID:24136188
NCBI chr17:5,034,360...5,086,456
Ensembl chr17:5,034,356...5,086,386
G
Naa38
N(alpha)-acetyltransferase 38, NatC auxiliary subunit
increases expression
EXP
Glafenine results in increased expression of NAA38 mRNA
CTD
PMID:24136188
NCBI chr10:54,117,754...54,118,913
Ensembl chr10:54,117,163...54,119,494
G
Nadk2
NAD kinase 2, mitochondrial
decreases expression
EXP
Glafenine results in decreased expression of NADK2 mRNA
CTD
PMID:24136188
NCBI chr 2:58,117,674...58,159,815
Ensembl chr 2:58,117,674...58,159,808
G
Naga
alpha-N-acetylgalactosaminidase
decreases expression
EXP
Glafenine results in decreased expression of NAGA mRNA
CTD
PMID:24136188
NCBI chr 7:113,846,358...113,855,430
Ensembl chr 7:113,846,374...113,855,315
G
Nans
N-acetylneuraminate synthase
increases expression
EXP
Glafenine results in increased expression of NANS mRNA
CTD
PMID:24136188
NCBI chr 5:60,780,441...60,797,583
Ensembl chr 5:60,780,392...60,814,950
G
Nat9
N-acetyltransferase 9
increases expression
EXP
Glafenine results in increased expression of NAT9 mRNA
CTD
PMID:24136188
NCBI chr10:100,422,326...100,427,510
Ensembl chr10:100,422,331...100,427,611
G
Nbn
nibrin
decreases expression
EXP
Glafenine results in decreased expression of NBN mRNA
CTD
PMID:24136188
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
G
Nckap1
NCK-associated protein 1
decreases expression
EXP
Glafenine results in decreased expression of NCKAP1 mRNA
CTD
PMID:24136188
NCBI chr 3:65,417,450...65,491,769
Ensembl chr 3:65,417,453...65,492,217
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
EXP
Glafenine results in decreased expression of NCOR1 mRNA
CTD
PMID:24136188
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
G
Ndfip1
Nedd4 family interacting protein 1
decreases expression
EXP
Glafenine results in decreased expression of NDFIP1 mRNA
CTD
PMID:24136188
NCBI chr18:30,265,808...30,316,068
Ensembl chr18:30,250,613...30,322,311
G
Ndrg2
NDRG family member 2
decreases expression
EXP
Glafenine results in decreased expression of NDRG2 mRNA
CTD
PMID:24136188
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Nectin2
nectin cell adhesion molecule 2
decreases expression
EXP
Glafenine results in decreased expression of NECTIN2 mRNA
CTD
PMID:24136188
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
G
Nectin3
nectin cell adhesion molecule 3
decreases expression
EXP
Glafenine results in decreased expression of NECTIN3 mRNA
CTD
PMID:24136188
NCBI chr11:54,362,712...54,469,351
Ensembl chr11:54,364,487...54,462,519
G
Nek6
NIMA-related kinase 6
increases expression
EXP
Glafenine results in increased expression of NEK6 mRNA
CTD
PMID:24136188
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
G
Nfatc3
nuclear factor of activated T-cells 3
decreases expression
EXP
Glafenine results in decreased expression of NFATC3 mRNA
CTD
PMID:24136188
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
G
Nfe2l1
NFE2 like bZIP transcription factor 1
decreases expression
EXP
Glafenine results in decreased expression of NFE2L1 mRNA
CTD
PMID:24136188
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
G
Nfib
nuclear factor I/B
decreases expression
EXP
Glafenine results in decreased expression of NFIB mRNA
CTD
PMID:24136188
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
G
Nfix
nuclear factor I X
decreases expression
EXP
Glafenine results in decreased expression of NFIX mRNA
CTD
PMID:24136188
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
G
Nfkb1
nuclear factor kappa B subunit 1
increases expression
EXP
Glafenine results in increased expression of NFKB1 mRNA
CTD
PMID:24136188
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
increases expression
EXP
Glafenine results in increased expression of NFKBIA mRNA
CTD
PMID:24136188
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbib
NFKB inhibitor beta
increases expression
EXP
Glafenine results in increased expression of NFKBIB mRNA
CTD
PMID:24136188
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
G
Nfkbiz
NFKB inhibitor zeta
increases expression
EXP
Glafenine results in increased expression of NFKBIZ mRNA
CTD
PMID:24136188
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Ngef
neuronal guanine nucleotide exchange factor
decreases expression
EXP
Glafenine results in decreased expression of NGEF mRNA
CTD
PMID:24136188
NCBI chr 9:88,146,956...88,244,454
Ensembl chr 9:88,146,956...88,244,914
G
Ngly1
N-glycanase 1
decreases expression
EXP
Glafenine results in decreased expression of NGLY1 mRNA
CTD
PMID:24136188
NCBI chr15:9,153,738...9,210,228
Ensembl chr15:9,153,738...9,204,630
G
Nherf1
NHERF family PDZ scaffold protein 1
increases expression
EXP
Glafenine results in increased expression of NHERF1 mRNA
CTD
PMID:24136188
NCBI chr10:100,403,189...100,420,290
Ensembl chr10:100,403,069...100,420,598
G
Nhp2
NHP2 ribonucleoprotein
increases expression
EXP
Glafenine results in increased expression of NHP2 mRNA
CTD
PMID:24136188
NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545
G
Nim1k
NIM1 serine/threonine protein kinase
decreases expression
EXP
Glafenine results in decreased expression of NIM1K mRNA
CTD
PMID:24136188
NCBI chr 2:51,670,764...51,714,782
Ensembl chr 2:51,670,772...51,714,762
G
Ninj1
ninjurin 1
increases expression
EXP
Glafenine results in increased expression of NINJ1 mRNA
CTD
PMID:24136188
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Nip7
nucleolar pre-rRNA processing protein NIP7
increases expression
EXP
Glafenine results in increased expression of NIP7 mRNA
CTD
PMID:24136188
NCBI chr19:34,962,557...34,964,700
Ensembl chr19:34,962,557...34,964,711
G
Nlrx1
NLR family member X1
decreases expression
EXP
Glafenine results in decreased expression of NLRX1 mRNA
CTD
PMID:24136188
NCBI chr 8:44,588,476...44,606,678
Ensembl chr 8:44,590,048...44,606,484
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
increases expression
EXP
Glafenine results in increased expression of NME1 mRNA
CTD
PMID:24136188
NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
increases expression
EXP
Glafenine results in increased expression of NME2 mRNA
CTD
PMID:24136188
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
G
Nme3
NME/NM23 nucleoside diphosphate kinase 3
decreases expression
EXP
Glafenine results in decreased expression of NME3 mRNA
CTD
PMID:24136188
NCBI chr10:13,917,309...13,918,415
Ensembl chr10:13,917,403...13,918,359
G
Nol12
nucleolar protein 12
increases expression
EXP
Glafenine results in increased expression of NOL12 mRNA
CTD
PMID:24136188
NCBI chr 7:110,493,294...110,498,908
Ensembl chr 7:110,493,246...110,498,907
G
Nol9
nucleolar protein 9
increases expression
EXP
Glafenine results in increased expression of NOL9 mRNA
CTD
PMID:24136188
NCBI chr 5:162,546,522...162,566,625
Ensembl chr 5:162,546,541...162,566,191
G
Nop16
NOP16 nucleolar protein
increases expression
EXP
Glafenine results in increased expression of NOP16 mRNA
CTD
PMID:24136188
NCBI chr17:10,022,950...10,027,867
Ensembl chr17:10,022,932...10,027,867
G
Nop2
NOP2 nucleolar protein
increases expression
EXP
Glafenine results in increased expression of NOP2 mRNA
CTD
PMID:24136188
NCBI chr 4:157,932,731...157,944,462
Ensembl chr 4:157,932,716...157,944,459
G
Nop53
NOP53 ribosome biogenesis factor
decreases expression
EXP
Glafenine results in decreased expression of NOP53 mRNA
CTD
PMID:24136188
NCBI chr 1:76,629,084...76,636,902
Ensembl chr 1:76,629,069...76,636,902
G
Nop56
NOP56 ribonucleoprotein
increases expression
EXP
Glafenine results in increased expression of NOP56 mRNA
CTD
PMID:24136188
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
G
Nop58
NOP58 ribonucleoprotein
increases expression
EXP
Glafenine results in increased expression of NOL5 mRNA
CTD
PMID:24136188
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
G
Nos1ap
nitric oxide synthase 1 adaptor protein
increases expression
EXP
Glafenine results in increased expression of NOS1AP mRNA
CTD
PMID:24136188
NCBI chr13:82,547,799...82,820,999
Ensembl chr13:82,530,577...82,820,949
G
Nostrin
nitric oxide synthase trafficking
increases expression
EXP
Glafenine results in increased expression of NOSTRIN mRNA
CTD
PMID:24136188
NCBI chr 3:53,904,746...53,970,995
Ensembl chr 3:53,904,827...53,970,988
G
Npas2
neuronal PAS domain protein 2
decreases expression
EXP
Glafenine results in decreased expression of NPAS2 mRNA
CTD
PMID:24136188
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
G
Npdc1
neural proliferation, differentiation and control, 1
increases expression
EXP
Glafenine results in increased expression of NPDC1 mRNA
CTD
PMID:24136188
NCBI chr 3:8,220,446...8,226,446
Ensembl chr 3:8,213,663...8,226,866
G
Npm1
nucleophosmin 1
increases expression
EXP
Glafenine results in increased expression of NPM1 mRNA
CTD
PMID:24136188
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
G
Nprl2
NPR2-like, GATOR1 complex subunit
decreases expression
EXP
Glafenine results in decreased expression of NPRL2 mRNA
CTD
PMID:24136188
NCBI chr 8:108,215,823...108,218,996
Ensembl chr 8:108,215,814...108,218,996
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Glafenine results in increased expression of NQO1 mRNA
CTD
PMID:24136188
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression
EXP
Glafenine results in decreased expression of NR1H4 mRNA
CTD
PMID:24136188
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases expression
EXP
Glafenine results in decreased expression of NR1I3 mRNA
CTD
PMID:24136188
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
EXP
Glafenine results in decreased expression of NR3C1 mRNA
CTD
PMID:24136188
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
multiple interactions
ISO
Glafenine binds to and results in increased activity of NR4A2 protein
CTD
PMID:31175960
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nrbf2
nuclear receptor binding factor 2
decreases expression
EXP
Glafenine results in decreased expression of NRBF2 mRNA
CTD
PMID:24136188
NCBI chr20:21,308,555...21,326,881
Ensembl chr20:21,308,576...21,326,818
G
Nrep
neuronal regeneration related protein
decreases expression
EXP
Glafenine results in decreased expression of NREP mRNA
CTD
PMID:24136188
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Nt5e
5' nucleotidase, ecto
decreases expression
EXP
Glafenine results in decreased expression of NT5E mRNA
CTD
PMID:24136188
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Nubpl
NUBP iron-sulfur cluster assembly factor like
decreases expression
EXP
Glafenine results in decreased expression of NUBPL mRNA
CTD
PMID:24136188
NCBI chr 6:69,559,278...69,781,254
Ensembl chr 6:69,559,291...69,781,253
G
Nucb2
nucleobindin 2
increases expression
EXP
Glafenine results in increased expression of NUCB2 mRNA
CTD
PMID:24136188
NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
G
Nudt12
nudix hydrolase 12
decreases expression
EXP
Glafenine results in decreased expression of NUDT12 mRNA
CTD
PMID:24136188
NCBI chr 9:98,741,627...98,755,039
Ensembl chr 9:98,742,360...98,755,039
G
Nudt14
nudix hydrolase 14
decreases expression
EXP
Glafenine results in decreased expression of NUDT14 mRNA
CTD
PMID:24136188
NCBI chr 6:132,010,309...132,017,298
Ensembl chr 6:132,010,297...132,017,298
G
Nus1
NUS1 dehydrodolichyl diphosphate synthase subunit
increases expression
EXP
Glafenine results in increased expression of NUS1 mRNA
CTD
PMID:24136188
NCBI chr20:31,811,817...31,838,562
Ensembl chr20:31,811,817...31,838,561
G
Nxt2
nuclear transport factor 2-like export factor 2
decreases expression
EXP
Glafenine results in decreased expression of NXT2 mRNA
CTD
PMID:24136188
NCBI chr X:105,855,616...105,862,902
Ensembl chr X:105,855,608...105,862,899
G
Oaf
out at first homolog
decreases expression
EXP
Glafenine results in decreased expression of OAF mRNA
CTD
PMID:24136188
NCBI chr 8:43,594,362...43,612,334
Ensembl chr 8:43,594,363...43,612,334
G
Oat
ornithine aminotransferase
decreases expression
EXP
Glafenine results in decreased expression of OAT mRNA
CTD
PMID:24136188
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Oaz2
ornithine decarboxylase antizyme 2
decreases expression
EXP
Glafenine results in decreased expression of OAZ2 mRNA
CTD
PMID:24136188
NCBI chr 8:66,199,694...66,213,513
Ensembl chr 8:66,199,706...66,231,453
G
Odc1
ornithine decarboxylase 1
increases expression
EXP
Glafenine results in increased expression of ODC1 mRNA
CTD
PMID:24136188
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Ola1
Obg-like ATPase 1
increases expression
EXP
Glafenine results in increased expression of OLA1 mRNA
CTD
PMID:24136188
NCBI chr 3:57,966,896...58,085,955
Ensembl chr 3:57,966,896...58,084,480
G
Oplah
5-oxoprolinase (ATP-hydrolysing)
decreases expression
EXP
Glafenine results in decreased expression of OPLAH mRNA
CTD
PMID:24136188
NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297
G
Orc2
origin recognition complex, subunit 2
increases expression
EXP
Glafenine results in increased expression of ORC2 mRNA
CTD
PMID:24136188
NCBI chr 9:60,001,631...60,038,301
Ensembl chr 9:60,001,910...60,038,195
G
Orc4
origin recognition complex, subunit 4
decreases expression
EXP
Glafenine results in decreased expression of ORC4 mRNA
CTD
PMID:24136188
NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824
G
Orm1
orosomucoid 1
increases expression
EXP
Glafenine results in increased expression of ORM1 mRNA
CTD
PMID:24136188
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Ormdl3
ORMDL sphingolipid biosynthesis regulator 3
decreases expression
EXP
Glafenine results in decreased expression of ORMDL3 mRNA
CTD
PMID:24136188
NCBI chr10:83,590,052...83,596,035
Ensembl chr10:83,590,071...83,598,620
G
Osbpl11
oxysterol binding protein-like 11
decreases expression
EXP
Glafenine results in decreased expression of OSBPL11 mRNA
CTD
PMID:24136188
NCBI chr11:67,533,669...67,616,795
Ensembl chr11:67,533,672...67,596,444
G
Osbpl8
oxysterol binding protein-like 8
decreases expression
EXP
Glafenine results in decreased expression of OSBPL8 mRNA
CTD
PMID:24136188
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
G
Osbpl9
oxysterol binding protein-like 9
decreases expression
EXP
Glafenine results in decreased expression of OSBPL9 mRNA
CTD
PMID:24136188
NCBI chr 5:123,819,106...123,962,213
Ensembl chr 5:123,819,104...123,962,196
G
Osgep
O-sialoglycoprotein endopeptidase
increases expression
EXP
Glafenine results in increased expression of OSGEP mRNA
CTD
PMID:24136188
NCBI chr15:24,137,149...24,144,568
Ensembl chr15:24,137,153...24,144,568
G
Ost4
oligosaccharyltransferase complex subunit 4, non-catalytic
increases expression
EXP
Glafenine results in increased expression of OST4 mRNA
CTD
PMID:24136188
NCBI chr 6:25,471,254...25,472,478
G
Ostc
oligosaccharyltransferase complex non-catalytic subunit
increases expression
EXP
Glafenine results in increased expression of OSTC mRNA
CTD
PMID:24136188
NCBI chr 2:219,250,549...219,266,076
Ensembl chr 2:219,236,952...219,266,107
G
Otc
ornithine transcarbamylase
decreases expression
EXP
Glafenine results in decreased expression of OTC mRNA
CTD
PMID:24136188
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
G
P2ry14
purinergic receptor P2Y14
decreases expression
EXP
Glafenine results in decreased expression of P2RY14 mRNA
CTD
PMID:24136188
NCBI chr 2:143,372,697...143,413,213
Ensembl chr 2:143,372,697...143,413,141
G
P3h1
prolyl 3-hydroxylase 1
increases expression
EXP
Glafenine results in increased expression of P3H1 mRNA
CTD
PMID:24136188
NCBI chr 5:132,841,868...132,856,664
Ensembl chr 5:132,841,928...132,856,659
G
P4hb
prolyl 4-hydroxylase subunit beta
increases expression
EXP
Glafenine results in increased expression of P4HB mRNA
CTD
PMID:24136188
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
G
Pa2g4
proliferation-associated 2G4
increases expression
EXP
Glafenine results in increased expression of PA2G4 mRNA
CTD
PMID:24136188
NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331
G
Pabpn1
poly(A) binding protein, nuclear 1
increases expression
EXP
Glafenine results in increased expression of PABPN1 mRNA
CTD
PMID:24136188
NCBI chr15:28,368,100...28,372,712
Ensembl chr15:28,368,100...28,372,703
G
Pah
phenylalanine hydroxylase
decreases expression
EXP
Glafenine results in decreased expression of PAH mRNA
CTD
PMID:24136188
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
G
Paics
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
decreases expression
EXP
Glafenine results in decreased expression of PAICS mRNA
CTD
PMID:24136188
NCBI chr14:31,199,086...31,232,731
Ensembl chr14:31,173,541...31,232,635
G
Pak1ip1
PAK1 interacting protein 1
increases expression
EXP
Glafenine results in increased expression of PAK1IP1 mRNA
CTD
PMID:24136188
NCBI chr17:23,742,217...23,753,325
Ensembl chr17:23,741,414...23,753,324
G
Palmd
palmdelphin
decreases expression
EXP
Glafenine results in decreased expression of PALMD mRNA
CTD
PMID:24136188
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
G
Pals1
protein associated with LIN7 1, MAGUK p55 family member
decreases expression
EXP
Glafenine results in decreased expression of PALS1 mRNA
CTD
PMID:24136188
NCBI chr 6:97,548,133...97,654,163
Ensembl chr 6:97,548,630...97,653,305
G
Pam
peptidylglycine alpha-amidating monooxygenase
decreases expression
EXP
Glafenine results in decreased expression of PAM mRNA
CTD
PMID:24136188
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Pank1
pantothenate kinase 1
decreases expression
EXP
Glafenine results in decreased expression of PANK1 mRNA
CTD
PMID:24136188
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
G
Paox
polyamine oxidase
increases expression
EXP
Glafenine results in increased expression of PAOX mRNA
CTD
PMID:24136188
NCBI chr 1:194,919,655...194,928,498
Ensembl chr 1:194,903,273...194,928,504
G
Papss1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
increases expression
EXP
Glafenine results in increased expression of PAPSS1 mRNA
CTD
PMID:24136188
NCBI chr 2:220,040,343...220,114,399
Ensembl chr 2:220,040,312...220,114,395
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
decreases expression
EXP
Glafenine results in decreased expression of PAPSS2 mRNA
CTD
PMID:24136188
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
G
Pbdc1
polysaccharide biosynthesis domain containing 1
increases expression
EXP
Glafenine results in increased expression of PBDC1 mRNA
CTD
PMID:24136188
NCBI chr X:70,154,106...70,197,827
Ensembl chr X:70,154,106...70,184,552
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of PBLD1 mRNA
CTD
PMID:24136188
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
G
Pbxip1
PBX homeobox interacting protein 1
decreases expression
EXP
Glafenine results in decreased expression of PBXIP1 mRNA
CTD
PMID:24136188
NCBI chr 2:174,856,339...174,868,922
Ensembl chr 2:174,856,397...174,868,919
G
Pcca
propionyl-CoA carboxylase subunit alpha
decreases expression
EXP
Glafenine results in decreased expression of PCCA mRNA
CTD
PMID:24136188
NCBI chr15:99,627,955...99,969,555
Ensembl chr15:99,627,982...99,968,266
G
Pcdh18
protocadherin 18
increases expression
EXP
Glafenine results in increased expression of PCDH18 mRNA
CTD
PMID:24136188
NCBI chr 2:133,831,996...133,845,992
Ensembl chr 2:133,832,001...133,845,883
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
increases expression
EXP
Glafenine results in increased expression of PCK2 mRNA
CTD
PMID:24136188
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
G
Pcmtd1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of PCMTD1 mRNA
CTD
PMID:24136188
NCBI chr 5:12,284,711...12,355,680
Ensembl chr 5:12,284,711...12,354,899
G
Pcmtd2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
decreases expression
EXP
Glafenine results in decreased expression of PCMTD2 mRNA
CTD
PMID:24136188
NCBI chr 3:168,960,312...168,979,504
Ensembl chr 3:168,960,305...168,979,497
G
Pcnx1
pecanex 1
decreases expression
EXP
Glafenine results in decreased expression of PCNX1 mRNA
CTD
PMID:24136188
NCBI chr 6:101,565,461...101,702,339
Ensembl chr 6:101,565,580...101,702,271
G
Pcolce
procollagen C-endopeptidase enhancer
increases expression
EXP
Glafenine results in increased expression of PCOLCE mRNA
CTD
PMID:24136188
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
increases expression
EXP
Glafenine results in increased expression of PCSK9 mRNA
CTD
PMID:24136188
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
G
Pdcd11
programmed cell death 11
increases expression
EXP
Glafenine results in increased expression of PDCD11 mRNA
CTD
PMID:24136188
NCBI chr 1:245,980,840...246,021,999
Ensembl chr 1:245,980,880...246,021,999
G
Pdcd6ip
programmed cell death 6 interacting protein
decreases expression
EXP
Glafenine results in decreased expression of PDCD6IP mRNA
CTD
PMID:24136188
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
G
Pde3b
phosphodiesterase 3B
decreases expression
EXP
Glafenine results in decreased expression of PDE3B mRNA
CTD
PMID:24136188
NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:168,607,022...168,769,334
G
Pde8a
phosphodiesterase 8A
decreases expression
EXP
Glafenine results in decreased expression of PDE8A mRNA
CTD
PMID:24136188
NCBI chr 1:135,166,143...135,288,986
Ensembl chr 1:135,166,237...135,288,024
G
Pdia4
protein disulfide isomerase family A, member 4
increases expression
EXP
Glafenine results in increased expression of PDIA4 mRNA
CTD
PMID:24136188
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pdia6
protein disulfide isomerase family A, member 6
increases expression
EXP
Glafenine results in increased expression of PDIA6 mRNA
CTD
PMID:24136188
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
G
Pdk2
pyruvate dehydrogenase kinase 2
decreases expression
EXP
Glafenine results in decreased expression of PDK2 mRNA
CTD
PMID:24136188
NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
decreases expression
EXP
Glafenine results in decreased expression of PDP2 mRNA
CTD
PMID:24136188
NCBI chr19:386,408...394,068
Ensembl chr19:386,406...394,074
G
Pdzd11
PDZ domain containing 11
increases expression
EXP
Glafenine results in increased expression of PDZD11 mRNA
CTD
PMID:24136188
NCBI chr X:65,718,689...65,721,742
Ensembl chr X:65,704,067...65,721,642
G
Pdzk1
PDZ domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of PDZK1 mRNA
CTD
PMID:24136188
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
G
Pdzrn3
PDZ domain containing RING finger 3
decreases expression
EXP
Glafenine results in decreased expression of PDZRN3 mRNA
CTD
PMID:24136188
NCBI chr 4:133,770,736...133,996,959
Ensembl chr 4:133,770,736...133,996,959
G
Perp
p53 apoptosis effector related to PMP22
decreases expression
EXP
Glafenine results in decreased expression of PERP mRNA
CTD
PMID:24136188
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
G
Pex11a
peroxisomal biogenesis factor 11 alpha
decreases expression
EXP
Glafenine results in decreased expression of PEX11A mRNA
CTD
PMID:24136188
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
G
Pex12
peroxisomal biogenesis factor 12
decreases expression
EXP
Glafenine results in decreased expression of PEX12 mRNA
CTD
PMID:24136188
NCBI chr10:68,095,776...68,103,812
Ensembl chr10:68,095,776...68,099,428
G
Pex13
peroxisomal biogenesis factor 13
decreases expression
EXP
Glafenine results in decreased expression of PEX13 mRNA
CTD
PMID:24136188
NCBI chr14:97,602,829...97,621,233
Ensembl chr14:97,603,539...97,621,262
G
Pex19
peroxisomal biogenesis factor 19
decreases expression
EXP
Glafenine results in decreased expression of PEX19 mRNA
CTD
PMID:24136188
NCBI chr13:84,592,277...84,608,793
Ensembl chr13:84,592,312...84,608,608
G
Pex5
peroxisomal biogenesis factor 5
decreases expression
EXP
Glafenine results in decreased expression of PEX5 mRNA
CTD
PMID:24136188
NCBI chr 4:157,270,671...157,296,432
Ensembl chr 4:157,270,672...157,296,431
G
Pfn1
profilin 1
increases expression
EXP
Glafenine results in increased expression of PFN1 mRNA
CTD
PMID:24136188
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
G
Pgrmc1
progesterone receptor membrane component 1
decreases expression
EXP
Glafenine results in decreased expression of PGRMC1 mRNA
CTD
PMID:24136188
NCBI chr X:115,832,865...115,841,060
Ensembl chr X:115,832,884...115,888,682
G
Pgrmc2
progesterone receptor membrane component 2
decreases expression
EXP
Glafenine results in decreased expression of PGRMC2 mRNA
CTD
PMID:24136188
NCBI chr 2:124,068,257...124,084,155
Ensembl chr 2:124,068,260...124,084,155
G
Pgs1
phosphatidylglycerophosphate synthase 1
increases expression
EXP
Glafenine results in increased expression of PGS1 mRNA
CTD
PMID:24136188
NCBI chr10:103,214,635...103,250,254
Ensembl chr10:103,214,646...103,250,254
G
Phgdh
phosphoglycerate dehydrogenase
increases expression
EXP
Glafenine results in increased expression of PHGDH mRNA
CTD
PMID:24136188
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phpt1
phosphohistidine phosphatase 1
increases expression
EXP
Glafenine results in increased expression of PHPT1 mRNA
CTD
PMID:24136188
NCBI chr 3:8,392,926...8,394,325
G
Phtf1
putative homeodomain transcription factor 1
decreases expression
EXP
Glafenine results in decreased expression of PHTF1 mRNA
CTD
PMID:24136188
NCBI chr 2:191,470,849...191,537,399
Ensembl chr 2:191,473,130...191,512,078
G
Phyhd1
phytanoyl-CoA dioxygenase domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of PHYHD1 mRNA
CTD
PMID:24136188
NCBI chr 3:13,535,670...13,553,797
Ensembl chr 3:13,540,056...13,553,797
G
Pink1
PTEN induced kinase 1
decreases expression
EXP
Glafenine results in decreased expression of PINK1 mRNA
CTD
PMID:24136188
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Pip4k2c
phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
decreases expression
EXP
Glafenine results in decreased expression of PIP4K2C mRNA
CTD
PMID:24136188
NCBI chr 7:63,020,004...63,035,086
Ensembl chr 7:63,020,000...63,035,078
G
Pithd1
PITH domain containing 1
decreases expression
EXP
Glafenine results in decreased expression of PITHD1 mRNA
CTD
PMID:24136188
NCBI chr 5:148,205,995...148,216,490
Ensembl chr 5:148,205,998...148,217,080
G
Pkn2
protein kinase N2
decreases expression
EXP
Glafenine results in decreased expression of PKN2 mRNA
CTD
PMID:24136188
NCBI chr 2:231,793,584...231,898,953
Ensembl chr 2:231,793,584...231,898,953
G
Pkp2
plakophilin 2
increases expression
EXP
Glafenine results in increased expression of PKP2 mRNA
CTD
PMID:24136188
NCBI chr11:84,661,783...84,727,730
Ensembl chr11:84,661,783...84,727,730
G
Pkp4
plakophilin 4
decreases expression
EXP
Glafenine results in decreased expression of PKP4 mRNA
CTD
PMID:24136188
NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:43,631,880...43,835,474
G
Pla1a
phospholipase A1 member A
increases expression
EXP
Glafenine results in increased expression of PLA1A mRNA
CTD
PMID:24136188
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
G
Plac8
placenta associated 8
increases expression
EXP
Glafenine results in increased expression of PLAC8 mRNA
CTD
PMID:24136188
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
G
Plekha5
pleckstrin homology domain containing A5
decreases expression
EXP
Glafenine results in decreased expression of PLEKHA5 mRNA
CTD
PMID:24136188
NCBI chr 4:173,333,891...173,503,546
Ensembl chr 4:173,334,055...173,503,546
G
Plekhf2
pleckstrin homology and FYVE domain containing 2
decreases expression
EXP
Glafenine results in decreased expression of PLEKHF2 mRNA
CTD
PMID:24136188
NCBI chr 5:24,091,077...24,106,758
Ensembl chr 5:24,090,688...24,106,601
G
Plin2
perilipin 2
decreases expression
EXP
Glafenine results in decreased expression of PLIN2 mRNA
CTD
PMID:24136188
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plk2
polo-like kinase 2
decreases expression
EXP
Glafenine results in decreased expression of PLK2 mRNA
CTD
PMID:24136188
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Plpp3
phospholipid phosphatase 3
decreases expression
EXP
Glafenine results in decreased expression of PLPP3 mRNA
CTD
PMID:24136188
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Plpp5
phospholipid phosphatase 5
increases expression
EXP
Glafenine results in increased expression of PLPP5 mRNA
CTD
PMID:24136188
NCBI chr16:66,349,483...66,353,887
Ensembl chr16:66,349,502...66,464,797
G
Pls1
plastin 1
decreases expression
EXP
Glafenine results in decreased expression of PLS1 mRNA
CTD
PMID:24136188
NCBI chr 8:96,316,703...96,426,592
Ensembl chr 8:96,317,849...96,385,195
G
Pls3
plastin 3
decreases expression
EXP
Glafenine results in decreased expression of PLS3 mRNA
CTD
PMID:24136188
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
G
Plxna2
plexin A2
increases expression
EXP
Glafenine results in increased expression of PLXNA2 mRNA
CTD
PMID:24136188
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
G
Plxnb1
plexin B1
increases expression
EXP
Glafenine results in increased expression of PLXNB1 mRNA
CTD
PMID:24136188
NCBI chr 8:109,743,470...109,769,153
Ensembl chr 8:109,744,697...109,769,027
G
Pmm2
phosphomannomutase 2
increases expression
EXP
Glafenine results in increased expression of PMM2 mRNA
CTD
PMID:24136188
NCBI chr10:6,961,521...6,982,913
Ensembl chr10:6,961,709...6,983,098
G
Pnkd
PNKD metallo-beta-lactamase domain containing
decreases expression
EXP
Glafenine results in decreased expression of PNKD mRNA
CTD
PMID:24136188
NCBI chr 9:75,868,620...75,937,126
Ensembl chr 9:75,867,468...75,937,124
G
Pnpla7
patatin-like phospholipase domain containing 7
decreases expression
EXP
Glafenine results in decreased expression of PNPLA7 mRNA
CTD
PMID:24136188
NCBI chr 3:7,782,572...7,861,504
Ensembl chr 3:7,782,572...7,861,497
G
Poglut2
protein O-glucosyltransferase 2
increases expression
EXP
Glafenine results in increased expression of POGLUT2 mRNA
CTD
PMID:24136188
NCBI chr 9:46,256,388...46,268,714
Ensembl chr 9:46,256,390...46,268,532
G
Polg
DNA polymerase gamma, catalytic subunit
decreases expression
EXP
Glafenine results in decreased expression of POLG mRNA
CTD
PMID:24136188
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
G
Polr2c
RNA polymerase II subunit C
increases expression
EXP
Glafenine results in increased expression of POLR2C mRNA
CTD
PMID:24136188
NCBI chr19:10,158,153...10,164,935
Ensembl chr19:10,157,823...10,164,945
G
Polr2h-ps1
polymerase (RNA) II (DNA directed) polypeptide H, pseudogene 1
increases expression
EXP
Glafenine results in increased expression of POLR2H-PS1 mRNA
CTD
PMID:24136188
NCBI chr10:104,854,977...104,856,390
G
Polr2i
RNA polymerase II subunit I
increases expression
EXP
Glafenine results in increased expression of POLR2I mRNA
CTD
PMID:24136188
NCBI chr 1:85,483,515...85,484,952
Ensembl chr 1:85,483,515...85,484,952
G
Polr2l
RNA polymerase II, I and III subunit L
increases expression
EXP
Glafenine results in increased expression of POLR2L mRNA
CTD
PMID:24136188
NCBI chr 1:196,570,051...196,572,060
G
Polr3d
RNA polymerase III subunit D
increases expression
EXP
Glafenine results in increased expression of POLR3D mRNA
CTD
PMID:24136188
NCBI chr15:45,511,587...45,516,256
Ensembl chr15:45,511,589...45,516,353
G
Polr3h
RNA polymerase III subunit H
increases expression
EXP
Glafenine results in increased expression of POLR3H mRNA
CTD
PMID:24136188
NCBI chr 7:113,429,434...113,439,743
Ensembl chr 7:113,429,451...113,439,778
G
Pon2
paraoxonase 2
decreases expression
EXP
Glafenine results in decreased expression of PON2 mRNA
CTD
PMID:24136188
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
G
Pon3
paraoxonase 3
decreases expression
EXP
Glafenine results in decreased expression of PON3 mRNA
CTD
PMID:24136188
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Pop7
POP7 homolog, ribonuclease P/MRP subunit
increases expression
EXP
Glafenine results in increased expression of POP7 mRNA
CTD
PMID:24136188
NCBI chr12:19,189,384...19,190,425
Ensembl chr12:19,189,138...19,190,674
G
Ppan
peter pan homolog
increases expression
EXP
Glafenine results in increased expression of PPAN mRNA
CTD
PMID:24136188
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
G
Ppfibp2
PPFIA binding protein 2
decreases expression
EXP
Glafenine results in decreased expression of PPFIBP2 mRNA
CTD
PMID:24136188
NCBI chr 1:161,504,774...161,687,339
Ensembl chr 1:161,504,890...161,655,212
G
Ppib
peptidylprolyl isomerase B
increases expression
EXP
Glafenine results in increased expression of PPIB mRNA
CTD
PMID:24136188
NCBI chr 8:66,603,877...66,609,734
Ensembl chr 8:66,603,861...66,630,428
G
Ppil3
peptidylprolyl isomerase like 3
increases expression
EXP
Glafenine results in increased expression of PPIL3 mRNA
CTD
PMID:24136188
NCBI chr 9:59,966,405...59,980,147
Ensembl chr 9:59,964,919...59,979,886
G
Ppm1a
protein phosphatase, Mg2+/Mn2+ dependent, 1A
decreases expression
EXP
Glafenine results in decreased expression of PPM1A mRNA
CTD
PMID:24136188
NCBI chr 6:91,439,094...91,486,139
Ensembl chr 6:91,438,834...91,480,697
G
Ppm1b
protein phosphatase, Mg2+/Mn2+ dependent, 1B
decreases expression
EXP
Glafenine results in decreased expression of PPM1B mRNA
CTD
PMID:24136188
NCBI chr 6:9,646,695...9,707,471
Ensembl chr 6:9,655,765...9,707,974
G
Ppp1r14a
protein phosphatase 1, regulatory (inhibitor) subunit 14A
increases expression
EXP
Glafenine results in increased expression of PPP1R14A mRNA
CTD
PMID:24136188
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
increases expression
EXP
Glafenine results in increased expression of PPP1R14B mRNA
CTD
PMID:24136188
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
G
Ppp1r15b
protein phosphatase 1, regulatory subunit 15B
decreases expression
EXP
Glafenine results in decreased expression of PPP1R15B mRNA
CTD
PMID:24136188
NCBI chr13:44,577,840...44,585,737
Ensembl chr13:44,577,932...44,585,737
G
Ppp1r21
protein phosphatase 1, regulatory subunit 21
decreases expression
EXP
Glafenine results in decreased expression of PPP1R21 mRNA
CTD
PMID:24136188
NCBI chr 6:5,901,518...5,970,684
Ensembl chr 6:5,901,518...5,970,684
G
Ppp2r5d
protein phosphatase 2, regulatory subunit B', delta
decreases expression
EXP
Glafenine results in decreased expression of PPP2R5D mRNA
CTD
PMID:24136188
NCBI chr 9:14,270,364...14,300,396
Ensembl chr 9:14,268,745...14,300,400
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
decreases expression
EXP
Glafenine results in decreased expression of PPP2R5E mRNA
CTD
PMID:24136188
NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:94,168,846...94,317,872
G
Ppp4r2
protein phosphatase 4, regulatory subunit 2
decreases expression
EXP
Glafenine results in decreased expression of PPP4R2 mRNA
CTD
PMID:24136188
NCBI chr 4:133,454,555...133,495,486
Ensembl chr 4:133,454,555...133,495,486
G
Ppt1
palmitoyl-protein thioesterase 1
decreases expression
EXP
Glafenine results in decreased expression of PPT1 mRNA
CTD
PMID:24136188
NCBI chr 5:135,121,164...135,142,048
Ensembl chr 5:135,121,163...135,142,048
G
Pptc7
protein phosphatase targeting COQ7
decreases expression
EXP
Glafenine results in decreased expression of PPTC7 mRNA
CTD
PMID:24136188
NCBI chr12:34,249,963...34,288,339
Ensembl chr12:34,249,977...34,288,339
G
Prdm15
PR/SET domain 15
decreases expression
EXP
Glafenine results in decreased expression of PRDM15 mRNA
CTD
PMID:24136188
NCBI chr11:37,164,608...37,225,172
Ensembl chr11:37,165,575...37,222,207
G
Preb
prolactin regulatory element binding
increases expression
EXP
Glafenine results in increased expression of PREB mRNA
CTD
PMID:24136188
NCBI chr 6:25,418,805...25,422,594
Ensembl chr 6:25,418,776...25,422,590
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
decreases expression
EXP
Glafenine results in decreased expression of PRKAA2 mRNA
CTD
PMID:24136188
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prkci
protein kinase C, iota
decreases expression
EXP
Glafenine results in decreased expression of PRKCI mRNA
CTD
PMID:24136188
NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352
G
Prkcsh
PRKCSH beta subunit of glucosidase II
increases expression
EXP
Glafenine results in increased expression of PRKCSH mRNA
CTD
PMID:24136188
NCBI chr 8:20,534,787...20,546,493
Ensembl chr 8:20,534,880...20,546,492
G
Prmt1
protein arginine methyltransferase 1
increases expression
EXP
Glafenine results in increased expression of PRMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:95,458,853...95,468,176
Ensembl chr 1:95,458,850...95,468,345
G
Prodh
proline dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of PRODH mRNA
CTD
PMID:24136188
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
G
Pros1
protein S
decreases expression
EXP
Glafenine results in decreased expression of PROS1 mRNA
CTD
PMID:24136188
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Prrc1
proline-rich coiled-coil 1
increases expression
EXP
Glafenine results in increased expression of PRRC1 mRNA
CTD
PMID:24136188
NCBI chr18:50,812,548...50,846,273
Ensembl chr18:50,812,552...50,849,476
G
Prss23
serine protease 23
decreases expression
EXP
Glafenine results in decreased expression of PRSS23 mRNA
CTD
PMID:24136188
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
G
Prss54
serine protease 54
increases expression
EXP
Glafenine results in increased expression of PRSS54 mRNA
CTD
PMID:24136188
NCBI chr19:9,479,995...9,496,838
Ensembl chr19:9,479,995...9,496,835
G
Prxl2b
peroxiredoxin like 2B
increases expression
EXP
Glafenine results in increased expression of PRXL2B mRNA
CTD
PMID:24136188
NCBI chr 5:165,462,610...165,465,213
G
Psmc3
proteasome 26S subunit, ATPase 3
decreases expression
EXP
Glafenine results in decreased expression of PSMC3 mRNA
CTD
PMID:24136188
NCBI chr 3:77,031,825...77,037,207
Ensembl chr 3:77,031,825...77,043,358
G
Psmc6
proteasome 26S subunit, ATPase 6
decreases expression
EXP
Glafenine results in decreased expression of PSMC6 mRNA
CTD
PMID:24136188
NCBI chr15:18,542,585...18,564,057
Ensembl chr15:18,542,563...18,564,055
G
Psmd11
proteasome 26S subunit, non-ATPase 11
decreases expression
EXP
Glafenine results in decreased expression of PSMD11 mRNA
CTD
PMID:24136188
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
G
Psmd14
proteasome 26S subunit, non-ATPase 14
increases expression
EXP
Glafenine results in increased expression of PSMD14 mRNA
CTD
PMID:24136188
NCBI chr 3:46,254,338...46,347,076
Ensembl chr 3:46,254,330...46,347,076
G
Psmd5
proteasome 26S subunit, non-ATPase 5
decreases expression
EXP
Glafenine results in decreased expression of PSMD5 mRNA
CTD
PMID:24136188
NCBI chr 3:18,133,715...18,151,000
Ensembl chr 3:18,133,717...18,151,029
G
Psph
phosphoserine phosphatase
increases expression
EXP
Glafenine results in increased expression of PSPH mRNA
CTD
PMID:24136188
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Ptger3
prostaglandin E receptor 3
decreases expression
EXP
Glafenine results in decreased expression of PTGER3 mRNA
CTD
PMID:24136188
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
G
Ptgis
prostaglandin I2 synthase
decreases expression
EXP
Glafenine results in decreased expression of PTGIS mRNA
CTD
PMID:24136188
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Ptgr1
prostaglandin reductase 1
decreases expression
EXP
Glafenine results in decreased expression of PTGR1 mRNA
CTD
PMID:24136188
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptma
prothymosin alpha
increases expression
EXP
Glafenine results in increased expression of PTMA mRNA
CTD
PMID:24136188
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
increases expression
EXP
Glafenine results in increased expression of PTPN2 mRNA
CTD
PMID:24136188
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
G
Ptpn3
protein tyrosine phosphatase, non-receptor type 3
increases expression
EXP
Glafenine results in increased expression of PTPN3 mRNA
CTD
PMID:24136188
NCBI chr 5:71,908,520...72,027,323
Ensembl chr 5:71,911,135...72,065,443
G
Ptrh2
peptidyl-tRNA hydrolase 2
increases expression
EXP
Glafenine results in increased expression of PTRH2 mRNA
CTD
PMID:24136188
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
G
Pum3
pumilio RNA-binding family member 3
increases expression
EXP
Glafenine results in increased expression of PUM3 mRNA
CTD
PMID:24136188
NCBI chr 1:225,074,332...225,113,995
Ensembl chr 1:225,074,333...225,114,025
G
Pxylp1
2-phosphoxylose phosphatase 1
decreases expression
EXP
Glafenine results in decreased expression of PXYLP1 mRNA
CTD
PMID:24136188
NCBI chr 8:97,419,766...97,485,163
Ensembl chr 8:97,419,776...97,485,064
G
Pycr1
pyrroline-5-carboxylate reductase 1
increases expression
EXP
Glafenine results in increased expression of PYCR1 mRNA
CTD
PMID:24136188
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Pygl
glycogen phosphorylase L
decreases expression
EXP
Glafenine results in decreased expression of PYGL mRNA
CTD
PMID:24136188
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Qng1
Q-nucleotide N-glycosylase 1
decreases expression
EXP
Glafenine results in decreased expression of QNG1 mRNA
CTD
PMID:24136188
NCBI chr17:6,281,377...6,288,976
Ensembl chr17:6,281,400...6,288,975
G
Qpctl
glutaminyl-peptide cyclotransferase-like
increases expression
EXP
Glafenine results in increased expression of QPCTL mRNA
CTD
PMID:24136188
NCBI chr 1:78,786,730...78,797,956
Ensembl chr 1:78,788,739...78,797,811
G
Rab30
RAB30, member RAS oncogene family
decreases expression
EXP
Glafenine results in decreased expression of RAB30 mRNA
CTD
PMID:24136188
NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181
G
Rab34
RAB34, member RAS oncogene family
decreases expression
EXP
Glafenine results in decreased expression of RAB34 mRNA
CTD
PMID:24136188
NCBI chr10:63,083,319...63,087,538
Ensembl chr10:63,083,338...63,087,538
G
Rab38
RAB38, member RAS oncogene family
decreases expression
EXP
Glafenine results in decreased expression of RAB38 mRNA
CTD
PMID:24136188
NCBI chr 1:142,182,566...142,262,923
Ensembl chr 1:142,182,556...142,262,924
G
Rabac1
Rab acceptor 1
increases expression
EXP
Glafenine results in increased expression of RABAC1 mRNA
CTD
PMID:24136188
NCBI chr 1:80,564,029...80,567,164
Ensembl chr 1:80,564,033...80,567,163
G
Rack1
receptor for activated C kinase 1
increases expression
EXP
Glafenine results in increased expression of RACK1 mRNA
CTD
PMID:24136188
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
G
Rad21
RAD21 cohesin complex component
decreases expression
EXP
Glafenine results in decreased expression of RAD21 mRNA
CTD
PMID:24136188
NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
EXP
Glafenine results in decreased expression of RAD23A mRNA
CTD
PMID:24136188
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Ralb
RAS like proto-oncogene B
increases expression
EXP
Glafenine results in increased expression of RALB mRNA
CTD
PMID:24136188
NCBI chr13:30,588,036...30,624,199
Ensembl chr13:30,588,033...30,624,202
G
Ralgps2
Ral GEF with PH domain and SH3 binding motif 2
decreases expression
EXP
Glafenine results in decreased expression of RALGPS2 mRNA
CTD
PMID:24136188
NCBI chr13:68,924,674...69,104,637
Ensembl chr13:68,928,474...69,056,549
G
Ramp2
receptor activity modifying protein 2
increases expression
EXP
Glafenine results in increased expression of RAMP2 mRNA
CTD
PMID:24136188
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
G
Ran
RAN, member RAS oncogene family
increases expression
EXP
Glafenine results in increased expression of RAN mRNA
CTD
PMID:24136188
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Ranbp10
RAN binding protein 10
decreases expression
EXP
Glafenine results in decreased expression of RANBP10 mRNA
CTD
PMID:24136188
NCBI chr19:33,656,046...33,716,864
Ensembl chr19:33,656,046...33,717,033
G
Rangap1
RAN GTPase activating protein 1
increases expression
EXP
Glafenine results in increased expression of RANGAP1 mRNA
CTD
PMID:24136188
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
G
Rangrf
RAN guanine nucleotide release factor
increases expression
EXP
Glafenine results in increased expression of RANGRF mRNA
CTD
PMID:24136188
NCBI chr10:53,677,467...53,678,880
Ensembl chr10:53,677,467...53,678,840
G
Rassf6
Ras association domain family member 6
decreases expression
EXP
Glafenine results in decreased expression of RASSF6 mRNA
CTD
PMID:24136188
NCBI chr14:17,433,328...17,473,565
Ensembl chr14:17,442,789...17,473,330
G
Rassf7
Ras association domain family member 7
decreases expression
EXP
Glafenine results in decreased expression of RASSF7 mRNA
CTD
PMID:24136188
NCBI chr 1:196,319,600...196,323,787
Ensembl chr 1:196,320,902...196,323,770
G
Rb1
RB transcriptional corepressor 1
decreases expression
EXP
Glafenine results in decreased expression of RB1 mRNA
CTD
PMID:24136188
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbfa
ribosome binding factor A
decreases expression
EXP
Glafenine results in decreased expression of RBFA mRNA
CTD
PMID:24136188
NCBI chr18:73,639,264...73,648,914
Ensembl chr18:73,639,260...73,648,915
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
EXP
Glafenine results in decreased expression of RBL2 mRNA
CTD
PMID:24136188
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
G
Rbm3
RNA binding motif protein 3
increases expression
EXP
Glafenine results in increased expression of RBM3 mRNA
CTD
PMID:24136188
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
G
Rbp1
retinol binding protein 1
increases expression
EXP
Glafenine results in increased expression of RBP1 mRNA
CTD
PMID:24136188
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
G
Rbpms2
RNA binding protein, mRNA processing factor 2
decreases expression
EXP
Glafenine results in decreased expression of RBPMS2 mRNA
CTD
PMID:24136188
NCBI chr 8:66,153,169...66,184,278
Ensembl chr 8:66,153,593...66,184,268
G
Rcbtb2
RCC1 and BTB domain containing protein 2
decreases expression
EXP
Glafenine results in decreased expression of RCBTB2 mRNA
CTD
PMID:24136188
NCBI chr15:48,319,809...48,364,441
Ensembl chr15:48,323,866...48,383,750
G
Rcl1
RNA terminal phosphate cyclase-like 1
increases expression
EXP
Glafenine results in increased expression of RCL1 mRNA
CTD
PMID:24136188
NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315
G
Rdh10
retinol dehydrogenase 10
decreases expression
EXP
Glafenine results in decreased expression of RDH10 mRNA
CTD
PMID:24136188
NCBI chr 5:3,186,671...3,215,572
Ensembl chr 5:3,188,445...3,215,572
G
Rdh16
retinol dehydrogenase 16
decreases expression
EXP
Glafenine results in decreased expression of RDH2 mRNA
CTD
PMID:24136188
NCBI chr 7:63,616,711...63,625,053
Ensembl chr 7:63,597,536...63,624,124
G
Rdh5
retinol dehydrogenase 5
decreases expression
EXP
Glafenine results in decreased expression of RDH5 mRNA
CTD
PMID:24136188
NCBI chr 7:1,341,172...1,346,863
Ensembl chr 7:1,340,934...1,351,558
G
Rdx
radixin
decreases expression
EXP
Glafenine results in decreased expression of RDX mRNA
CTD
PMID:24136188
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
G
Recql
RecQ like helicase
increases expression
EXP
Glafenine results in increased expression of RECQL mRNA
CTD
PMID:24136188
NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
G
Reep3
receptor accessory protein 3
decreases expression
EXP
Glafenine results in decreased expression of REEP3 mRNA
CTD
PMID:24136188
NCBI chr20:21,493,868...21,578,698
Ensembl chr20:21,493,954...21,578,697
G
Reep4
receptor accessory protein 4
decreases expression
EXP
Glafenine results in decreased expression of REEP4 mRNA
CTD
PMID:24136188
NCBI chr15:45,620,317...45,623,524
Ensembl chr15:45,619,941...45,623,526
G
Reep5
receptor accessory protein 5
increases expression
EXP
Glafenine results in increased expression of REEP5 mRNA
CTD
PMID:24136188
NCBI chr18:25,945,375...25,983,271
Ensembl chr18:25,945,381...25,976,509
G
Retreg1
reticulophagy regulator 1
increases expression
EXP
Glafenine results in increased expression of RETREG1 mRNA
CTD
PMID:24136188
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
G
Retreg3
reticulophagy regulator family member 3
decreases expression
EXP
Glafenine results in decreased expression of RETREG3 mRNA
CTD
PMID:24136188
NCBI chr10:86,028,767...86,052,575
Ensembl chr10:86,028,774...86,052,692
G
Rexo2
RNA exonuclease 2
increases expression
EXP
Glafenine results in increased expression of REXO2 mRNA
CTD
PMID:24136188
NCBI chr 8:48,811,900...48,823,622
Ensembl chr 8:48,811,900...48,823,622
G
Rfc1
replication factor C subunit 1
decreases expression
EXP
Glafenine results in decreased expression of RFC1 mRNA
CTD
PMID:24136188
NCBI chr14:42,966,279...43,041,372
Ensembl chr14:42,966,324...43,041,370
G
RGD1309362
similar to interferon-inducible GTPase
decreases expression
EXP
Glafenine results in decreased expression of RGD1309362 mRNA
CTD
PMID:24136188
G
Rgs2
regulator of G-protein signaling 2
increases expression
EXP
Glafenine results in increased expression of RGS2 mRNA
CTD
PMID:24136188
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs5
regulator of G-protein signaling 5
increases expression
EXP
Glafenine results in increased expression of RGS5 mRNA
CTD
PMID:24136188
NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518
G
Rin2
Ras and Rab interactor 2
decreases expression
EXP
Glafenine results in decreased expression of RIN2 mRNA
CTD
PMID:24136188
NCBI chr 3:133,086,858...133,303,604
Ensembl chr 3:133,086,749...133,303,604
G
Rint1
RAD50 interactor 1
increases expression
EXP
Glafenine results in increased expression of RINT1 mRNA
CTD
PMID:24136188
NCBI chr 4:11,319,416...11,355,740
Ensembl chr 4:11,320,955...11,355,736
G
Rmdn2
regulator of microtubule dynamics 2
decreases expression
EXP
Glafenine results in decreased expression of RMDN2 mRNA
CTD
PMID:24136188
NCBI chr 6:15,372,569...15,443,000
Ensembl chr 6:15,375,496...15,441,480
G
Rmi1
RecQ mediated genome instability 1
decreases expression
EXP
Glafenine results in decreased expression of RMI1 mRNA
CTD
PMID:24136188
NCBI chr17:6,256,533...6,264,523
Ensembl chr17:6,256,450...6,264,695
G
Rmnd1
required for meiotic nuclear division 1 homolog
decreases expression
EXP
Glafenine results in decreased expression of RMND1 mRNA
CTD
PMID:24136188
NCBI chr 1:40,859,829...40,894,376
Ensembl chr 1:40,859,829...40,894,314
G
Rmnd5a
required for meiotic nuclear division 5 homolog A
decreases expression
EXP
Glafenine results in decreased expression of RMND5A mRNA
CTD
PMID:24136188
NCBI chr 4:103,375,846...103,432,890
Ensembl chr 4:103,379,908...103,433,051
G
Rnase4
ribonuclease A family member 4
decreases expression
EXP
Glafenine results in decreased expression of RNASE4 mRNA
CTD
PMID:24136188
NCBI chr15:24,312,765...24,330,112
Ensembl chr15:24,312,464...24,330,117
G
Rnaseh2a
ribonuclease H2, subunit A
decreases expression
EXP
Glafenine results in decreased expression of RNASEH2A mRNA
CTD
PMID:24136188
NCBI chr19:23,186,325...23,196,045
Ensembl chr19:23,186,383...23,196,041
G
Rnd2
Rho family GTPase 2
increases expression
EXP
Glafenine results in increased expression of RND2 mRNA
CTD
PMID:24136188
NCBI chr10:86,399,151...86,402,750
Ensembl chr10:86,399,148...86,402,742
G
Rnf103
ring finger protein 103
decreases expression
EXP
Glafenine results in decreased expression of RNF103 mRNA
CTD
PMID:24136188
NCBI chr 4:103,526,456...103,542,529
Ensembl chr 4:103,526,502...103,555,919
G
Rnf11l2
ring finger protein 11-like 2
decreases expression
EXP
Glafenine results in decreased expression of RNF11L2 mRNA
CTD
PMID:24136188
NCBI chr 9:82,181,779...82,183,568
Ensembl chr 9:82,183,050...82,183,514
G
Rnf125
ring finger protein 125
decreases expression
EXP
Glafenine results in decreased expression of RNF125 mRNA
CTD
PMID:24136188
NCBI chr18:12,254,066...12,275,719
Ensembl chr18:12,253,852...12,275,983
G
Rnf126
ring finger protein 126
increases expression
EXP
Glafenine results in increased expression of RNF126 mRNA
CTD
PMID:24136188
NCBI chr 7:9,939,359...9,946,963
Ensembl chr 7:9,938,229...9,946,738
G
Rnf128
ring finger protein 128
decreases expression
EXP
Glafenine results in decreased expression of RNF128 mRNA
CTD
PMID:24136188
NCBI chr X:103,183,643...103,298,431
Ensembl chr X:103,183,831...103,298,423
G
Rnf146
ring finger protein 146
decreases expression
EXP
Glafenine results in decreased expression of RNF146 mRNA
CTD
PMID:24136188
NCBI chr 1:28,458,864...28,475,758
Ensembl chr 1:28,458,887...28,475,923
G
Rnf149
ring finger protein 149
decreases expression
EXP
Glafenine results in decreased expression of RNF149 mRNA
CTD
PMID:24136188
NCBI chr 9:41,826,825...41,854,381
Ensembl chr 9:41,830,233...41,854,279
G
Rnf181
ring finger protein 181
increases expression
EXP
Glafenine results in increased expression of RNF181 mRNA
CTD
PMID:24136188
NCBI chr 4:104,414,586...104,421,433
Ensembl chr 4:104,414,605...104,421,309
G
Rnf19a
ring finger protein 19A, RBR E3 ubiquitin protein ligase
decreases expression
EXP
Glafenine results in decreased expression of RNF19A mRNA
CTD
PMID:24136188
NCBI chr 7:67,425,833...67,465,214
Ensembl chr 7:67,425,837...67,465,222
G
Rnf25
ring finger protein 25
increases expression
EXP
Glafenine results in increased expression of RNF25 mRNA
CTD
PMID:24136188
NCBI chr 9:76,170,037...76,176,924
Ensembl chr 9:76,170,037...76,176,849
G
Rnf7
ring finger protein 7
increases expression
EXP
Glafenine results in increased expression of RNF7 mRNA
CTD
PMID:24136188
NCBI chr 8:97,038,845...97,048,080
Ensembl chr 8:97,038,840...97,047,824
G
Rnpepl1
arginyl aminopeptidase like 1
increases expression
EXP
Glafenine results in increased expression of RNPEPL1 mRNA
CTD
PMID:24136188
NCBI chr 9:93,476,600...93,486,331
Ensembl chr 9:93,472,390...93,486,331
G
Rorc
RAR-related orphan receptor C
decreases expression
EXP
Glafenine results in decreased expression of RORC mRNA
CTD
PMID:24136188
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
Rpa1
replication protein A1
decreases expression
EXP
Glafenine results in decreased expression of RPA1 mRNA
CTD
PMID:24136188
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpa3
replication protein A3
increases expression
EXP
Glafenine results in increased expression of RPA3 mRNA
CTD
PMID:24136188
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:36,304,651...36,307,709
G
Rpap2
RNA polymerase II associated protein 2
decreases expression
EXP
Glafenine results in decreased expression of RPAP2 mRNA
CTD
PMID:24136188
NCBI chr14:2,109,044...2,187,343
Ensembl chr14:2,109,053...2,187,350
G
Rpf2
ribosome production factor 2 homolog
increases expression
EXP
Glafenine results in increased expression of RPF2 mRNA
CTD
PMID:24136188
NCBI chr20:43,630,003...43,651,477
Ensembl chr20:43,629,951...43,651,509
G
Rpl10a
ribosomal protein L10A
increases expression
EXP
Glafenine results in increased expression of RPL10A mRNA
CTD
PMID:24136188
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357
G
Rpl11
ribosomal protein L11
increases expression
EXP
Glafenine results in increased expression of RPL11 mRNA
CTD
PMID:24136188
NCBI chr 5:148,274,060...148,277,708
Ensembl chr 5:148,274,069...148,277,599
G
Rpl12
ribosomal protein L12
increases expression
EXP
Glafenine results in increased expression of RPL12 mRNA
CTD
PMID:24136188
NCBI chr 3:16,264,269...16,266,645
Ensembl chr 3:16,264,251...16,266,642
G
Rpl13
ribosomal protein L13
increases expression
EXP
Glafenine results in increased expression of RPL13 mRNA
CTD
PMID:24136188
NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014
G
Rpl14
ribosomal protein L14
increases expression
EXP
Glafenine results in increased expression of RPL14 mRNA
CTD
PMID:24136188
NCBI chr 8:120,286,035...120,289,160
Ensembl chr 8:120,284,645...120,289,064
G
Rpl18a
ribosomal protein L18A
increases expression
EXP
Glafenine results in increased expression of RPL18A mRNA
CTD
PMID:24136188
NCBI chr16:18,542,555...18,544,578
Ensembl chr16:18,542,566...18,545,546
G
Rpl22l1
ribosomal protein L22 like 1
increases expression
EXP
Glafenine results in increased expression of RPL22L1 mRNA
CTD
PMID:24136188
NCBI chr 2:111,754,687...111,756,623
Ensembl chr 2:111,754,687...111,756,625
G
Rpl23
ribosomal protein L23
increases expression
EXP
Glafenine results in increased expression of RPL23 mRNA
CTD
PMID:24136188
NCBI chr10:82,771,878...82,775,840
Ensembl chr10:82,771,538...82,775,870
G
Rpl23a
ribosomal protein L23A
increases expression
EXP
Glafenine results in increased expression of RPL23A mRNA
CTD
PMID:24136188
NCBI chr10:63,076,660...63,079,346
Ensembl chr10:63,076,066...63,079,346
G
Rpl28
ribosomal protein L28
increases expression
EXP
Glafenine results in increased expression of RPL28 mRNA
CTD
PMID:24136188
NCBI chr 1:69,052,148...69,054,735
Ensembl chr 1:69,053,203...69,055,032
G
Rpl29
ribosomal protein L29
increases expression
EXP
Glafenine results in increased expression of RPL29 mRNA
CTD
PMID:24136188
NCBI chr 8:107,068,929...107,070,963
Ensembl chr 8:107,068,480...107,070,914
G
Rpl3
ribosomal protein L3
increases expression
EXP
Glafenine results in increased expression of RPL3 mRNA
CTD
PMID:24136188
NCBI chr 7:111,622,255...111,627,640
Ensembl chr 7:111,621,610...111,636,468
G
Rpl34
ribosomal protein L34
increases expression
EXP
Glafenine results in increased expression of RPL34 mRNA
CTD
PMID:24136188
NCBI chr 2:219,284,373...219,288,108
Ensembl chr 2:219,284,382...219,288,111
G
Rpl36a
ribosomal protein L36A
increases expression
EXP
Glafenine results in increased expression of RPL36A mRNA
CTD
PMID:24136188
NCBI chr X:97,766,179...97,768,892
Ensembl chr X:97,766,179...97,768,892
G
Rpl38-ps3
ribosomal protein L38, pseudogene 3
increases expression
EXP
Glafenine results in increased expression of RPL38-PS3 mRNA
CTD
PMID:24136188
NCBI chr16:10,182,688...10,183,002
G
Rpl41
ribosomal protein L41
increases expression
EXP
Glafenine results in increased expression of RPL41 mRNA
CTD
PMID:24136188
NCBI chr 7:977,885...978,965
G
Rpl8
ribosomal protein L8
increases expression
EXP
Glafenine results in increased expression of RPL8 mRNA
CTD
PMID:24136188
NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:108,622,324...108,628,482 Ensembl chr 3:108,622,324...108,628,482
G
Rplp0
ribosomal protein lateral stalk subunit P0
increases expression
EXP
Glafenine results in increased expression of RPLP0 mRNA
CTD
PMID:24136188
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:41,054,179...41,057,632
G
Rplp1
ribosomal protein lateral stalk subunit P1
increases expression
EXP
Glafenine results in increased expression of RPLP1 mRNA
CTD
PMID:24136188
NCBI chr 8:62,394,008...62,395,341
Ensembl chr 8:62,393,177...62,395,339
G
Rplp2
ribosomal protein lateral stalk subunit P2
increases expression
EXP
Glafenine results in increased expression of RPLP2 mRNA
CTD
PMID:24136188
NCBI chr 1:196,546,086...196,548,636
Ensembl chr 1:196,546,352...196,548,645
G
Rpn1
ribophorin I
increases expression
EXP
Glafenine results in increased expression of RPN1 mRNA
CTD
PMID:24136188
NCBI chr 4:120,543,667...120,565,069
Ensembl chr 4:120,543,667...120,565,069
G
Rpn2
ribophorin II
increases expression
EXP
Glafenine results in increased expression of RPN2 mRNA
CTD
PMID:24136188
NCBI chr 3:145,941,787...145,989,271
Ensembl chr 3:145,941,839...145,989,543
G
Rps10
ribosomal protein S10
increases expression
EXP
Glafenine results in increased expression of RPS10 mRNA
CTD
PMID:24136188
NCBI chr20:5,694,313...5,698,922
Ensembl chr20:5,694,313...5,699,044 Ensembl chr 6:5,694,313...5,699,044
G
Rps11
ribosomal protein S11
increases expression
EXP
Glafenine results in increased expression of RPS11 mRNA
CTD
PMID:24136188
NCBI chr 1:95,605,690...95,607,798
Ensembl chr 1:95,605,692...95,607,874
G
Rps12
ribosomal protein S12
increases expression
EXP
Glafenine results in increased expression of RPS12 mRNA
CTD
PMID:24136188
NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
G
Rps13
ribosomal protein S13
increases expression
EXP
Glafenine results in increased expression of RPS13 mRNA
CTD
PMID:24136188
NCBI chr 1:170,572,925...170,575,355
Ensembl chr 1:170,572,921...170,575,355 Ensembl chr 3:170,572,921...170,575,355
G
Rps16
ribosomal protein S16
increases expression
EXP
Glafenine results in increased expression of RPS16 mRNA
CTD
PMID:24136188
NCBI chr 1:83,643,066...83,646,056
Ensembl chr 1:83,643,130...83,646,206
G
Rps19
ribosomal protein S19
increases expression
EXP
Glafenine results in increased expression of RPS19 mRNA
CTD
PMID:24136188
NCBI chr 1:80,480,718...80,486,511
Ensembl chr 1:80,480,951...80,486,508
G
Rps20
ribosomal protein S20
increases expression
EXP
Glafenine results in increased expression of RPS20 mRNA
CTD
PMID:24136188
NCBI chr 5:16,819,095...16,820,476
Ensembl chr 5:16,819,304...16,820,475 Ensembl chr 9:16,819,304...16,820,475 Ensembl chr 3:16,819,304...16,820,475
G
Rps24
ribosomal protein S24
increases expression
EXP
Glafenine results in increased expression of RPS24 mRNA
CTD
PMID:24136188
NCBI chr16:89,538...94,267
Ensembl chr16:89,604...94,279
G
Rps25
ribosomal protein s25
increases expression
EXP
Glafenine results in increased expression of RPS25 mRNA
CTD
PMID:24136188
NCBI chr 8:44,733,623...44,735,999
Ensembl chr 8:44,733,029...44,737,271
G
Rps26
ribosomal protein S26
increases expression
EXP
Glafenine results in increased expression of RPS26 mRNA
CTD
PMID:24136188
NCBI chr 7:1,057,332...1,058,882
G
Rps27a
ribosomal protein S27a
increases expression
EXP
Glafenine results in increased expression of RPS27A mRNA
CTD
PMID:24136188
NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011 Ensembl chr 5:103,285,734...103,288,011
G
Rps3
ribosomal protein S3
increases expression
EXP
Glafenine results in increased expression of RPS3 mRNA
CTD
PMID:24136188
NCBI chr 1:153,778,363...153,783,663
Ensembl chr 1:153,777,472...153,783,680
G
Rps5
ribosomal protein S5
increases expression
EXP
Glafenine results in increased expression of RPS5 mRNA
CTD
PMID:24136188
NCBI chr 1:73,538,776...73,543,073
Ensembl chr 1:73,538,776...73,543,073
G
Rps7
ribosomal protein S7
increases expression
EXP
Glafenine results in increased expression of RPS7 mRNA
CTD
PMID:24136188
NCBI chr 6:45,266,200...45,271,064
Ensembl chr 6:45,223,980...45,271,145
G
Rps9
ribosomal protein S9
increases expression
EXP
Glafenine results in increased expression of RPS9 mRNA
CTD
PMID:24136188
NCBI chr 1:65,511,723...65,515,076
Ensembl chr 1:65,511,723...65,515,123
G
Rpsa
ribosomal protein SA
increases expression
EXP
Glafenine results in increased expression of RPSA mRNA
CTD
PMID:24136188
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
G
Rras
RAS related
increases expression
EXP
Glafenine results in increased expression of RRAS mRNA
CTD
PMID:24136188
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
G
Rrbp1
ribosome binding protein 1
increases expression
EXP
Glafenine results in increased expression of RRBP1 mRNA
CTD
PMID:24136188
NCBI chr 3:131,314,996...131,376,930
Ensembl chr 3:131,314,998...131,376,981
G
Rrp15
ribosomal RNA processing 15 homolog
increases expression
EXP
Glafenine results in increased expression of RRP15 mRNA
CTD
PMID:24136188
NCBI chr13:98,276,276...98,299,357
Ensembl chr13:98,276,134...98,299,370
G
RT1-DMb
RT1 class II, locus DMb
increases expression
EXP
Glafenine results in increased expression of HLA-DMB mRNA
CTD
PMID:24136188
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
G
RT1-S3
RT1 class Ib, locus S3
decreases expression
EXP
Glafenine results in decreased expression of RT1-S3 mRNA
CTD
PMID:24136188
NCBI chr20:2,670,654...2,675,411
Ensembl chr20:2,670,709...2,675,411
G
Rusf1
RUS family member 1
increases expression
EXP
Glafenine results in increased expression of RUSF1 mRNA
CTD
PMID:24136188
NCBI chr 1:182,852,257...182,881,652
Ensembl chr 1:182,852,262...182,880,732
G
Rwdd4
RWD domain containing 4
increases expression
EXP
Glafenine results in increased expression of RWDD4 mRNA
CTD
PMID:24136188
NCBI chr16:44,714,698...44,733,090
Ensembl chr16:44,714,699...44,733,098
G
Rxrg
retinoid X receptor gamma
decreases expression
EXP
Glafenine results in decreased expression of RXRG mRNA
CTD
PMID:24136188
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
Rxylt1
ribitol xylosyltransferase 1
decreases expression
EXP
Glafenine results in decreased expression of RXYLT1 mRNA
CTD
PMID:24136188
NCBI chr 7:57,770,841...57,782,695
Ensembl chr 7:57,770,842...57,782,657
G
S100a11
S100 calcium binding protein A11
increases expression
EXP
Glafenine results in increased expression of S100A11 mRNA
CTD
PMID:24136188
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a8
S100 calcium binding protein A8
increases expression
EXP
Glafenine results in increased expression of S100A8 mRNA
CTD
PMID:24136188
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
EXP
Glafenine results in increased expression of S100A9 mRNA
CTD
PMID:24136188
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Sap18
Sin3A associated protein 18
increases expression
EXP
Glafenine results in increased expression of SAP18 mRNA
CTD
PMID:24136188
NCBI chr15:31,943,228...31,947,534
Ensembl chr15:31,943,230...31,950,038 Ensembl chr10:31,943,230...31,950,038
G
Sar1a
secretion associated, Ras related GTPase 1A
increases expression
EXP
Glafenine results in increased expression of SAR1A mRNA
CTD
PMID:24136188
NCBI chr20:29,623,529...29,635,935
Ensembl chr20:29,623,553...29,635,935
G
Saraf
store-operated calcium entry-associated regulatory factor
increases expression
EXP
Glafenine results in increased expression of SARAF mRNA
CTD
PMID:24136188
NCBI chr16:58,017,231...58,035,481
Ensembl chr16:58,017,231...58,035,545
G
Sat2
spermidine/spermine N1-acetyltransferase family member 2
decreases expression
EXP
Glafenine results in decreased expression of SAT2 mRNA
CTD
PMID:24136188
NCBI chr10:54,340,756...54,343,507
Ensembl chr10:54,340,372...54,343,224
G
Scamp4
secretory carrier membrane protein 4
increases expression
EXP
Glafenine results in increased expression of SCAMP4 mRNA
CTD
PMID:24136188
NCBI chr 7:9,101,504...9,113,929
Ensembl chr 7:9,101,489...9,113,967
G
Scarb1
scavenger receptor class B, member 1
increases expression
EXP
Glafenine results in increased expression of SCARB1 mRNA
CTD
PMID:24136188
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Scpep1
serine carboxypeptidase 1
decreases expression
EXP
Glafenine results in decreased expression of SCPEP1 mRNA
CTD
PMID:24136188
NCBI chr10:73,703,275...73,732,892
Ensembl chr10:73,703,278...73,732,850
G
Sdc2
syndecan 2
decreases expression
EXP
Glafenine results in decreased expression of SDC2 mRNA
CTD
PMID:24136188
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
G
Sdc4
syndecan 4
increases expression
EXP
Glafenine results in increased expression of SDC4 mRNA
CTD
PMID:24136188
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
EXP
Glafenine results in increased expression of SDF2L1 mRNA
CTD
PMID:24136188
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
G
Sds
serine dehydratase
decreases expression
EXP
Glafenine results in decreased expression of SDS mRNA
CTD
PMID:24136188
NCBI chr12:36,083,226...36,090,540
Ensembl chr12:36,083,229...36,088,203
G
Sec11a
SEC11 homolog A, signal peptidase complex subunit
increases expression
EXP
Glafenine results in increased expression of SEC11A mRNA
CTD
PMID:24136188
NCBI chr 1:134,881,448...134,909,427
Ensembl chr 1:134,875,265...134,915,069
G
Sec11c
SEC11 homolog C, signal peptidase complex subunit
increases expression
EXP
Glafenine results in increased expression of SEC11C mRNA
CTD
PMID:24136188
NCBI chr18:59,320,932...59,337,272
Ensembl chr18:59,320,884...59,337,364
G
Sec13
SEC13 homolog, nuclear pore and COPII coat complex component
increases expression
EXP
Glafenine results in increased expression of SEC13 mRNA
CTD
PMID:24136188
NCBI chr 4:146,877,739...146,891,130
Ensembl chr 4:146,875,524...146,891,173
G
Sec14l2
SEC14-like lipid binding 2
decreases expression
EXP
Glafenine results in decreased expression of SEC14L2 mRNA
CTD
PMID:24136188
NCBI chr14:78,973,805...78,998,480
Ensembl chr14:78,973,808...78,993,788
G
Sec16a
SEC16 homolog A, endoplasmic reticulum export factor
increases expression
EXP
Glafenine results in increased expression of SEC16A mRNA
CTD
PMID:24136188
NCBI chr 3:9,229,687...9,264,837
Ensembl chr 3:9,229,687...9,264,273
G
Sec22a
SEC22 homolog A, vesicle trafficking protein
decreases expression
EXP
Glafenine results in decreased expression of SEC22A mRNA
CTD
PMID:24136188
NCBI chr11:65,402,583...65,462,329
Ensembl chr11:65,402,684...65,462,319
G
Sec22b
SEC22 homolog B, vesicle trafficking protein
increases expression
EXP
Glafenine results in increased expression of SEC22B mRNA
CTD
PMID:24136188
NCBI chr 2:185,500,029...185,520,811
Ensembl chr 2:185,500,004...185,522,026
G
Sec23b
Sec23 homolog B, COPII coat complex component
increases expression
EXP
Glafenine results in increased expression of SEC23B mRNA
CTD
PMID:24136188
NCBI chr 3:131,939,011...131,981,489
Ensembl chr 3:131,939,337...131,981,489
G
Sec23ip
SEC23 interacting protein
increases expression
EXP
Glafenine results in increased expression of SEC23IP mRNA
CTD
PMID:24136188
NCBI chr 1:183,320,950...183,363,944
Ensembl chr 1:183,321,075...183,363,920
G
Sec61a1
SEC61 translocon subunit alpha 1
increases expression
EXP
Glafenine results in increased expression of SEC61A1 mRNA
CTD
PMID:24136188
NCBI chr 4:120,973,519...120,987,871
Ensembl chr 4:120,960,626...120,987,925
G
Sec61b
SEC61 translocon subunit beta
increases expression
EXP
Glafenine results in increased expression of SEC61B mRNA
CTD
PMID:24136188
NCBI chr 5:61,773,594...61,781,804
Ensembl chr 5:61,773,594...61,781,804
G
Sec61g
Sec61 translocon subunit gamma
increases expression
EXP
Glafenine results in increased expression of SEC61G mRNA
CTD
PMID:24136188
NCBI chr14:90,899,766...90,906,143
Ensembl chr14:90,899,768...90,906,162
G
Selenbp1
selenium binding protein 1
decreases expression
EXP
Glafenine results in decreased expression of SELENBP1 mRNA
CTD
PMID:24136188
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Selenof
selenoprotein F
increases expression
EXP
Glafenine results in increased expression of SELENOF mRNA
CTD
PMID:24136188
NCBI chr 2:233,642,075...233,674,853
Ensembl chr 2:233,641,932...233,674,846
G
Selenoh
selenoprotein H
increases expression
EXP
Glafenine results in increased expression of SELENOH mRNA
CTD
PMID:24136188
NCBI chr 3:69,751,850...69,753,417
Ensembl chr 3:69,752,757...69,753,417
G
Selenok
selenoprotein K
increases expression
EXP
Glafenine results in increased expression of SELENOK mRNA
CTD
PMID:24136188
NCBI chr16:5,152,066...5,160,648
Ensembl chr16:5,152,066...5,159,188
G
Selenos
selenoprotein S
increases expression
EXP
Glafenine results in increased expression of SELENOS mRNA
CTD
PMID:24136188
NCBI chr 1:119,659,779...119,669,546
Ensembl chr 1:119,659,751...119,669,833
G
Sema4a
semaphorin 4A
increases expression
EXP
Glafenine results in increased expression of SEMA4A mRNA
CTD
PMID:24136188
NCBI chr 2:173,896,432...173,917,903
Ensembl chr 2:173,896,439...173,914,442
G
Sema4g
semaphorin 4G
decreases expression
EXP
Glafenine results in decreased expression of SEMA4G mRNA
CTD
PMID:24136188
NCBI chr 1:243,849,979...243,865,343
Ensembl chr 1:243,853,854...243,865,341
G
Sepsecs
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
decreases expression
EXP
Glafenine results in decreased expression of SEPSECS mRNA
CTD
PMID:24136188
NCBI chr14:58,311,484...58,341,745
Ensembl chr14:58,311,499...58,341,740
G
Septin11
septin 11
increases expression
EXP
Glafenine results in increased expression of SEPTIN11 mRNA
CTD
PMID:24136188
NCBI chr14:14,844,759...14,990,856
Ensembl chr14:14,844,580...14,990,853
G
Serf1
small EDRK-rich factor 1
decreases expression
EXP
Glafenine results in decreased expression of SERF1 mRNA
CTD
PMID:24136188
NCBI chr 2:31,475,902...31,482,030
Ensembl chr 2:31,475,703...31,482,032
G
Serp1
stress-associated endoplasmic reticulum protein 1
increases expression
EXP
Glafenine results in increased expression of SERP1 mRNA
CTD
PMID:24136188
NCBI chr 2:142,757,254...142,761,243
Ensembl chr 2:142,757,270...142,761,116
G
Serpina10
serpin family A member 10
increases expression
EXP
Glafenine results in increased expression of SERPINA10 mRNA
CTD
PMID:24136188
NCBI chr 6:122,756,106...122,764,544
Ensembl chr 6:122,756,108...122,764,544
G
Serpina11
serpin family A member 11
increases expression
EXP
Glafenine results in increased expression of SERPINA11 mRNA
CTD
PMID:24136188
NCBI chr 6:122,903,246...122,912,695
Ensembl chr 6:122,903,250...122,912,670
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
EXP
Glafenine results in increased expression of SERPINA3N mRNA
CTD
PMID:24136188
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpina6
serpin family A member 6
decreases expression
EXP
Glafenine results in decreased expression of SERPINA6 mRNA
CTD
PMID:24136188
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
G
Serpinb9
serpin family B member 9
increases expression
EXP
Glafenine results in increased expression of SERPINB9 mRNA
CTD
PMID:24136188
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
G
Serpinf1
serpin family F member 1
decreases expression
EXP
Glafenine results in decreased expression of SERPINF1 mRNA
CTD
PMID:24136188
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Serpinf2
serpin family F member 2
increases expression
EXP
Glafenine results in increased expression of SERPINF2 mRNA
CTD
PMID:24136188
NCBI chr10:60,272,400...60,280,506
Ensembl chr10:60,272,400...60,281,243
G
Setd3
SET domain containing 3, actin N3(tau)-histidine methyltransferase
decreases expression
EXP
Glafenine results in decreased expression of SETD3 mRNA
CTD
PMID:24136188
NCBI chr 6:127,023,058...127,090,020
Ensembl chr 6:127,023,058...127,090,008
G
Sez6
seizure related 6 homolog
decreases expression
EXP
Glafenine results in decreased expression of SEZ6 mRNA
CTD
PMID:24136188
NCBI chr10:62,818,931...62,868,686
Ensembl chr10:62,819,069...62,868,671
G
Sf3b5
splicing factor 3b, subunit 5
increases expression
EXP
Glafenine results in increased expression of SF3B5 mRNA
CTD
PMID:24136188
NCBI chr 1:7,357,040...7,357,752
Ensembl chr 1:7,350,731...7,357,839
G
Sft2d2
SFT2 domain containing 2
decreases expression
EXP
Glafenine results in decreased expression of SFT2D2 mRNA
CTD
PMID:24136188
NCBI chr13:77,484,778...77,504,123
Ensembl chr13:77,484,636...77,504,112
G
Sfxn1
sideroflexin 1
decreases expression
EXP
Glafenine results in decreased expression of SFXN1 mRNA
CTD
PMID:24136188
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
G
Sgpp1
sphingosine-1-phosphate phosphatase 1
decreases expression
EXP
Glafenine results in decreased expression of SGPP1 mRNA
CTD
PMID:24136188
NCBI chr 6:94,425,339...94,446,534
Ensembl chr 6:94,425,339...94,446,534
G
Sh3bp5
SH3-domain binding protein 5
decreases expression
EXP
Glafenine results in decreased expression of SH3BP5 mRNA
CTD
PMID:24136188
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,583,465...6,698,975
G
Shc1
SHC adaptor protein 1
increases expression
EXP
Glafenine results in increased expression of SHC1 mRNA
CTD
PMID:24136188
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
G
Siae
sialic acid acetylesterase
decreases expression
EXP
Glafenine results in decreased expression of SIAE mRNA
CTD
PMID:24136188
NCBI chr 8:37,318,724...37,354,004
Ensembl chr 8:37,318,747...37,353,996
G
Sigirr
single Ig and TIR domain containing
decreases expression
EXP
Glafenine results in decreased expression of SIGIRR mRNA
CTD
PMID:24136188
NCBI chr 1:196,195,363...196,208,692
Ensembl chr 1:196,199,462...196,202,269
G
Sirpa
signal-regulatory protein alpha
increases expression
EXP
Glafenine results in increased expression of SIRPA mRNA
CTD
PMID:24136188
NCBI chr 3:116,819,730...116,858,099
Ensembl chr 3:116,819,726...116,858,098
G
Slc10a1
solute carrier family 10 member 1
decreases expression
EXP
Glafenine results in decreased expression of SLC10A1 mRNA
CTD
PMID:24136188
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc11a2
solute carrier family 11 member 2
increases expression
EXP
Glafenine results in increased expression of SLC11A2 mRNA
CTD
PMID:24136188
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc13a3
solute carrier family 13 member 3
increases expression
EXP
Glafenine results in increased expression of SLC13A3 mRNA
CTD
PMID:24136188
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc13a5
solute carrier family 13 member 5
increases expression
EXP
Glafenine results in increased expression of SLC13A5 mRNA
CTD
PMID:24136188
NCBI chr10:56,866,249...56,891,189
Ensembl chr10:56,866,249...56,890,945
G
Slc16a1
solute carrier family 16 member 1
increases expression
EXP
Glafenine results in increased expression of SLC16A1 mRNA
CTD
PMID:24136188
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc16a7
solute carrier family 16 member 7
decreases expression
EXP
Glafenine results in decreased expression of SLC16A7 mRNA
CTD
PMID:24136188
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
G
Slc17a1
solute carrier family 17 member 1
decreases expression
EXP
Glafenine results in decreased expression of SLC17A1 mRNA
CTD
PMID:24136188
NCBI chr17:41,219,461...41,255,199
Ensembl chr17:41,222,049...41,253,304
G
Slc17a2
solute carrier family 17, member 2
decreases expression
EXP
Glafenine results in decreased expression of SLC17A2 mRNA
CTD
PMID:24136188
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc17a4
solute carrier family 17, member 4
decreases expression
EXP
Glafenine results in decreased expression of SLC17A4 mRNA
CTD
PMID:24136188
NCBI chr17:41,201,546...41,218,752
Ensembl chr17:41,207,552...41,218,752
G
Slc22a1
solute carrier family 22 member 1
decreases expression
EXP
Glafenine results in decreased expression of SLC22A1 mRNA
CTD
PMID:24136188
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a5
solute carrier family 22 member 5
decreases expression
EXP
Glafenine results in decreased expression of SLC22A5 mRNA
CTD
PMID:24136188
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc25a16
solute carrier family 25 member 16
decreases expression
EXP
Glafenine results in decreased expression of SLC25A16 mRNA
CTD
PMID:24136188
NCBI chr20:25,691,474...25,717,558
Ensembl chr20:25,662,055...25,716,319
G
Slc25a30
solute carrier family 25, member 30
decreases expression
EXP
Glafenine results in decreased expression of SLC25A30 mRNA
CTD
PMID:24136188
NCBI chr15:51,076,998...51,099,613
Ensembl chr15:51,077,002...51,099,613
G
Slc27a5
solute carrier family 27 member 5
decreases expression
EXP
Glafenine results in decreased expression of SLC27A5 mRNA
CTD
PMID:24136188
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
G
Slc2a2
solute carrier family 2 member 2
decreases expression
EXP
Glafenine results in decreased expression of SLC2A2 mRNA
CTD
PMID:24136188
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
G
Slc30a5
solute carrier family 30 member 5
increases expression
EXP
Glafenine results in increased expression of SLC30A5 mRNA
CTD
PMID:24136188
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
G
Slc30a7
solute carrier family 30 member 7
increases expression
EXP
Glafenine results in increased expression of SLC30A7 mRNA
CTD
PMID:24136188
NCBI chr 2:203,855,484...203,922,155
Ensembl chr 2:203,859,175...203,922,132
G
Slc35b1
solute carrier family 35, member B1
increases expression
EXP
Glafenine results in increased expression of SLC35B1 mRNA
CTD
PMID:24136188
NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,327,945...80,335,274
G
Slc35b4
solute carrier family 35 member B4
increases expression
EXP
Glafenine results in increased expression of SLC35B4 mRNA
CTD
PMID:24136188
NCBI chr 4:62,776,993...62,799,013
Ensembl chr 4:62,776,993...62,799,003
G
Slc35e1
solute carrier family 35, member E1
increases expression
EXP
Glafenine results in increased expression of SLC35E1 mRNA
CTD
PMID:24136188
NCBI chr16:17,350,938...17,364,185
Ensembl chr16:17,350,988...17,363,268
G
Slc37a4
solute carrier family 37 member 4
decreases expression
EXP
Glafenine results in decreased expression of SLC37A4 mRNA
CTD
PMID:24136188
NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
G
Slc38a10
solute carrier family 38, member 10
increases expression
EXP
Glafenine results in increased expression of SLC38A10 mRNA
CTD
PMID:24136188
NCBI chr10:105,386,836...105,436,636
Ensembl chr10:105,386,836...105,436,636
G
Slc38a3
solute carrier family 38, member 3
increases expression
EXP
Glafenine results in increased expression of SLC38A3 mRNA
CTD
PMID:24136188
NCBI chr 8:108,323,889...108,339,959
Ensembl chr 8:108,323,894...108,339,988
G
Slc39a14
solute carrier family 39 member 14
increases expression
EXP
Glafenine results in increased expression of SLC39A14 mRNA
CTD
PMID:24136188
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc39a7
solute carrier family 39 member 7
increases expression
EXP
Glafenine results in increased expression of SLC39A7 mRNA
CTD
PMID:24136188
NCBI chr20:4,823,166...4,826,538
Ensembl chr20:4,822,012...4,826,537
G
Slc39a8
solute carrier family 39 member 8
decreases expression
EXP
Glafenine results in decreased expression of SLC39A8 mRNA
CTD
PMID:24136188
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
G
Slc41a2
solute carrier family 41 member 2
increases expression
EXP
Glafenine results in increased expression of SLC41A2 mRNA
CTD
PMID:24136188
NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166
G
Slc43a1
solute carrier family 43 member 1
increases expression
EXP
Glafenine results in increased expression of SLC43A1 mRNA
CTD
PMID:24136188
NCBI chr 3:69,920,586...69,946,768
Ensembl chr 3:69,920,649...69,946,768
G
Slc44a1
solute carrier family 44 member 1
increases expression
EXP
Glafenine results in increased expression of SLC44A1 mRNA
CTD
PMID:24136188
NCBI chr 5:68,061,941...68,241,912
Ensembl chr 5:68,063,618...68,241,909
G
Slc46a3
solute carrier family 46, member 3
decreases expression
EXP
Glafenine results in decreased expression of SLC46A3 mRNA
CTD
PMID:24136188
NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
G
Slc49a4
solute carrier family 49 member 4
decreases expression
EXP
Glafenine results in decreased expression of SLC49A4 mRNA
CTD
PMID:24136188
NCBI chr11:64,995,629...65,068,929
Ensembl chr11:64,995,679...65,068,926
G
Slc66a2
solute carrier family 66 member 2
decreases expression
EXP
Glafenine results in decreased expression of SLC66A2 mRNA
CTD
PMID:24136188
NCBI chr18:73,702,472...73,739,678
Ensembl chr18:73,702,564...73,739,676
G
Slc7a7
solute carrier family 7 member 7
increases expression
EXP
Glafenine results in increased expression of SLC7A7 mRNA
CTD
PMID:24136188
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
decreases expression
EXP
Glafenine results in decreased expression of SLCO1A2 mRNA
CTD
PMID:24136188
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slco1b2
solute carrier organic anion transporter family member 1B2
decreases expression
EXP
Glafenine results in decreased expression of SLCO1B2 mRNA
CTD
PMID:24136188
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
decreases expression
EXP
Glafenine results in decreased expression of SLCO2B1 mRNA
CTD
PMID:24136188
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
G
Smagp
small cell adhesion glycoprotein
decreases expression
EXP
Glafenine results in decreased expression of SMAGP mRNA
CTD
PMID:24136188
NCBI chr 7:131,720,260...131,738,711
Ensembl chr 7:131,718,740...131,738,691
G
Smarca2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
decreases expression
EXP
Glafenine results in decreased expression of SMARCA2 mRNA
CTD
PMID:24136188
NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684
G
Smarcb1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
increases expression
EXP
Glafenine results in increased expression of SMARCB1 mRNA
CTD
PMID:24136188
NCBI chr20:12,741,164...12,763,616
Ensembl chr20:12,741,477...12,763,620
G
Smc6
structural maintenance of chromosomes 6
decreases expression
EXP
Glafenine results in decreased expression of SMC6 mRNA
CTD
PMID:24136188
NCBI chr 6:33,978,730...34,033,201
Ensembl chr 6:33,978,716...34,031,746
G
Smim11
small integral membrane protein 11
increases expression
EXP
Glafenine results in increased expression of SMIM11 mRNA
CTD
PMID:24136188
NCBI chr11:31,533,257...31,543,002
Ensembl chr11:31,532,764...31,543,002
G
Smim7
small integral membrane protein 7
increases expression
EXP
Glafenine results in increased expression of SMIM7 mRNA
CTD
PMID:24136188
NCBI chr16:17,274,417...17,278,336
Ensembl chr16:17,273,258...17,278,336
G
Smn1
survival of motor neuron 1, telomeric
increases expression
EXP
Glafenine results in increased expression of SMN1 mRNA
CTD
PMID:24136188
NCBI chr 2:31,490,018...31,501,065
Ensembl chr 2:31,490,015...31,501,060
G
Smoc1
SPARC related modular calcium binding 1
decreases expression
EXP
Glafenine results in decreased expression of SMOC1 mRNA
CTD
PMID:24136188
NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699
G
Smoc2
SPARC related modular calcium binding 2
increases expression
EXP
Glafenine results in increased expression of SMOC2 mRNA
CTD
PMID:24136188
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
G
Smpdl3a
sphingomyelin phosphodiesterase, acid-like 3A
decreases expression
EXP
Glafenine results in decreased expression of SMPDL3A mRNA
CTD
PMID:24136188
NCBI chr20:37,132,592...37,155,567
Ensembl chr20:37,132,592...37,155,567
G
Snd1
staphylococcal nuclease and tudor domain containing 1
increases expression
EXP
Glafenine results in increased expression of SND1 mRNA
CTD
PMID:24136188
NCBI chr 4:57,095,205...57,494,501
Ensembl chr 4:57,095,208...57,530,843
G
Snrnp70
small nuclear ribonucleoprotein U1 subunit 70
increases expression
EXP
Glafenine results in increased expression of SNRNP70 mRNA
CTD
PMID:24136188
NCBI chr 1:95,856,038...95,876,434
Ensembl chr 1:95,856,036...95,876,392
G
Snrpb
small nuclear ribonucleoprotein polypeptides B and B1
increases expression
EXP
Glafenine results in increased expression of SNRPB mRNA
CTD
PMID:24136188
NCBI chr 3:117,369,816...117,379,344
Ensembl chr 3:117,370,100...117,379,339
G
Snrpd2
small nuclear ribonucleoprotein D2 polypeptide
increases expression
EXP
Glafenine results in increased expression of SNRPD2 mRNA
CTD
PMID:24136188
NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351
G
Snrpf
small nuclear ribonucleoprotein polypeptide F
increases expression
EXP
Glafenine results in increased expression of SNRPF mRNA
CTD
PMID:24136188
NCBI chr 7:28,130,427...28,137,129
Ensembl chr 7:28,130,427...28,137,129
G
Snu13
small nuclear ribonucleoprotein 13
increases expression
EXP
Glafenine results in increased expression of SNU13 mRNA
CTD
PMID:24136188
NCBI chr 7:113,565,293...113,570,887
Ensembl chr 7:113,565,295...113,570,872 Ensembl chr 1:113,565,295...113,570,872
G
Sod1
superoxide dismutase 1
decreases activity
EXP
Glafenine results in decreased activity of SOD1 protein
CTD
PMID:24136188
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases expression
EXP
Glafenine results in increased expression of SOD2 mRNA
CTD
PMID:24136188
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sorbs1
sorbin and SH3 domain containing 1
increases expression
EXP
Glafenine results in increased expression of SORBS1 mRNA
CTD
PMID:24136188
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
G
Sord
sorbitol dehydrogenase
decreases expression
EXP
Glafenine results in decreased expression of SORD mRNA
CTD
PMID:24136188
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Spast
spastin
decreases expression
EXP
Glafenine results in decreased expression of SPAST mRNA
CTD
PMID:24136188
NCBI chr 6:21,055,349...21,106,586
Ensembl chr 6:21,055,349...21,107,954
G
Spcs1
signal peptidase complex subunit 1
increases expression
EXP
Glafenine results in increased expression of SPCS1 mRNA
CTD
PMID:24136188
NCBI chr16:6,190,208...6,191,776
Ensembl chr16:6,190,262...6,192,000
G
Spcs2
signal peptidase complex subunit 2
increases expression
EXP
Glafenine results in increased expression of SPCS2 mRNA
CTD
PMID:24136188
NCBI chr 1:154,163,724...154,183,152
Ensembl chr 1:154,163,724...154,183,186
G
Spcs3
signal peptidase complex subunit 3
increases expression
EXP
Glafenine results in increased expression of SPCS3 mRNA
CTD
PMID:24136188
NCBI chr16:37,305,358...37,310,792
Ensembl chr16:37,305,305...37,331,746
G
Spg21
SPG21 abhydrolase domain containing, maspardin
decreases expression
EXP
Glafenine results in decreased expression of SPG21 mRNA
CTD
PMID:24136188
NCBI chr 8:65,980,992...66,008,537
Ensembl chr 8:65,980,962...66,008,536
G
Spink1
serine peptidase inhibitor, Kazal type 1
increases expression
EXP
Glafenine results in increased expression of SPINK1 mRNA
CTD
PMID:24136188
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Spsb4
splA/ryanodine receptor domain and SOCS box containing 4
increases expression
EXP
Glafenine results in increased expression of SPSB4 mRNA
CTD
PMID:24136188
NCBI chr 8:97,536,519...97,609,757
Ensembl chr 8:97,536,520...97,609,787
G
Sqle
squalene epoxidase
increases expression
EXP
Glafenine results in increased expression of SQLE mRNA
CTD
PMID:24136188
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Sqor
sulfide quinone oxidoreductase
decreases expression
EXP
Glafenine results in decreased expression of SQOR mRNA
CTD
PMID:24136188
NCBI chr 3:109,841,225...109,886,724
Ensembl chr 3:109,841,250...109,960,778
G
Srebf2
sterol regulatory element binding transcription factor 2
increases expression
EXP
Glafenine results in increased expression of SREBF2 mRNA
CTD
PMID:24136188
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Sri
sorcin
increases expression
EXP
Glafenine results in increased expression of SRI mRNA
CTD
PMID:24136188
NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
G
Srm
spermidine synthase
increases expression
EXP
Glafenine results in increased expression of SRM mRNA
CTD
PMID:24136188
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
G
Srp19
signal recognition particle 19
increases expression
EXP
Glafenine results in increased expression of SRP19 mRNA
CTD
PMID:24136188
NCBI chr18:25,931,734...25,937,974
Ensembl chr18:25,931,589...25,938,017
G
Srp68
signal recognition particle 68
increases expression
EXP
Glafenine results in increased expression of SRP68 mRNA
CTD
PMID:24136188
NCBI chr10:101,481,213...101,508,035
Ensembl chr10:101,481,212...101,508,035
G
Srp72
signal recognition particle 72
increases expression
EXP
Glafenine results in increased expression of SRP72 mRNA
CTD
PMID:24136188
NCBI chr14:31,168,175...31,195,717
Ensembl chr14:31,168,293...31,195,729
G
Srp9
signal recognition particle 9
increases expression
EXP
Glafenine results in increased expression of SRP9 mRNA
CTD
PMID:24136188
NCBI chr13:93,832,580...93,840,720
Ensembl chr13:93,832,580...93,840,720
G
Srpra
SRP receptor subunit alpha
increases expression
EXP
Glafenine results in increased expression of SRPRA mRNA
CTD
PMID:24136188
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Srprb
SRP receptor subunit beta
increases expression
EXP
Glafenine results in increased expression of SRPRB mRNA
CTD
PMID:24136188
NCBI chr 8:103,768,685...103,782,632
G
Srr
serine racemase
decreases expression
EXP
Glafenine results in decreased expression of SRR mRNA
CTD
PMID:24136188
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
G
Srrt
serrate, RNA effector molecule
increases expression
EXP
Glafenine results in increased expression of SRRT mRNA
CTD
PMID:24136188
NCBI chr12:19,392,578...19,406,098
Ensembl chr12:19,392,625...19,406,095
G
Srsf2
serine and arginine rich splicing factor 2
increases expression
EXP
Glafenine results in increased expression of SRSF2 mRNA
CTD
PMID:24136188
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
G
Ss18l2
SS18 like 2
increases expression
EXP
Glafenine results in increased expression of SS18L2 mRNA
CTD
PMID:24136188
NCBI chr 8:121,375,263...121,377,877
Ensembl chr 8:121,375,308...121,377,877
G
Ssr1
signal sequence receptor subunit 1
increases expression
EXP
Glafenine results in increased expression of SSR1 mRNA
CTD
PMID:24136188
NCBI chr17:26,833,720...26,861,821
Ensembl chr17:26,833,741...26,861,821
G
Ssr2
signal sequence receptor subunit 2
increases expression
EXP
Glafenine results in increased expression of SSR2 mRNA
CTD
PMID:24136188
NCBI chr 2:174,048,291...174,057,043
Ensembl chr 2:174,048,460...174,057,042
G
Ssr3
signal sequence receptor subunit 3
increases expression
EXP
Glafenine results in increased expression of SSR3 mRNA
CTD
PMID:24136188
NCBI chr 2:149,605,005...149,625,069
Ensembl chr 2:149,605,005...149,625,132
G
Ssr4
signal sequence receptor subunit 4
increases expression
EXP
Glafenine results in increased expression of SSR4 mRNA
CTD
PMID:24136188
NCBI chr X:151,524,191...151,528,218
Ensembl chr X:151,524,009...151,528,202
G
Ssu72
SSU72 homolog, RNA polymerase II CTD phosphatase
increases expression
EXP
Glafenine results in increased expression of SSU72 mRNA
CTD
PMID:24136188
NCBI chr 5:166,312,267...166,343,432
Ensembl chr 5:166,313,650...166,343,429
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
EXP
Glafenine results in decreased expression of SSX2IP mRNA
CTD
PMID:24136188
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
St3gal4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
increases expression
EXP
Glafenine results in increased expression of ST3GAL4 mRNA
CTD
PMID:24136188
NCBI chr 8:33,415,666...33,465,319
Ensembl chr 8:33,415,671...33,524,389
G
Stab2
stabilin 2
increases expression
EXP
Glafenine results in increased expression of STAB2 mRNA
CTD
PMID:24136188
NCBI chr 7:21,249,426...21,433,051
Ensembl chr 7:21,249,391...21,434,042
G
Stac3
SH3 and cysteine rich domain 3
decreases expression
EXP
Glafenine results in decreased expression of STAC3 mRNA
CTD
PMID:24136188
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
G
Stag2
STAG2 cohesin complex component
decreases expression
EXP
Glafenine results in decreased expression of STAG2 mRNA
CTD
PMID:24136188
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
G
Stap2
signal transducing adaptor family member 2
increases expression
EXP
Glafenine results in increased expression of STAP2 mRNA
CTD
PMID:24136188
NCBI chr 9:828,369...838,648
Ensembl chr 9:828,372...837,219
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
Glafenine results in increased expression of STAT3 mRNA
CTD
PMID:24136188
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Steap4
STEAP4 metalloreductase
increases expression
EXP
Glafenine results in increased expression of STEAP4 mRNA
CTD
PMID:24136188
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
G
Stmn1
stathmin 1
decreases expression
EXP
Glafenine results in decreased expression of STMN1 mRNA
CTD
PMID:24136188
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Stra6l
STRA6-like
increases expression
EXP
Glafenine results in increased expression of STRA6L mRNA
CTD
PMID:24136188
NCBI chr 5:60,106,949...60,147,546
Ensembl chr 5:60,107,085...60,147,539
G
Stradb
STE20 related adaptor beta
decreases expression
EXP
Glafenine results in decreased expression of STRADB mRNA
CTD
PMID:24136188
NCBI chr 9:60,414,182...60,433,084
Ensembl chr 9:60,414,182...60,433,084
G
Stt3a
STT3 oligosaccharyltransferase complex catalytic subunit A
increases expression
EXP
Glafenine results in increased expression of STT3A mRNA
CTD
PMID:24136188
NCBI chr 8:36,443,623...36,483,111
Ensembl chr 8:36,446,788...36,483,293
G
Stub1
STIP1 homology and U-box containing protein 1
increases expression
EXP
Glafenine results in increased expression of STUB1 mRNA
CTD
PMID:24136188
NCBI chr10:14,850,765...14,853,046
Ensembl chr10:14,850,765...14,853,046
G
Stx7
syntaxin 7
decreases expression
EXP
Glafenine results in decreased expression of STX7 mRNA
CTD
PMID:24136188
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Stxbp3
syntaxin binding protein 3
decreases expression
EXP
Glafenine results in decreased expression of STXBP3 mRNA
CTD
PMID:24136188
NCBI chr 2:196,442,738...196,485,733
Ensembl chr 2:196,442,634...196,485,671
G
Sult1b1
sulfotransferase family 1B member 1
decreases expression
EXP
Glafenine results in decreased expression of SULT1B1 mRNA
CTD
PMID:24136188
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
G
Sult1c2a
sulfotransferase family 1C member 2A
decreases expression
EXP
Glafenine results in decreased expression of SULT1C2A mRNA
CTD
PMID:24136188
NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
G
Sult1e1
sulfotransferase family 1E member 1
decreases expression
EXP
Glafenine results in decreased expression of SULT1E1 mRNA
CTD
PMID:24136188
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Sun2
Sad1 and UNC84 domain containing 2
decreases expression
EXP
Glafenine results in decreased expression of SUN2 mRNA
CTD
PMID:24136188
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
G
Suox
sulfite oxidase
decreases expression
EXP
Glafenine results in decreased expression of SUOX mRNA
CTD
PMID:24136188
NCBI chr 7:1,103,149...1,107,156
Ensembl chr 7:1,103,151...1,107,038
G
Swsap1
SWIM-type zinc finger 7 associated protein 1
increases expression
EXP
Glafenine results in increased expression of SWSAP1 mRNA
CTD
PMID:24136188
NCBI chr 8:20,486,680...20,489,213
Ensembl chr 8:20,486,678...20,489,211
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
EXP
Glafenine results in decreased expression of SYNE2 mRNA
CTD
PMID:24136188
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Synj2bp
synaptojanin 2 binding protein
decreases expression
EXP
Glafenine results in decreased expression of SYNJ2BP mRNA
CTD
PMID:24136188
NCBI chr 6:101,189,714...101,227,400
Ensembl chr 6:101,189,714...101,227,406
G
Sys1
Sys1 golgi trafficking protein
increases expression
EXP
Glafenine results in increased expression of SYS1 mRNA
CTD
PMID:24136188
NCBI chr 3:153,191,061...153,195,463
Ensembl chr 3:153,191,090...153,220,651
G
Syvn1
synoviolin 1
increases expression
EXP
Glafenine results in increased expression of SYVN1 mRNA
CTD
PMID:24136188
NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
G
Taf10
TATA-box binding protein associated factor 10
increases expression
EXP
Glafenine results in increased expression of TAF10 mRNA
CTD
PMID:24136188
NCBI chr 1:160,095,108...160,096,401
Ensembl chr 1:160,095,108...160,096,376
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
increases expression
EXP
Glafenine results in increased expression of TAF1D mRNA
CTD
PMID:24136188
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
G
Taf9
TATA-box binding protein associated factor 9
increases expression
EXP
Glafenine results in increased expression of TAF9 mRNA
CTD
PMID:24136188
NCBI chr 2:31,794,316...31,798,324
Ensembl chr 2:31,794,142...31,798,769
G
Tafazzin
tafazzin, phospholipid-lysophospholipid transacylase
decreases expression
EXP
Glafenine results in decreased expression of TAFAZZIN mRNA
CTD
PMID:24136188
NCBI chr X:152,065,539...152,076,178
Ensembl chr X:152,065,609...152,074,001
G
Tagln2
transgelin 2
increases expression
EXP
Glafenine results in increased expression of TAGLN2 mRNA
CTD
PMID:24136188
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
G
Tardbp
TAR DNA binding protein
increases expression
EXP
Glafenine results in increased expression of TARDBP mRNA
CTD
PMID:24136188
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
G
Tars1
threonyl-tRNA synthetase 1
increases expression
EXP
Glafenine results in increased expression of TARS1 mRNA
CTD
PMID:24136188
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
G
Tbc1d23
TBC1 domain family, member 23
decreases expression
EXP
Glafenine results in decreased expression of TBC1D23 mRNA
CTD
PMID:24136188
NCBI chr11:43,303,355...43,361,507
Ensembl chr11:43,303,355...43,361,503
G
Tbc1d8
TBC1 domain family, member 8
decreases expression
EXP
Glafenine results in decreased expression of TBC1D8 mRNA
CTD
PMID:24136188
NCBI chr 9:41,651,394...41,761,432
Ensembl chr 9:41,651,395...41,761,409
G
Tbcb
tubulin folding cofactor B
increases expression
EXP
Glafenine results in increased expression of TBCB mRNA
CTD
PMID:24136188
NCBI chr 1:85,477,639...85,483,488
Ensembl chr 1:85,477,640...85,483,488
G
Tbl1xr1
TBL1X/Y related 1
decreases expression
EXP
Glafenine results in decreased expression of TBL1XR1 mRNA
CTD
PMID:24136188
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
G
Tcea3
transcription elongation factor A3
decreases expression
EXP
Glafenine results in decreased expression of TCEA3 mRNA
CTD
PMID:24136188
NCBI chr 5:148,476,941...148,509,452
Ensembl chr 5:148,476,941...148,509,448
G
Tceal8
transcription elongation factor A like 8
increases expression
EXP
Glafenine results in increased expression of TCEAL8 mRNA
CTD
PMID:24136188
NCBI chr X:99,171,307...99,173,377
Ensembl chr X:99,171,177...99,173,710
G
Tceal9
transcription elongation factor A like 9
increases expression
EXP
Glafenine results in increased expression of TCEAL9 mRNA
CTD
PMID:24136188
NCBI chr X:99,245,645...99,247,720
Ensembl chr X:99,228,458...99,247,763
G
Tcf25
transcription factor 25
increases expression
EXP
Glafenine results in increased expression of TCF25 mRNA
CTD
PMID:24136188
NCBI chr19:51,415,341...51,449,725
Ensembl chr19:51,415,543...51,449,723
G
Tcp11l2
t-complex 11 like 2
decreases expression
EXP
Glafenine results in decreased expression of TCP11L2 mRNA
CTD
PMID:24136188
NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095
G
Tec
tec protein tyrosine kinase
decreases expression
EXP
Glafenine results in decreased expression of TEC mRNA
CTD
PMID:24136188
NCBI chr14:35,352,551...35,461,585
Ensembl chr14:35,352,829...35,461,557
G
Tex2
testis expressed 2
decreases expression
EXP
Glafenine results in decreased expression of TEX2 mRNA
CTD
PMID:24136188
NCBI chr10:91,436,629...91,546,240
Ensembl chr10:91,436,694...91,546,270
G
Tex261
testis expressed 261
increases expression
EXP
Glafenine results in increased expression of TEX261 mRNA
CTD
PMID:24136188
NCBI chr 4:116,253,547...116,260,730
Ensembl chr 4:116,244,600...116,260,253
G
Tex264
testis expressed 264
decreases expression
EXP
Glafenine results in decreased expression of TEX264 mRNA
CTD
PMID:24136188
NCBI chr 8:107,295,806...107,322,858
Ensembl chr 8:107,295,806...107,323,232
G
Tf
transferrin
increases expression
EXP
Glafenine results in increased expression of TF mRNA
CTD
PMID:24136188
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tfr2
transferrin receptor 2
increases expression
EXP
Glafenine results in increased expression of TFR2 mRNA
CTD
PMID:24136188
NCBI chr12:19,107,673...19,124,622
Ensembl chr12:19,107,673...19,124,591
G
Tfrc
transferrin receptor
increases expression
EXP
Glafenine results in increased expression of TFRC mRNA
CTD
PMID:24136188
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfbr1
transforming growth factor, beta receptor 1
decreases expression
EXP
Glafenine results in decreased expression of TGFBR1 mRNA
CTD
PMID:24136188
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgm1
transglutaminase 1
increases expression
EXP
Glafenine results in increased expression of TGM1 mRNA
CTD
PMID:24136188
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Thap11
THAP domain containing 11
decreases expression
EXP
Glafenine results in decreased expression of THAP11 mRNA
CTD
PMID:24136188
NCBI chr19:33,746,977...33,748,794
Ensembl chr19:33,746,854...33,749,540
G
Thg1l
tRNA-histidine guanylyltransferase 1-like
increases expression
EXP
Glafenine results in increased expression of THG1L mRNA
CTD
PMID:24136188
NCBI chr10:30,387,929...30,396,579
Ensembl chr10:30,387,940...30,396,687
G
Thnsl2
threonine synthase-like 2
decreases expression
EXP
Glafenine results in decreased expression of THNSL2 mRNA
CTD
PMID:24136188
NCBI chr 4:103,112,974...103,132,122
Ensembl chr 4:103,112,963...103,132,017
G
Timm10b
translocase of inner mitochondrial membrane 10B
increases expression
EXP
Glafenine results in increased expression of TIMM10B mRNA
CTD
PMID:24136188
NCBI chr 1:159,980,525...159,983,371
Ensembl chr 1:159,980,484...159,981,642
G
Timm17a
translocase of inner mitochondrial membrane 17A
increases expression
EXP
Glafenine results in increased expression of TIMM17A mRNA
CTD
PMID:24136188
NCBI chr13:46,731,117...46,742,604
Ensembl chr13:46,730,660...46,742,655
G
Timm8a1
translocase of inner mitochondrial membrane 8A1
increases expression
EXP
Glafenine results in increased expression of TIMM8A1 mRNA
CTD
PMID:24136188
NCBI chr X:97,717,932...97,722,170
Ensembl chr X:97,717,920...97,721,960
G
Timm8b
translocase of inner mitochondrial membrane 8 homolog B
increases expression
EXP
Glafenine results in increased expression of TIMM8B mRNA
CTD
PMID:24136188
NCBI chr 8:50,954,350...50,955,730
Ensembl chr 8:50,954,342...50,955,729
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Glafenine results in increased expression of TIMP1 mRNA
CTD
PMID:24136188
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Timp3
TIMP metallopeptidase inhibitor 3
increases expression
EXP
Glafenine results in increased expression of TIMP3 mRNA
CTD
PMID:24136188
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tlcd4
TLC domain containing 4
decreases expression
EXP
Glafenine results in decreased expression of TLCD4 mRNA
CTD
PMID:24136188
NCBI chr 2:209,284,873...209,360,156
Ensembl chr 2:209,289,732...209,341,353
G
Tma7
translation machinery associated 7 homolog
increases expression
EXP
Glafenine results in increased expression of TMA7 mRNA
CTD
PMID:24136188
NCBI chr 8:109,726,213...109,730,902
Ensembl chr 8:109,726,196...109,735,474
G
Tmbim6
transmembrane BAX inhibitor motif containing 6
decreases expression
EXP
Glafenine results in decreased expression of TMBIM6 mRNA
CTD
PMID:24136188
NCBI chr 7:130,527,313...130,542,567
Ensembl chr 7:130,527,316...130,543,633
G
Tmed10
transmembrane p24 trafficking protein 10
increases expression
EXP
Glafenine results in increased expression of TMED10 mRNA
CTD
PMID:24136188
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
G
Tmed3
transmembrane p24 trafficking protein 3
increases expression
EXP
Glafenine results in increased expression of TMED3 mRNA
CTD
PMID:24136188
NCBI chr 8:90,241,516...90,249,429
Ensembl chr 8:90,241,516...90,249,346
G
Tmed9
transmembrane p24 trafficking protein 9
increases expression
EXP
Glafenine results in increased expression of TMED9 mRNA
CTD
PMID:24136188
NCBI chr17:9,029,646...9,034,160
Ensembl chr17:9,029,646...9,034,176
G
Tmem106b
transmembrane protein 106B
decreases expression
EXP
Glafenine results in decreased expression of TMEM106B mRNA
CTD
PMID:24136188
NCBI chr 4:41,328,125...41,347,315
Ensembl chr 4:41,327,994...41,345,619
G
Tmem140
transmembrane protein 140
decreases expression
EXP
Glafenine results in decreased expression of TMEM140 mRNA
CTD
PMID:24136188
NCBI chr 4:63,536,477...63,547,478
Ensembl chr 4:63,536,168...63,548,455
G
Tmem141
transmembrane protein 141
decreases expression
EXP
Glafenine results in decreased expression of TMEM141 mRNA
CTD
PMID:24136188
NCBI chr 3:8,439,533...8,441,491
Ensembl chr 3:8,439,533...8,441,491
G
Tmem176a
transmembrane protein 176A
increases expression
EXP
Glafenine results in increased expression of TMEM176A mRNA
CTD
PMID:24136188
NCBI chr 4:77,774,940...77,778,620
Ensembl chr 4:77,774,843...77,778,620
G
Tmem19
transmembrane protein 19
decreases expression
EXP
Glafenine results in decreased expression of TMEM19 mRNA
CTD
PMID:24136188
NCBI chr 7:50,958,884...50,985,601
Ensembl chr 7:50,958,888...50,986,809
G
Tmem208
transmembrane protein 208
increases expression
EXP
Glafenine results in increased expression of TMEM208 mRNA
CTD
PMID:24136188
NCBI chr19:33,203,587...33,206,287
Ensembl chr19:33,203,587...33,212,183
G
Tmem214
transmembrane protein 214
increases expression
EXP
Glafenine results in increased expression of TMEM214 mRNA
CTD
PMID:24136188
NCBI chr 6:25,501,575...25,510,444
Ensembl chr 6:25,502,698...25,510,444
G
Tmem218
transmembrane protein 218
decreases expression
EXP
Glafenine results in decreased expression of TMEM218 mRNA
CTD
PMID:24136188
NCBI chr 8:36,924,553...36,940,564
Ensembl chr 8:36,924,585...36,939,927
G
Tmem222
transmembrane protein 222
increases expression
EXP
Glafenine results in increased expression of TMEM222 mRNA
CTD
PMID:24136188
NCBI chr 5:145,465,847...145,477,932
Ensembl chr 5:145,465,847...145,484,491
G
Tmem248
transmembrane protein 248
increases expression
EXP
Glafenine results in increased expression of TMEM248 mRNA
CTD
PMID:24136188
NCBI chr12:26,430,775...26,457,105
Ensembl chr12:26,432,953...26,457,105
G
Tmem258
transmembrane protein 258
increases expression
EXP
Glafenine results in increased expression of TMEM258 mRNA
CTD
PMID:24136188
NCBI chr 1:206,849,723...206,853,623
G
Tmem30b
transmembrane protein 30B
increases expression
EXP
Glafenine results in increased expression of TMEM30B mRNA
CTD
PMID:24136188
NCBI chr 6:92,251,626...92,254,702
Ensembl chr 6:92,249,790...92,254,842
G
Tmem39a
transmembrane protein 39a
increases expression
EXP
Glafenine results in increased expression of TMEM39A mRNA
CTD
PMID:24136188
NCBI chr11:62,160,631...62,189,964
Ensembl chr11:62,160,631...62,189,964
G
Tmem42
transmembrane protein 42
decreases expression
EXP
Glafenine results in decreased expression of TMEM42 mRNA
CTD
PMID:24136188
NCBI chr 8:122,674,793...122,677,290
Ensembl chr 8:122,674,070...122,677,276
G
Tmem64
transmembrane protein 64
decreases expression
EXP
Glafenine results in decreased expression of TMEM64 mRNA
CTD
PMID:24136188
NCBI chr 5:28,698,947...28,745,384
Ensembl chr 5:28,698,918...28,745,330
G
Tmem97
transmembrane protein 97
increases expression
EXP
Glafenine results in increased expression of TMEM97 mRNA
CTD
PMID:24136188
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
G
Tmem9b
TMEM9 domain family, member B
increases expression
EXP
Glafenine results in increased expression of TMEM9B mRNA
CTD
PMID:24136188
NCBI chr 1:163,755,307...163,783,880
Ensembl chr 1:163,764,433...163,783,278
G
Tmpo
thymopoietin
decreases expression
EXP
Glafenine results in decreased expression of TMPO mRNA
CTD
PMID:24136188
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tmsb10
thymosin, beta 10
increases expression
EXP
Glafenine results in increased expression of TMSB10 mRNA
CTD
PMID:24136188
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tmt1a
thiol methyltransferase 1A
decreases expression
EXP
Glafenine results in decreased expression of METTL7A mRNA
CTD
PMID:24136188
NCBI chr 7:131,452,099...131,460,154
Ensembl chr 7:131,451,641...131,460,154
G
Tnf
tumor necrosis factor
increases expression
EXP
Glafenine results in increased expression of TNF
CTD
PMID:24136188
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip2
TNF alpha induced protein 2
increases expression
EXP
Glafenine results in increased expression of TNFAIP2 mRNA
CTD
PMID:24136188
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
EXP
Glafenine results in increased expression of TNFRSF12A mRNA
CTD
PMID:24136188
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
EXP
Glafenine results in increased expression of TNFRSF1A mRNA
CTD
PMID:24136188
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
EXP
Glafenine results in increased expression of TNFRSF9 mRNA
CTD
PMID:24136188
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tob1
transducer of ErbB-2.1
decreases expression
EXP
Glafenine results in decreased expression of TOB1 mRNA
CTD
PMID:24136188
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
G
Tomm40
translocase of outer mitochondrial membrane 40
increases expression
EXP
Glafenine results in increased expression of TOMM40 mRNA
CTD
PMID:24136188
NCBI chr 1:79,358,781...79,370,882
Ensembl chr 1:79,358,786...79,370,915
G
Tomm6
translocase of outer mitochondrial membrane 6
increases expression
EXP
Glafenine results in increased expression of TOMM6 mRNA
CTD
PMID:24136188
NCBI chr 9:13,304,269...13,305,637
G
Tomm7
translocase of outer mitochondrial membrane 7
increases expression
EXP
Glafenine results in increased expression of TOMM7 mRNA
CTD
PMID:24136188
NCBI chr 4:11,305,122...11,311,963
Ensembl chr 4:11,305,110...11,311,962
G
Top1mt
DNA topoisomerase I mitochondrial
decreases expression
EXP
Glafenine results in decreased expression of TOP1MT mRNA
CTD
PMID:24136188
NCBI chr 7:107,338,092...107,368,125
Ensembl chr 7:107,342,527...107,366,049
G
Top2b
DNA topoisomerase II beta
decreases expression
EXP
Glafenine results in decreased expression of TOP2B mRNA
CTD
PMID:24136188
NCBI chr15:9,051,340...9,111,721
Ensembl chr15:9,051,341...9,112,085
G
Tp53
tumor protein p53
increases expression
EXP
Glafenine results in increased expression of TP53 mRNA
CTD
PMID:24136188
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53i3
tumor protein p53 inducible protein 3
decreases expression
EXP
Glafenine results in decreased expression of TP53I3 mRNA
CTD
PMID:24136188
NCBI chr 6:27,818,327...27,825,753
G
Tpk1
thiamin pyrophosphokinase 1
decreases expression
EXP
Glafenine results in decreased expression of TERF2IP mRNA
CTD
PMID:24136188
NCBI chr 4:72,170,134...72,557,707
Ensembl chr 4:72,170,134...72,557,694
G
Tpm4
tropomyosin 4
increases expression
EXP
Glafenine results in increased expression of TPM4 mRNA
CTD
PMID:24136188
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tpst2
tyrosylprotein sulfotransferase 2
decreases expression
EXP
Glafenine results in decreased expression of TPST2 mRNA
CTD
PMID:24136188
NCBI chr12:44,321,875...44,363,892
Ensembl chr12:44,321,875...44,362,329
G
Tra2a
transformer 2 alpha
increases expression
EXP
Glafenine results in increased expression of TRA2A mRNA
CTD
PMID:24136188
NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
G
Trabd
TraB domain containing
increases expression
EXP
Glafenine results in increased expression of TRABD mRNA
CTD
PMID:24136188
NCBI chr 7:120,155,042...120,166,015
Ensembl chr 7:120,155,042...120,166,015
G
Trap1
TNF receptor-associated protein 1
decreases expression
EXP
Glafenine results in decreased expression of TRAP1 mRNA
CTD
PMID:24136188
NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,464,821...11,498,981
G
Trappc1
trafficking protein particle complex subunit 1
increases expression
EXP
Glafenine results in increased expression of TRAPPC1 mRNA
CTD
PMID:24136188
NCBI chr10:54,045,598...54,047,184
Ensembl chr10:54,045,537...54,047,331
G
Trappc12
trafficking protein particle complex subunit 12
decreases expression
EXP
Glafenine results in decreased expression of TRAPPC12 mRNA
CTD
PMID:24136188
NCBI chr 6:45,321,496...45,386,967
Ensembl chr 6:45,321,497...45,386,952
G
Trim14
tripartite motif-containing 14
decreases expression
EXP
Glafenine results in decreased expression of TRIM14 mRNA
CTD
PMID:24136188
NCBI chr 5:60,800,568...60,824,858
Ensembl chr 5:60,800,032...60,824,858
G
Trim2
tripartite motif-containing 2
decreases expression
EXP
Glafenine results in decreased expression of TRIM2 mRNA
CTD
PMID:24136188
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trim26
tripartite motif-containing 26
decreases expression
EXP
Glafenine results in decreased expression of TRIM26 mRNA
CTD
PMID:24136188
NCBI chr20:1,708,297...1,731,176
Ensembl chr20:1,709,788...1,731,120
G
Trim27
tripartite motif-containing 27
increases expression
EXP
Glafenine results in increased expression of TRIM27 mRNA
CTD
PMID:24136188
NCBI chr17:43,538,282...43,550,633
Ensembl chr17:43,538,285...43,550,643
G
Trim5
tripartite motif-containing 5
decreases expression
EXP
Glafenine results in decreased expression of TRIM5 mRNA
CTD
PMID:24136188
NCBI chr 1:158,720,407...158,737,393
Ensembl chr 1:158,720,410...158,814,012
G
Trim6
tripartite motif containing 6
decreases expression
EXP
Glafenine results in decreased expression of TRIM6 mRNA
CTD
PMID:24136188
NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:158,683,746...158,696,914
G
Trir
telomerase RNA component interacting RNase
increases expression
EXP
Glafenine results in increased expression of TRIR mRNA
CTD
PMID:24136188
NCBI chr19:23,125,083...23,128,502
Ensembl chr19:23,125,083...23,128,510
G
Trmt2a
tRNA methyltransferase 2 homolog A
increases expression
EXP
Glafenine results in increased expression of TRMT2A mRNA
CTD
PMID:24136188
NCBI chr11:82,737,689...82,742,423
Ensembl chr11:82,737,689...82,742,336
G
Trmt61a
tRNA methyltransferase 61A
increases expression
EXP
Glafenine results in increased expression of TRMT61A mRNA
CTD
PMID:24136188
NCBI chr 6:130,737,230...130,743,251
Ensembl chr 6:130,737,219...130,743,243
G
Tsfm
Ts translation elongation factor, mitochondrial
increases expression
EXP
Glafenine results in increased expression of TSFM mRNA
CTD
PMID:24136188
NCBI chr 7:62,828,997...62,864,784
Ensembl chr 7:62,845,488...62,864,769
G
Tshz1
teashirt zinc finger homeobox 1
decreases expression
EXP
Glafenine results in decreased expression of TSHZ1 mRNA
CTD
PMID:24136188
NCBI chr18:77,376,399...77,452,815
Ensembl chr18:77,377,394...77,453,509
G
Tspan14
tetraspanin 14
increases expression
EXP
Glafenine results in increased expression of TSPAN14 mRNA
CTD
PMID:24136188
NCBI chr16:16,784,242...16,841,368
Ensembl chr16:16,783,234...16,841,400
G
Tspan4
tetraspanin 4
increases expression
EXP
Glafenine results in increased expression of TSPAN4 mRNA
CTD
PMID:24136188
NCBI chr 1:196,571,307...196,593,842
Ensembl chr 1:196,572,228...196,617,448
G
Tspan6
tetraspanin 6
decreases expression
EXP
Glafenine results in decreased expression of TSPAN6 mRNA
CTD
PMID:24136188
NCBI chr X:97,092,394...97,099,659
Ensembl chr X:97,092,388...97,099,309
G
Tspo
translocator protein
increases expression
EXP
Glafenine results in increased expression of TSPO mRNA
CTD
PMID:24136188
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
G
Tssc4
tumor suppressing subtransferable candidate 4
increases expression
EXP
Glafenine results in increased expression of TSSC4 mRNA
CTD
PMID:24136188
NCBI chr 1:198,251,986...198,254,810
Ensembl chr 1:198,235,487...198,254,980
G
Ttc23
tetratricopeptide repeat domain 23
decreases expression
EXP
Glafenine results in decreased expression of TTC23 mRNA
CTD
PMID:24136188
NCBI chr 1:121,245,996...121,329,500
Ensembl chr 1:121,248,084...121,329,494
G
Ttc39c
tetratricopeptide repeat domain 39C
decreases expression
EXP
Glafenine results in decreased expression of TTC39C mRNA
CTD
PMID:24136188
NCBI chr18:3,768,802...3,887,932
Ensembl chr18:3,805,183...3,887,930
G
Ttll12
tubulin tyrosine ligase like 12
increases expression
EXP
Glafenine results in increased expression of TTLL12 mRNA
CTD
PMID:24136188
NCBI chr 7:114,731,890...114,751,237
Ensembl chr 7:114,731,892...114,751,356
G
Ttpa
alpha tocopherol transfer protein
decreases expression
EXP
Glafenine results in decreased expression of TTPA mRNA
CTD
PMID:24136188
NCBI chr 5:33,497,537...33,518,936
Ensembl chr 5:33,497,137...33,518,073
G
Tuba1c
tubulin, alpha 1C
increases expression
EXP
Glafenine results in increased expression of TUBA1C mRNA
CTD
PMID:24136188
NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tuba4a
tubulin, alpha 4A
increases expression
EXP
Glafenine results in increased expression of TUBA4A mRNA
CTD
PMID:24136188
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Tubb6
tubulin, beta 6 class V
increases expression
EXP
Glafenine results in increased expression of TUBB6 mRNA
CTD
PMID:24136188
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Tut4
terminal uridylyl transferase 4
decreases expression
EXP
Glafenine results in decreased expression of TUT4 mRNA
CTD
PMID:24136188
NCBI chr 5:123,201,723...123,306,582
Ensembl chr 5:123,203,003...123,306,465
G
Tut7
terminal uridylyl transferase 7
decreases expression
EXP
Glafenine results in decreased expression of TUT7 mRNA
CTD
PMID:24136188
NCBI chr17:4,849,287...4,903,542
Ensembl chr17:4,849,283...4,903,169
G
Twf1
twinfilin actin-binding protein 1
increases expression
EXP
Glafenine results in increased expression of TWF1 mRNA
CTD
PMID:24136188
NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
G
Twnk
twinkle mtDNA helicase
decreases expression
EXP
Glafenine results in decreased expression of TWNK mRNA
CTD
PMID:24136188
NCBI chr 1:243,867,568...243,874,802
Ensembl chr 1:243,868,330...243,874,802
G
Twsg1
twisted gastrulation BMP signaling modulator 1
decreases expression
EXP
Glafenine results in decreased expression of TWSG1 mRNA
CTD
PMID:24136188
NCBI chr 9:105,533,116...105,567,460
Ensembl chr 9:105,533,136...105,567,479
G
Txndc15
thioredoxin domain containing 15
decreases expression
EXP
Glafenine results in decreased expression of TXNDC15 mRNA
CTD
PMID:24136188
NCBI chr17:8,898,074...8,910,538
Ensembl chr17:8,845,084...8,910,539
G
Tysnd1
trypsin like peroxisomal matrix peptidase 1
decreases expression
EXP
Glafenine results in decreased expression of TYSND1 mRNA
CTD
PMID:24136188
NCBI chr20:29,637,942...29,646,492
Ensembl chr20:29,638,277...29,643,995
G
U2af1
U2 small nuclear RNA auxiliary factor 1
increases expression
EXP
Glafenine results in increased expression of U2AF1 mRNA
CTD
PMID:24136188
NCBI chr20:9,742,904...9,753,840
Ensembl chr20:9,742,905...9,753,832
G
Uap1
UDP-N-acetylglucosamine pyrophosphorylase 1
increases expression
EXP
Glafenine results in increased expression of UAP1 mRNA
CTD
PMID:24136188
NCBI chr13:82,342,946...82,377,558
Ensembl chr13:82,342,946...82,377,469
G
Uba1
ubiquitin-like modifier activating enzyme 1
increases expression
EXP
Glafenine results in increased expression of UBA1 mRNA
CTD
PMID:24136188
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
G
Uba5
ubiquitin-like modifier activating enzyme 5
increases expression
EXP
Glafenine results in increased expression of UBA5 mRNA
CTD
PMID:24136188
NCBI chr 8:104,665,241...104,680,915
Ensembl chr 8:104,665,046...104,680,894
G
Ube2b
ubiquitin-conjugating enzyme E2B
decreases expression
EXP
Glafenine results in decreased expression of UBE2B mRNA
CTD
PMID:24136188
NCBI chr10:36,248,434...36,263,379
Ensembl chr10:36,248,438...36,264,665
G
Ube2f
ubiquitin-conjugating enzyme E2F (putative)
increases expression
EXP
Glafenine results in increased expression of UBE2F mRNA
CTD
PMID:24136188
NCBI chr 9:91,845,975...91,881,145
Ensembl chr 9:91,845,987...91,880,594
G
Ube2g2
ubiquitin-conjugating enzyme E2G 2
increases expression
EXP
Glafenine results in increased expression of UBE2G2 mRNA
CTD
PMID:24136188
NCBI chr20:10,983,734...11,005,468
Ensembl chr20:10,983,742...11,005,447
G
Ube2j1
ubiquitin-conjugating enzyme E2, J1
increases expression
EXP
Glafenine results in increased expression of UBE2J1 mRNA
CTD
PMID:24136188
NCBI chr 5:47,422,476...47,441,476
Ensembl chr 5:47,422,587...47,441,461
G
Ube2n
ubiquitin-conjugating enzyme E2N
increases expression
EXP
Glafenine results in increased expression of UBE2N mRNA
CTD
PMID:24136188
NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355
G
Ubfd1
ubiquitin family domain containing 1
increases expression
EXP
Glafenine results in increased expression of UBFD1 mRNA
CTD
PMID:24136188
NCBI chr 1:176,626,003...176,640,993
Ensembl chr 1:176,625,657...176,640,993
G
Ubl5
ubiquitin-like 5
increases expression
EXP
Glafenine results in increased expression of UBL5 mRNA
CTD
PMID:24136188
NCBI chr 8:19,181,504...19,185,224
Ensembl chr 8:19,181,615...19,185,217
G
Ubqln1
ubiquilin 1
decreases expression
EXP
Glafenine results in decreased expression of UBQLN1 mRNA
CTD
PMID:24136188
NCBI chr17:6,439,002...6,477,096
Ensembl chr17:6,439,002...6,477,090
G
Ubqln2
ubiquilin 2
decreases expression
EXP
Glafenine results in decreased expression of UBQLN2 mRNA
CTD
PMID:24136188
NCBI chr X:17,853,086...17,856,505
Ensembl chr X:17,853,114...17,856,505
G
Ubr2
ubiquitin protein ligase E3 component n-recognin 2
decreases expression
EXP
Glafenine results in decreased expression of UBR2 mRNA
CTD
PMID:24136188
NCBI chr 9:13,982,427...14,062,315
Ensembl chr 9:13,982,329...14,062,139
G
Ubr3
ubiquitin protein ligase E3 component n-recognin 3
decreases expression
EXP
Glafenine results in decreased expression of UBR3 mRNA
CTD
PMID:24136188
NCBI chr 3:54,649,803...54,806,779
Ensembl chr 3:54,649,992...54,806,247
G
Ubr5
ubiquitin protein ligase E3 component n-recognin 5
decreases expression
EXP
Glafenine results in decreased expression of UBR5 mRNA
CTD
PMID:24136188
NCBI chr 7:69,115,216...69,224,843
Ensembl chr 7:69,116,761...69,224,903
G
Ufc1
ubiquitin-fold modifier conjugating enzyme 1
increases expression
EXP
Glafenine results in increased expression of UFC1 mRNA
CTD
PMID:24136188
NCBI chr13:83,709,329...83,719,762
Ensembl chr13:83,709,330...83,716,076
G
Ufm1
ubiquitin-fold modifier 1
increases expression
EXP
Glafenine results in increased expression of UFM1 mRNA
CTD
PMID:24136188
NCBI chr 2:137,969,476...137,977,620
Ensembl chr 2:137,966,678...137,978,089 Ensembl chr 2:137,966,678...137,978,089
G
Ufsp2
UFM1-specific peptidase 2
increases expression
EXP
Glafenine results in increased expression of UFSP2 mRNA
CTD
PMID:24136188
NCBI chr16:46,272,016...46,291,080
Ensembl chr16:46,272,016...46,291,059
G
Ugp2
UDP-glucose pyrophosphorylase 2
decreases expression
EXP
Glafenine results in decreased expression of UGP2 mRNA
CTD
PMID:24136188
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
decreases expression
EXP
Glafenine results in decreased expression of UGT1A6 mRNA
CTD
PMID:24136188
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases expression
EXP
Glafenine results in decreased expression of UGT2B17 mRNA
CTD
PMID:24136188
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Umps
uridine monophosphate synthetase
increases expression
EXP
Glafenine results in increased expression of UMPS mRNA
CTD
PMID:24136188
NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903
G
Uqcc5
ubiquinol-cytochrome c reductase complex assembly factor 5
increases expression
EXP
Glafenine results in increased expression of UQCC5 mRNA
CTD
PMID:24136188
NCBI chr16:6,316,631...6,320,471
Ensembl chr16:6,286,300...6,320,642
G
Usf1
upstream transcription factor 1
decreases expression
EXP
Glafenine results in decreased expression of USF1 mRNA
CTD
PMID:24136188
NCBI chr13:83,845,230...83,854,875
Ensembl chr13:83,822,035...83,854,885
G
Uso1
USO1 vesicle transport factor
increases expression
EXP
Glafenine results in increased expression of USO1 mRNA
CTD
PMID:24136188
NCBI chr14:15,866,638...15,932,185
Ensembl chr14:15,866,638...15,932,171
G
Usp25
ubiquitin specific peptidase 25
decreases expression
EXP
Glafenine results in decreased expression of USP25 mRNA
CTD
PMID:24136188
NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Glafenine results in increased expression of VCAM1 mRNA
CTD
PMID:24136188
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vipr1
vasoactive intestinal peptide receptor 1
decreases expression
EXP
Glafenine results in decreased expression of VIPR1 mRNA
CTD
PMID:24136188
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
G
Vkorc1l1
vitamin K epoxide reductase complex, subunit 1-like 1
increases expression
EXP
Glafenine results in increased expression of VKORC1L1 mRNA
CTD
PMID:24136188
NCBI chr12:26,717,959...26,768,193
Ensembl chr12:26,623,976...26,768,225
G
Vnn1
vanin 1
decreases expression
EXP
Glafenine results in decreased expression of VNN1 mRNA
CTD
PMID:24136188
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Vps41
VPS41 subunit of HOPS complex
decreases expression
EXP
Glafenine results in decreased expression of VPS41 mRNA
CTD
PMID:24136188
NCBI chr17:46,063,132...46,227,533
Ensembl chr17:46,063,124...46,227,791
G
Vps50
VPS50 subunit of EARP/GARPII complex
decreases expression
EXP
Glafenine results in decreased expression of VPS50 mRNA
CTD
PMID:24136188
NCBI chr 4:31,484,424...31,585,617
Ensembl chr 4:31,484,463...31,585,617
G
Vwa8
von Willebrand factor A domain containing 8
decreases expression
EXP
Glafenine results in decreased expression of VWA8 mRNA
CTD
PMID:24136188
NCBI chr15:54,252,703...54,576,871
Ensembl chr15:54,252,584...54,576,870
G
Wars1
tryptophanyl-tRNA synthetase 1
increases expression
EXP
Glafenine results in increased expression of WARS1 mRNA
CTD
PMID:24136188
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
G
Washc2c
WASH complex subunit 2C
decreases expression
EXP
Glafenine results in decreased expression of WASHC2C mRNA
CTD
PMID:24136188
NCBI chr 4:149,267,851...149,325,850
Ensembl chr 4:149,267,924...149,325,851
G
Washc4
WASH complex subunit 4
decreases expression
EXP
Glafenine results in decreased expression of WASHC4 mRNA
CTD
PMID:24136188
NCBI chr 7:20,187,905...20,240,228
Ensembl chr 7:20,187,922...20,240,226
G
Wdr18
WD repeat domain 18
increases expression
EXP
Glafenine results in increased expression of WDR18 mRNA
CTD
PMID:24136188
NCBI chr 7:9,740,245...9,748,041
Ensembl chr 7:9,739,604...9,748,070
G
Wdr36
WD repeat domain 36
increases expression
EXP
Glafenine results in increased expression of WDR36 mRNA
CTD
PMID:24136188
NCBI chr18:24,473,657...24,501,773
Ensembl chr18:24,473,663...24,508,092
G
Wdr6
WD repeat domain 6
decreases expression
EXP
Glafenine results in decreased expression of WDR6 mRNA
CTD
PMID:24136188
NCBI chr 8:109,268,079...109,274,504
Ensembl chr 8:109,268,079...109,274,499
G
Wdr83os
WD repeat domain 83 opposite strand
increases expression
EXP
Glafenine results in increased expression of WDR83OS mRNA
CTD
PMID:24136188
NCBI chr19:23,075,373...23,076,745
Ensembl chr19:23,075,376...23,076,894
G
Wwp1
WW domain containing E3 ubiquitin protein ligase 1
decreases expression
EXP
Glafenine results in decreased expression of WWP1 mRNA
CTD
PMID:24136188
NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
decreases expression
EXP
Glafenine results in decreased expression of XPC mRNA
CTD
PMID:24136188
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
G
Xpnpep2
X-prolyl aminopeptidase 2
decreases expression
EXP
Glafenine results in decreased expression of XPNPEP2 mRNA
CTD
PMID:24136188
NCBI chr X:127,287,765...127,317,036
Ensembl chr X:127,287,979...127,317,223
G
Xylb
xylulokinase
decreases expression
EXP
Glafenine results in decreased expression of XYLB mRNA
CTD
PMID:24136188
NCBI chr 8:119,093,466...119,128,858
Ensembl chr 8:119,096,029...119,128,848
G
Xylt2
xylosyltransferase 2
decreases expression
EXP
Glafenine results in decreased expression of XYLT2 mRNA
CTD
PMID:24136188
NCBI chr10:79,605,910...79,619,482
Ensembl chr10:79,606,007...79,619,391
G
Yars1
tyrosyl-tRNA synthetase 1
increases expression
EXP
Glafenine results in increased expression of YARS1 mRNA
CTD
PMID:24136188
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Yif1a
Yip1 interacting factor homolog A, membrane trafficking protein
increases expression
EXP
Glafenine results in increased expression of YIF1A mRNA
CTD
PMID:24136188
NCBI chr 1:202,394,923...202,399,125
Ensembl chr 1:202,394,897...202,399,427
G
Yipf4
Yip1 domain family, member 4
decreases expression
EXP
Glafenine results in decreased expression of YIPF4 mRNA
CTD
PMID:24136188
NCBI chr 6:20,950,774...20,962,195
Ensembl chr 6:20,950,501...20,962,229
G
Ykt6
YKT6 v-SNARE homolog
increases expression
EXP
Glafenine results in increased expression of YKT6 mRNA
CTD
PMID:24136188
NCBI chr14:80,832,187...80,843,394
Ensembl chr14:80,832,187...80,843,385
G
Ypel5
yippee-like 5
decreases expression
EXP
Glafenine results in decreased expression of YPEL5 mRNA
CTD
PMID:24136188
NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
increases expression
EXP
Glafenine results in increased expression of YWHAB mRNA
CTD
PMID:24136188
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Zbtb20
zinc finger and BTB domain containing 20
decreases expression
EXP
Glafenine results in decreased expression of ZBTB20 mRNA
CTD
PMID:24136188
NCBI chr11:57,052,129...57,791,214
Ensembl chr11:57,072,880...57,510,210
G
Zbtb43
zinc finger and BTB domain containing 43
decreases expression
EXP
Glafenine results in decreased expression of ZBTB43 mRNA
CTD
PMID:24136188
NCBI chr 3:16,744,535...16,763,854
Ensembl chr 3:16,744,535...16,763,909
G
Zc3h14
zinc finger CCCH type containing 14
decreases expression
EXP
Glafenine results in decreased expression of ZC3H14 mRNA
CTD
PMID:24136188
NCBI chr 6:118,006,420...118,044,480
Ensembl chr 6:118,006,458...118,044,105
G
Zc3h15
zinc finger CCCH-type containing 15
increases expression
EXP
Glafenine results in increased expression of ZC3H15 mRNA
CTD
PMID:24136188
NCBI chr 3:68,744,591...68,764,335
Ensembl chr 3:68,744,604...68,764,333
G
Zcchc17
zinc finger CCHC-type containing 17
increases expression
EXP
Glafenine results in increased expression of ZCCHC17 mRNA
CTD
PMID:24136188
NCBI chr 5:142,658,626...142,700,440
Ensembl chr 5:142,658,589...142,700,426
G
Zfp277
zinc finger protein 277
decreases expression
EXP
Glafenine results in decreased expression of ZFP277 mRNA
CTD
PMID:24136188
NCBI chr 6:57,383,454...57,512,785
Ensembl chr 6:57,383,951...57,512,765
G
Zfp46
zinc finger protein 46
increases expression
EXP
Glafenine results in increased expression of ZFP46 mRNA
CTD
PMID:24136188
NCBI chr 5:148,519,398...148,529,903
Ensembl chr 5:148,520,855...148,529,459
G
Zfp467
zinc finger protein 467
decreases expression
EXP
Glafenine results in decreased expression of ZFP467 mRNA
CTD
PMID:24136188
NCBI chr 4:77,385,752...77,394,709
Ensembl chr 4:77,385,758...77,392,229
G
Zfpl1
zinc finger protein-like 1
increases expression
EXP
Glafenine results in increased expression of ZFPL1 mRNA
CTD
PMID:24136188
NCBI chr 1:203,374,500...203,378,518
Ensembl chr 1:203,374,504...203,378,487
G
Zfyve26
zinc finger FYVE-type containing 26
decreases expression
EXP
Glafenine results in decreased expression of ZFYVE26 mRNA
CTD
PMID:24136188
NCBI chr 6:98,031,874...98,095,538
Ensembl chr 6:98,032,520...98,095,480
G
Znrd2
zinc ribbon domain containing 2
increases expression
EXP
Glafenine results in increased expression of ZNRD2 mRNA
CTD
PMID:24136188
NCBI chr 1:203,017,682...203,019,465
Ensembl chr 1:203,017,682...203,019,465
G
Zswim8
zinc finger, SWIM-type containing 8
increases expression
EXP
Glafenine results in increased expression of ZSWIM8 mRNA
CTD
PMID:24136188
NCBI chr15:3,573,780...3,589,501
Ensembl chr15:3,573,780...3,589,487
G
Zyx
zyxin
increases expression
EXP
Glafenine results in increased expression of ZYX mRNA
CTD
PMID:24136188
NCBI chr 4:71,236,767...71,246,553
Ensembl chr 4:71,237,451...71,246,553
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases activity
ISO
Meclofenamic Acid results in decreased activity of AKR1C1 protein
CTD
PMID:19010312 PMID:26362498 PMID:27163852
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
decreases activity
ISO
Meclofenamic Acid results in decreased activity of AKR1C2 protein
CTD
PMID:19010312 PMID:26362498 PMID:27163852
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases activity
ISO
Meclofenamic Acid results in decreased activity of AKR1C3 protein
CTD
PMID:19010312 PMID:26362498 PMID:27163852
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Alox5
arachidonate 5-lipoxygenase
decreases activity
ISO
Meclofenamic Acid results in decreased activity of ALOX5 protein
CTD
PMID:3020588
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Ren
renin
multiple interactions
EXP
Meclofenamic Acid inhibits the reaction [Yohimbine results in increased expression of REN protein]
CTD
PMID:6323192
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Sell
selectin L
decreases expression
ISO
Meclofenamic Acid results in decreased expression of SELL protein
CTD
PMID:12147693
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Slc16a2
solute carrier family 16 member 2
multiple interactions
ISO
Meclofenamic Acid inhibits the reaction [SLC16A2 protein results in increased uptake of Triiodothyronine]
CTD
PMID:28119167
NCBI chr X:68,725,365...68,848,572
Ensembl chr X:68,723,261...68,848,771
G
Sult1a1
sulfotransferase family 1A member 1
decreases activity
ISO
Meclofenamic Acid results in decreased activity of SULT1A1 protein
CTD
PMID:17073578
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Sult1e1
sulfotransferase family 1E member 1
decreases activity
ISO
Meclofenamic Acid results in decreased activity of SULT1E1 protein
CTD
PMID:17073578
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Meclofenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
CTD
PMID:10328874
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions
ISO
Meclofenamic Acid inhibits the reaction [UGT2B7 protein results in increased chemical synthesis of aldosterone 18-glucuronide]; Meclofenamic Acid inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]
CTD
PMID:19740398
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases activity
ISO
Mefenamic Acid analog results in decreased activity of AKR1C1 protein
CTD
PMID:19010312
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
decreases activity
ISO
Mefenamic Acid analog results in decreased activity of AKR1C2 protein
CTD
PMID:19010312
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases activity
ISO
Mefenamic Acid analog results in decreased activity of AKR1C3 protein
CTD
PMID:19010312
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Alb
albumin
multiple interactions affects binding
ISO
Mefenamic Acid inhibits the reaction [Valproic Acid binds to ALB protein] Mefenamic Acid binds to ALB protein
CTD
PMID:8946661
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases glutathionylation increases hydroxylation
ISO
CYP1A1 protein results in increased glutathionylation of Mefenamic Acid analog CYP1A1 protein results in increased hydroxylation of Mefenamic Acid
CTD
PMID:25372302
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity increases oxidation multiple interactions increases hydroxylation increases glutathionylation
ISO
Mefenamic Acid results in decreased activity of CYP1A2 protein CYP1A2 protein results in increased oxidation of Mefenamic Acid SOD1 protein inhibits the reaction [CYP1A2 protein results in increased oxidation of Mefenamic Acid] CYP1A2 protein results in increased hydroxylation of Mefenamic Acid CYP1A2 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:18816299 PMID:25372302 PMID:33259822
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Mefenamic Acid results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases hydroxylation
ISO
CYP2C19 protein results in increased hydroxylation of Mefenamic Acid
CTD
PMID:25372302
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases hydroxylation increases glutathionylation
ISO
CYP3A4 protein results in increased hydroxylation of Mefenamic Acid CYP3A4 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Gsta1
glutathione S-transferase alpha 1
increases glutathionylation
ISO
GSTA1 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta2
glutathione S-transferase alpha 2
increases glutathionylation
ISO
GSTA2 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gstm1
glutathione S-transferase mu 1
increases glutathionylation
ISO
GSTM1 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm5
glutathione S-transferase, mu 5
increases glutathionylation
ISO
GSTM3 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gstp1
glutathione S-transferase pi 1
increases glutathionylation
ISO
GSTP1 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hpgd
15-hydroxyprostaglandin dehydrogenase
increases activity increases expression
ISO
Mefenamic Acid results in increased activity of HPGD protein Mefenamic Acid results in increased expression of HPGD mRNA
CTD
PMID:19501039
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
G
Il1b
interleukin 1 beta
decreases secretion
ISO
Mefenamic Acid results in decreased secretion of IL1B protein
CTD
PMID:10393680
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
decreases secretion
ISO
Mefenamic Acid results in decreased secretion of IL6 protein
CTD
PMID:10393680
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kcnk10
potassium two pore domain channel subfamily K member 10
multiple interactions
ISO
Mefenamic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695
G
Kcnk2
potassium two pore domain channel subfamily K member 2
multiple interactions
ISO
Mefenamic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kcnk4
potassium two pore domain channel subfamily K member 4
multiple interactions
ISO
Mefenamic Acid promotes the reaction [KCNK4 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr 1:204,117,941...204,129,494
Ensembl chr 1:204,114,572...204,125,925
G
Mr1
major histocompatibility complex, class I-related
affects expression
ISO
Mefenamic Acid affects the expression of MR1 mRNA
CTD
PMID:25811541
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
Mefenamic Acid inhibits the reaction [NQO1 protein results in increased reduction of 2,6-Dichloroindophenol]
CTD
PMID:29281794
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
multiple interactions
ISO
Mefenamic Acid inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; NQO2 protein results in increased reduction of and results in decreased glutathionylation of Mefenamic Acid metabolite
CTD
PMID:29281794
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Mefenamic Acid results in increased activity of NR1I2 protein
CTD
PMID:28728110
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Pon1
paraoxonase 1
multiple interactions
ISO
[pyrrolidine analog binds to Palladium binds to Mefenamic Acid] which results in decreased activity of PON1 protein; [pyrrolidine analog binds to Platinum binds to Mefenamic Acid] which results in decreased activity of PON1 protein
CTD
PMID:29512227
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Sell
selectin L
decreases expression
ISO
Mefenamic Acid results in decreased expression of SELL protein
CTD
PMID:12147693
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Slc22a1
solute carrier family 22 member 1
decreases activity
ISO
Mefenamic Acid results in decreased activity of SLC22A1 protein
CTD
PMID:12388633
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a25
solute carrier family 22, member 25
decreases activity
ISO
Mefenamic Acid results in decreased activity of SLC22A9 protein
CTD
PMID:12388633
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
G
Slc22a6
solute carrier family 22 member 6
decreases activity
ISO
Mefenamic Acid results in decreased activity of SLC22A6 protein
CTD
PMID:12388633
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a7
solute carrier family 22 member 7
decreases activity
ISO
Mefenamic Acid results in decreased activity of SLC22A7 protein
CTD
PMID:12388633
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
SOD1 protein inhibits the reaction [CYP1A2 protein results in increased oxidation of Mefenamic Acid]
CTD
PMID:33259822
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sult1a1
sulfotransferase family 1A member 1
multiple interactions decreases activity
ISO EXP
[Mefenamic Acid results in decreased activity of SULT1A1 protein] which results in decreased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of 6-hydroxymelatonin]; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of Dopamine]; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of harmol]; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of naringenin]; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of salicylamide]
CTD
PMID:11181495 PMID:29596660
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Tyr
tyrosinase
decreases expression
ISO
Mefenamic Acid results in decreased expression of TYR mRNA; Mefenamic Acid results in decreased expression of TYR protein
CTD
PMID:21079976
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of Mefenamic Acid
CTD
PMID:15117964
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions
ISO
Mefenamic Acid inhibits the reaction [UGT2B7 protein results in increased chemical synthesis of aldosterone 18-glucuronide]; Mefenamic Acid inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Mefenamic Acid inhibits the reaction [UGT2B7 protein results in increased metabolism of bromfenac]
CTD
PMID:19740398 PMID:31815452
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation multiple interactions
ISO
Procaine results in increased phosphorylation of AKT1 protein HRH1 protein affects the reaction [Procaine results in increased phosphorylation of AKT1 protein]
CTD
PMID:32061592
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alpl
alkaline phosphatase, biomineralization associated
increases expression
ISO
Procaine results in increased expression of ALPL mRNA
CTD
PMID:22083529
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Calca
calcitonin-related polypeptide alpha
increases secretion
ISO
Procaine results in increased secretion of CALCA protein
CTD
PMID:18172555
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Capn1
calpain 1
multiple interactions
ISO
Procaine inhibits the reaction [Paraoxon results in increased expression of CAPN1 protein]
CTD
PMID:26998625
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
G
Capn2
calpain 2
multiple interactions
ISO
Procaine inhibits the reaction [Paraoxon results in increased expression of CAPN2 protein]
CTD
PMID:26998625
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Casp12
caspase 12
multiple interactions
ISO
Procaine inhibits the reaction [Paraoxon results in increased expression of and affects the activity of CASP12 protein]; Procaine inhibits the reaction [Paraoxon results in increased expression of CASP12 protein]
CTD
PMID:20079824 PMID:26998625
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
multiple interactions
ISO
Procaine inhibits the reaction [Paraoxon results in increased expression of and affects the activity of CASP3 protein]
CTD
PMID:26998625
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cdh5
cadherin 5
decreases expression multiple interactions
ISO
Procaine results in decreased expression of CDH5 protein HRH1 protein affects the reaction [Procaine results in decreased expression of CDH5 protein]
CTD
PMID:32061592
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
G
Ces2h
carboxylesterase 2H
increases hydrolysis
ISO
CES2 protein results in increased hydrolysis of Procaine
CTD
PMID:9300133 PMID:15475733
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Esr1
estrogen receptor 1
increases expression
ISO
Procaine results in increased expression of ESR1 mRNA
CTD
PMID:22083529
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Hrh1
histamine receptor H 1
multiple interactions affects binding
ISO
[HRH1 protein binds to Procaine] which results in increased import of Calcium; HRH1 protein affects the reaction [Procaine results in decreased expression of CDH5 protein]; HRH1 protein affects the reaction [Procaine results in increased phosphorylation of AKT1 protein]; HRH1 protein affects the reaction [Procaine results in increased phosphorylation of ITPR1 protein]; HRH1 protein affects the reaction [Procaine results in increased phosphorylation of MAPK1 protein]; HRH1 protein affects the reaction [Procaine results in increased phosphorylation of MAPK3 protein]; HRH1 protein affects the reaction [Procaine results in increased phosphorylation of PLCG1 protein]; HRH1 protein affects the reaction [Procaine results in increased transport of fluorescein isothiocyanate bovine serum albumin]
CTD
PMID:32061592
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
[Procaine co-treated with Paraoxon] results in increased expression of HSPA5 protein
CTD
PMID:26998625
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
increases phosphorylation multiple interactions
ISO
Procaine results in increased phosphorylation of ITPR1 protein HRH1 protein affects the reaction [Procaine results in increased phosphorylation of ITPR1 protein]
CTD
PMID:32061592
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions
ISO
Procaine results in increased phosphorylation of MAPK1 protein HRH1 protein affects the reaction [Procaine results in increased phosphorylation of MAPK1 protein]
CTD
PMID:32061592
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions
ISO
Procaine results in increased phosphorylation of MAPK3 protein HRH1 protein affects the reaction [Procaine results in increased phosphorylation of MAPK3 protein]
CTD
PMID:32061592
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Procaine results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Plcg1
phospholipase C, gamma 1
increases phosphorylation multiple interactions
ISO
Procaine results in increased phosphorylation of PLCG1 protein HRH1 protein affects the reaction [Procaine results in increased phosphorylation of PLCG1 protein]
CTD
PMID:32061592
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
increases activity
EXP
Procaine results in increased activity of TRPV1 protein
CTD
PMID:18172555
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions
ISO
sirtinol inhibits the reaction [S-allylcysteine results in increased phosphorylation of ACACA protein]
CTD
PMID:23465592
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
AHR mutant form inhibits the reaction [sirtinol results in increased expression of CYP1A1 mRNA]; AHR mutant form inhibits the reaction [sirtinol results in increased expression of NQO1 mRNA]
CTD
PMID:22495798
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]]
CTD
PMID:26450947
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
App
amyloid beta precursor protein
multiple interactions
ISO
sirtinol inhibits the reaction [cilostazol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]]
CTD
PMID:24254769
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of BAX protein]] sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein]]; sirtinol promotes the reaction [cudraflavone B results in increased expression of BAX protein]
CTD
PMID:23881456 PMID:25665036 PMID:26450947 PMID:28851138
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]; sirtinol promotes the reaction [cudraflavone B results in decreased expression of BCL2 protein]
CTD
PMID:23881456 PMID:28851138
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
ISO EXP
sirtinol inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein]]; sirtinol promotes the reaction [cudraflavone B results in increased activity of CASP3 protein] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form]]; sirtinol promotes the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; sirtinol results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:20697895 PMID:23881456 PMID:24889822 PMID:25665036 PMID:26251326 PMID:26450947 PMID:28851138 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol results in increased activity of CASP9 protein]
CTD
PMID:20697895
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]]
CTD
PMID:20531350
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
sirtinol results in increased expression of CCL20 mRNA
CTD
PMID:22385246
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Cd40
CD40 molecule
multiple interactions
ISO
sirtinol promotes the reaction [TNF protein results in increased expression of CD40 mRNA]
CTD
PMID:22717288
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
sirtinol results in increased expression of CDKN1A mRNA; sirtinol results in increased expression of CDKN1A protein sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1A protein]
CTD
PMID:22495798 PMID:23881456
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
ISO
sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein]
CTD
PMID:23881456
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Col10a1
collagen type X alpha 1 chain
decreases expression
ISO
sirtinol results in decreased expression of COL10A1 protein
CTD
PMID:26251326
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
G
Col1a1
collagen type I alpha 1 chain
decreases expression
ISO
sirtinol results in decreased expression of COL1A1 protein
CTD
PMID:26251326
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col2a1
collagen type II alpha 1 chain
decreases expression
ISO
sirtinol results in decreased expression of COL2A1 protein
CTD
PMID:26251326
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Cyba
cytochrome b-245 alpha chain
increases expression
EXP
sirtinol results in increased expression of CYBA mRNA
CTD
PMID:23422569
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cybb
cytochrome b-245 beta chain
multiple interactions
ISO
sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein]]
CTD
PMID:28851138
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions
ISO
sirtinol results in increased expression of CYP1A1 mRNA AHR mutant form inhibits the reaction [sirtinol results in increased expression of CYP1A1 mRNA]
CTD
PMID:22495798
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Ep300
E1A binding protein p300
multiple interactions
ISO
sirtinol inhibits the reaction [cilostazol affects the expression of EP300 protein]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of EP300 protein]]
CTD
PMID:24254769 PMID:25665036
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
F3
coagulation factor III, tissue factor
multiple interactions
ISO
sirtinol promotes the reaction [TNF protein results in increased expression of F3 mRNA]; sirtinol promotes the reaction [TNF protein results in increased expression of F3 protein]
CTD
PMID:20978007
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fbxo32
F-box protein 32
multiple interactions
ISO
[sirtinol results in decreased activity of SIRT1 protein] which results in decreased expression of FBXO32 mRNA
CTD
PMID:22146233
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
G
Foxo1
forkhead box O1
multiple interactions increases acetylation
ISO EXP
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased acetylation of FOXO1 protein]] sirtinol results in increased acetylation of FOXO1 protein sirtinol inhibits the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein]]; sirtinol promotes the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein]
CTD
PMID:24889822 PMID:25665036
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Gh1
growth hormone 1
multiple interactions increases secretion increases expression
EXP
sirtinol inhibits the reaction [resveratrol results in decreased secretion of GH1 protein] sirtinol results in increased secretion of GH1 protein sirtinol results in increased expression of GH1 mRNA
CTD
PMID:23292070
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Igf1r
insulin-like growth factor 1 receptor
decreases expression
ISO
sirtinol results in decreased expression of IGF1R mRNA
CTD
PMID:22495798
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igfbp3
insulin-like growth factor binding protein 3
increases expression
ISO
sirtinol results in increased expression of IGFBP3 mRNA
CTD
PMID:22495798
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Il1b
interleukin 1 beta
multiple interactions increases expression
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]] sirtinol results in increased expression of IL1B mRNA
CTD
PMID:20531350 PMID:22385246 PMID:23973301
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Klf2
KLF transcription factor 2
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol results in increased expression of KLF2 mRNA]
CTD
PMID:19815564
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
G
Klk1c10
kallikrein 1-related peptidase C10
decreases expression multiple interactions
ISO
sirtinol results in decreased expression of KLK3 mRNA; sirtinol results in decreased expression of KLK3 protein sirtinol inhibits the reaction [Estradiol results in increased expression of KLK3 mRNA]
CTD
PMID:22495798
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
sirtinol results in decreased phosphorylation of MAPK1 protein
CTD
PMID:21745208
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
ISO
sirtinol results in decreased phosphorylation of MAPK3 protein
CTD
PMID:21745208
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mir141
microRNA 141
multiple interactions
EXP
sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NOS1 protein]]; sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SNCA protein]]
CTD
PMID:33204711
NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
EXP
sirtinol inhibits the reaction [resveratrol results in decreased expression of MYC protein]
CTD
PMID:24395567
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nanog
Nanog homeobox
multiple interactions
ISO
sirtinol inhibits the reaction [cordycepin results in increased expression of NANOG mRNA]
CTD
PMID:36881089
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
sirtinol inhibits the reaction [resveratrol results in increased expression of NFE2L2 protein]
CTD
PMID:24395567
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
increases degradation
ISO
sirtinol results in increased degradation of NFKBIA protein
CTD
PMID:21745208
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nkx3-1
NK3 homeobox 1
decreases expression
ISO
sirtinol results in decreased expression of NKX3-1 mRNA
CTD
PMID:22495798
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nos1
nitric oxide synthase 1
multiple interactions
EXP
sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NOS1 protein]]
CTD
PMID:33204711
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nox4
NADPH oxidase 4
multiple interactions increases expression
EXP
resveratrol inhibits the reaction [sirtinol results in increased expression of NOX4 mRNA]
CTD
PMID:23422569
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions increases expression
ISO
AHR mutant form inhibits the reaction [sirtinol results in increased expression of NQO1 mRNA]
CTD
PMID:22495798
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol results in increased expression of NR0B2 mRNA]
CTD
PMID:26044878
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Pdk1
pyruvate dehydrogenase kinase 1
multiple interactions
EXP
sirtinol inhibits the reaction [resveratrol results in decreased expression of PDK1 protein]
CTD
PMID:24395567
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
G
Pdk4
pyruvate dehydrogenase kinase 4
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of PDK4 protein]]
CTD
PMID:26450947
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pdpk1
3-phosphoinositide dependent protein kinase-1
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased expression of PDPK1 protein]]
CTD
PMID:26450947
NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
G
Pou5f1
POU class 5 homeobox 1
multiple interactions
ISO
sirtinol inhibits the reaction [cordycepin results in increased expression of POU5F1 mRNA]
CTD
PMID:36881089
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions
ISO EXP
sirtinol inhibits the reaction [Melatonin inhibits the reaction [Cadmium Chloride results in increased acetylation of PPARGC1A protein]]; sirtinol inhibits the reaction [Melatonin inhibits the reaction [Cadmium results in increased acetylation of PPARGC1A protein]] sirtinol inhibits the reaction [genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PPARGC1A protein]] sirtinol inhibits the reaction [resveratrol results in increased expression of PPARGC1A protein]
CTD
PMID:24395567 PMID:25159133 PMID:28477916
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
ISO
sirtinol inhibits the reaction [genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PRKN protein]]
CTD
PMID:28477916
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]]
CTD
PMID:23257246
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rb1
RB transcriptional corepressor 1
multiple interactions
ISO
sirtinol promotes the reaction [cudraflavone B results in decreased phosphorylation of RB1 protein]
CTD
PMID:23881456
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions increases localization
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased acetylation of RELA protein]] sirtinol promotes the reaction [TNF protein results in increased acetylation of RELA protein] sirtinol results in increased localization of RELA protein
CTD
PMID:21745208 PMID:22717288 PMID:23257246
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Shc1
SHC adaptor protein 1
multiple interactions increases expression
ISO
sirtinol inhibits the reaction [SIRT1 protein binds to SHC1 promoter] sirtinol results in increased expression of SHC1 mRNA; sirtinol results in increased expression of SHC1 protein
CTD
PMID:21778425
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
G
Sirt1
sirtuin 1
decreases activity multiple interactions
ISO EXP
sirtinol analog results in decreased activity of SIRT1 protein; sirtinol results in decreased activity of SIRT1 protein sirtinol inhibits the reaction [cobaltous chloride results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [Resveratrol results in increased expression of and results in increased activity of SIRT1 protein] [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to Glucose; sirtinol inhibits the reaction [cilostazol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]]; sirtinol inhibits the reaction [cilostazol results in increased phosphorylation of SIRT1 protein]; sirtinol inhibits the reaction [genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of SIRT1 protein]]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased activity of SIRT1 protein]]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]] [sirtinol results in decreased activity of SIRT1 protein] promotes the reaction [Hydrogen Peroxide results in increased acetylation of TP53 protein]; [sirtinol results in decreased activity of SIRT1 protein] which results in decreased expression of FBXO32 mRNA; [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to Plant Extracts; [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to Resveratrol; [sirtinol results in decreased activity of SIRT1 protein] which results in increased susceptibility to Hydrogen Peroxide; sirtinol inhibits the reaction [[Resveratrol co-treated with TNF protein] results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [cordycepin results in increased expression of SIRT1 mRNA]; sirtinol inhibits the reaction [cudraflavone B results in increased expression of SIRT1 mRNA]; sirtinol inhibits the reaction [cudraflavone B results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [Melatonin inhibits the reaction [Cadmium Chloride results in decreased expression of and results in decreased activity of SIRT1 protein]]; sirtinol inhibits the reaction [Melatonin inhibits the reaction [Cadmium results in decreased expression of and results in decreased activity of SIRT1 protein]]; sirtinol inhibits the reaction [SIRT1 protein binds to SHC1 promoter]
CTD
PMID:16302818 PMID:18681908 PMID:19288225 PMID:20370652 PMID:20531350 PMID:20610621 PMID:20697895 PMID:20978007 PMID:21745208 PMID:21778425 PMID:22146233 PMID:22385246 PMID:22563892 PMID:22669716 PMID:23257246 PMID:23315983 PMID:23479127 PMID:23881456 PMID:23973301 PMID:24254769 PMID:24395567 PMID:24998427 PMID:25159133 PMID:25665036 PMID:26450947 PMID:28477916 PMID:36881089 More...
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sirt2
sirtuin 2
decreases activity
ISO
sirtinol analog results in decreased activity of SIRT2 protein; sirtinol results in decreased activity of SIRT2 protein
CTD
PMID:16302818 PMID:24998427
NCBI chr 1:84,053,883...84,076,975
Ensembl chr 1:84,052,903...84,076,975
G
Smad1
SMAD family member 1
decreases phosphorylation
ISO
sirtinol results in decreased phosphorylation of SMAD1 protein
CTD
PMID:21745208
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smad5
SMAD family member 5
decreases phosphorylation
ISO
sirtinol results in decreased phosphorylation of SMAD5 protein
CTD
PMID:21745208
NCBI chr17:7,862,332...7,891,678
Ensembl chr17:7,864,720...7,891,634
G
Smad9
SMAD family member 9
decreases phosphorylation
ISO
sirtinol results in decreased phosphorylation of SMAD9 protein
CTD
PMID:21745208
NCBI chr 2:138,956,326...139,006,315
Ensembl chr 2:138,986,471...139,006,307
G
Snca
synuclein alpha
multiple interactions
EXP
sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SNCA protein]]
CTD
PMID:33204711
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Sox2
SRY-box transcription factor 2
multiple interactions
ISO
sirtinol inhibits the reaction [cordycepin results in increased expression of SOX2 mRNA]
CTD
PMID:36881089
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Sqstm1
sequestosome 1
multiple interactions
EXP
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of SQSTM1 protein]]; sirtinol promotes the reaction [Hydrogen Peroxide results in increased expression of SQSTM1 protein]
CTD
PMID:24889822
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
sirtinol inhibits the reaction [S-allylcysteine results in decreased expression of SREBF1 protein]
CTD
PMID:23465592
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO EXP
sirtinol inhibits the reaction [[resveratrol co-treated with TNF protein] results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased acetylation of RELA protein]]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]]; sirtinol promotes the reaction [TNF protein results in increased expression of F3 mRNA]; sirtinol promotes the reaction [TNF protein results in increased expression of F3 protein] Sirtinol promotes the reactions [Lipopolysaccharide, acetate, acetaldehyde increases secretion of Tnf protein from Kupffer cells] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; sirtinol promotes the reaction [TNF protein results in increased acetylation of RELA protein]; sirtinol promotes the reaction [TNF protein results in increased expression of CD40 mRNA] sirtinol results in increased expression of TNF mRNA
CTD RGD
PMID:20978007 PMID:22385246 PMID:22717288 PMID:23257246 PMID:23973301 PMID:19299582 More...
RGD:9585771
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions
ISO
[sirtinol results in decreased activity of SIRT1 protein] promotes the reaction [Hydrogen Peroxide results in increased acetylation of TP53 protein]; sirtinol promotes the reaction [arsenic disulfide results in increased expression of and results in increased phosphorylation of TP53 protein]; sirtinol promotes the reaction [cudraflavone B results in increased expression of TP53 protein] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of TRP53 protein]]
CTD
PMID:18298901 PMID:18681908 PMID:23881456 PMID:25665036
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trim63
tripartite motif containing 63
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of TRIM63 protein]]
CTD
PMID:25665036 PMID:26450947
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
G
Usp7
ubiquitin specific peptidase 7
multiple interactions
ISO
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of USP7 protein]]
CTD
PMID:25665036
NCBI chr10:6,880,684...6,925,355
Ensembl chr10:6,828,795...6,925,355
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP
[sirtinol co-treated with cobaltous chloride] results in increased cleavage of VEGFA protein; sirtinol inhibits the reaction [cobaltous chloride results in increased secretion of VEGFA protein]
CTD
PMID:22669716
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions increases transport affects uptake
ISO
3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased transport of tolfenamic acid] ABCG2 protein affects the uptake of tolfenamic acid
CTD
PMID:34062171
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases activity multiple interactions
ISO
tolfenamic acid results in decreased activity of AKR1C3 protein [tolfenamic acid results in decreased activity of AKR1C3 protein] which results in increased chemical synthesis of farnesoic acid; [tolfenamic acid results in decreased activity of AKR1C3 protein] which results in increased metabolism of Farnesol; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [tolfenamic acid inhibits the reaction [AKR1C3 protein results in decreased susceptibility to Cisplatin]]; tolfenamic acid inhibits the reaction [AKR1C3 protein results in decreased susceptibility to Cisplatin]
CTD
PMID:21187079 PMID:23165153
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Alb
albumin
multiple interactions
ISO
ALB protein inhibits the reaction [tolfenamic acid results in decreased activity of CYP1A2 protein]
CTD
PMID:17618427
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
App
amyloid beta precursor protein
multiple interactions
ISO
[lead acetate co-treated with tolfenamic acid] results in decreased expression of APP mRNA; tolfenamic acid inhibits the reaction [lead acetate results in increased expression of APP protein modified form]
CTD
PMID:24462621
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Bace1
beta-secretase 1
decreases expression
ISO
tolfenamic acid results in decreased expression of BACE1 mRNA; tolfenamic acid results in decreased expression of BACE1 protein
CTD
PMID:24462621
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Cav1
caveolin 1
multiple interactions
ISO
CAV1 protein affects the reaction [tolfenamic acid results in decreased expression of TGFBR2 protein]
CTD
PMID:31381904
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cdh1
cadherin 1
multiple interactions
ISO
[tolfenamic acid co-treated with TGFB1 protein] results in increased expression of CDH1 protein; tolfenamic acid inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA]; tolfenamic acid inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]
CTD
PMID:31381904
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions decreases activity
ISO
ALB protein inhibits the reaction [tolfenamic acid results in decreased activity of CYP1A2 protein]
CTD
PMID:17618427 PMID:18816299
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Hk2
hexokinase 2
multiple interactions
ISO
tolfenamic acid affects the reaction [TGFB1 protein affects the expression of HK2 protein]
CTD
PMID:31381904
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
tolfenamic acid inhibits the reaction [TGFB1 protein results in increased expression of MMP2 protein]
CTD
PMID:31381904
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Psmb10
proteasome 20S subunit beta 10
increases expression
ISO
tolfenamic acid results in increased expression of PSMB10 mRNA
CTD
PMID:23165153
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Psmb9
proteasome 20S subunit beta 9
increases expression
ISO
tolfenamic acid results in increased expression of PSMB9 mRNA
CTD
PMID:23165153
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Slc2a1
solute carrier family 2 member 1
multiple interactions
ISO
tolfenamic acid affects the reaction [TGFB1 protein affects the expression of SLC2A1 protein]
CTD
PMID:31381904
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Smad2
SMAD family member 2
multiple interactions
ISO
tolfenamic acid inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]
CTD
PMID:31381904
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Snai1
snail family transcriptional repressor 1
multiple interactions
ISO
tolfenamic acid inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 mRNA]; tolfenamic acid inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 protein]
CTD
PMID:31381904
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
G
Sp1
Sp1 transcription factor
multiple interactions
ISO
tolfenamic acid inhibits the reaction [lead acetate results in increased expression of SP1 protein]
CTD
PMID:24462621
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[tolfenamic acid co-treated with TGFB1 protein] results in increased expression of CDH1 protein; tolfenamic acid affects the reaction [TGFB1 protein affects the expression of HK2 protein]; tolfenamic acid affects the reaction [TGFB1 protein affects the expression of SLC2A1 protein]; tolfenamic acid inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA]; tolfenamic acid inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]; tolfenamic acid inhibits the reaction [TGFB1 protein results in increased expression of MMP2 protein]; tolfenamic acid inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 mRNA]; tolfenamic acid inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 protein]; tolfenamic acid inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]
CTD
PMID:31381904
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tolfenamic acid results in decreased expression of TGFBR1 protein]
CTD
PMID:31381904
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgfbr2
transforming growth factor, beta receptor 2
decreases expression multiple interactions
ISO
tolfenamic acid results in decreased expression of TGFBR2 protein CAV1 protein affects the reaction [tolfenamic acid results in decreased expression of TGFBR2 protein]; Cycloheximide inhibits the reaction [tolfenamic acid results in decreased expression of TGFBR2 protein]; methyl-beta-cyclodextrin inhibits the reaction [tolfenamic acid results in decreased expression of TGFBR2 protein]
CTD
PMID:31381904
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Acvr1
activin A receptor type 1
decreases expression affects expression multiple interactions
EXP
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] tranilast inhibits the reaction [TGF-b1 increases mRNA expression in rat carotid artery smooth muscle cell culture] tranilast inhibits the reaction [PDGF-BB increases mRNA expression in rat carotid artery smooth muscle cell culture]
RGD
PMID:9622270 PMID:9622270 PMID:9622270
RGD:329845558 , RGD:329845558 , RGD:329845558
NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:42,978,561...43,098,241
G
Ahr
aryl hydrocarbon receptor
increases response to substance multiple interactions increases expression
ISO
AHR protein results in increased susceptibility to tranilast AHR protein promotes the reaction [tranilast results in increased expression of AHR mRNA]; AHR protein promotes the reaction [tranilast results in increased expression of CYP1A1 mRNA]; tranilast promotes the reaction [AHR protein binds to CYP1A1 promoter]
CTD
PMID:25826687
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Casp8
caspase 8
multiple interactions
EXP
tranilast inhibits the reaction [Cisplatin results in increased expression of CASP8 protein]
CTD
PMID:34047436
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cxcr4
C-X-C motif chemokine receptor 4
decreases expression
ISO
tranilast results in decreased expression of CXCR4 mRNA
CTD
PMID:25826687
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
ISO
AHR protein promotes the reaction [tranilast results in increased expression of CYP1A1 mRNA]; tranilast promotes the reaction [AHR protein binds to CYP1A1 promoter]
CTD
PMID:25826687
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
affects expression
ISO
tranilast affects the expression of CYP1B1 mRNA
CTD
PMID:25826687
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
tranilast inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Itgav
integrin subunit alpha V
decreases expression
EXP
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery]
RGD
PMID:9622270
RGD:329845558
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Itgb3
integrin subunit beta 3
decreases expression
EXP
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery]
RGD
PMID:9622270
RGD:329845558
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
tranilast inhibits the reaction [Cisplatin results in increased expression of RELA protein]
CTD
PMID:34047436
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Slc22a8
solute carrier family 22 member 8
multiple interactions
EXP
tranilast inhibits the reaction [SLC22A8 protein results in increased uptake of Methotrexate]; tranilast inhibits the reaction [SLC22A8 protein results in increased uptake of Penicillin G]
CTD
PMID:35019195
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Tgfb1
transforming growth factor, beta 1
decreases expression
EXP
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery]
RGD
PMID:9622270
RGD:329845558
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb3
transforming growth factor, beta 3
decreases expression
EXP
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery]
RGD
PMID:9622270
RGD:329845558
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tgfbr1
transforming growth factor, beta receptor 1
decreases expression affects expression multiple interactions
EXP
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] tranilast inhibits the reaction [TGF-b1 increases mRNA expression in rat carotid artery smooth muscle cell culture] tranilast inhibits the reaction [PDGF-BB increases mRNA expression in rat carotid artery smooth muscle cell culture]
RGD
PMID:9622270 PMID:9622270 PMID:9622270
RGD:329845558 , RGD:329845558 , RGD:329845558
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgfbr2
transforming growth factor, beta receptor 2
decreases expression affects expression multiple interactions
EXP
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] tranilast inhibits the reaction [TGF-b1 increases mRNA expression in rat carotid artery smooth muscle cell culture] tranilast inhibits the reaction [PDGF-BB increases mRNA expression in rat carotid artery smooth muscle cell culture]
RGD
PMID:9622270 PMID:9622270 PMID:9622270
RGD:329845558 , RGD:329845558 , RGD:329845558
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Tnf
tumor necrosis factor
multiple interactions
EXP
tranilast inhibits the reaction [Cisplatin results in increased expression of TNF protein]
CTD
PMID:34047436
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
multiple interactions
EXP
tranilast inhibits the reaction [Cisplatin results in increased expression of TNFSF10 protein]
CTD
PMID:34047436
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
decreases activity
ISO
tranilast results in decreased activity of TRPV2 protein
CTD
PMID:30235802
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
G
Slc6a2
solute carrier family 6 member 2
multiple interactions
ISO
tricaine inhibits the reaction [[Desipramine results in decreased activity of SLC6A2 protein] which results in decreased abundance of Norepinephrine]
CTD
PMID:16725121
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19811
role
19818
application
19630
NMR chemical shift reference compound
17936
ammonia
17795
organic amino compound
17795
amino acid
15943
aromatic amino acid
3807
aminobenzoic acid
1641
(R)-2-(1-methyl-2-oxopropylamino)-benzoic acid
0
2,3,4,5-tetrafluoro-6-(3-methoxyanilino)benzoic acid
0
2-((2-hydroxyethyl)amino)benzoic acid
0
2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide
0
2-(pyridin-4-ylmethylamino)benzoic acid
0
2-Amino-3-methylbenzoate
0
2-Amino-4-chlorobenzoic acid
0
2-Amino-4-methylbenzoic acid
0
2-Amino-6-fluorobenzoic acid
0
2-[(1-acetyl-3-indolyl)amino]benzoic acid
0
2-[(3-Methyl-2-pentanyl)amino]-6-(methylsulfanyl)benzoic acid
0
2-[(6-butoxy-3-pyridinyl)amino]-4-chlorobenzoic acid
0
2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoic acid
0
2-amino-5-chlorobenzoic acid
0
2-amino-N-[[4-(1,3-benzodioxol-5-ylamino)-4-oxobutan-2-ylidene]amino]benzamide
0
2-hydroxylaminobenzoic acid
0
3-[(3,5-dibromo-6-oxo-1-cyclohexa-2,4-dienylidene)methylamino]-2-methylbenzoic acid
0
3-[[5-[[5-(4-carboxyphenyl)-2-furanyl]methylidene]-4-oxo-2-thiazolyl]amino]benzoic acid
0
3-amino-2,4-dihydroxybenzoic acid
0
3-amino-4-hydroxybenzoic acid +
0
3-amino-5-hydroxybenzoic acid
0
3-aminobenzoic acid +
3
3-hydroxy-4-methylanthranilic acid +
0
3-hydroxyanthranilic acid
0
3-methoxyanthranilic acid
0
4-(dimethylamino)-N-[1-(3-methoxyphenyl)ethylideneamino]benzamide
0
4-[cyclohexyl(methyl)amino]-N-(6-methyl-2-pyridinyl)-3-nitrobenzamide
0
4-amino-2-chlorobenzoic acid +
0
4-amino-N-(2-furanyl)benzamide
0
4-aminobenzoic acid +
31
4-aminosalicylic acid
9
4-nitroanthranilic acid +
0
5-amino-2-(dimethylamino)benzoic acid
0
5-fluoroanthranilic acid
0
5-nitroanthranilic acid
0
AMPK activator PT 1
0
Acetrizoic acid
0
Aminoansamycin D
0
Aminoansamycin F
0
Anthranoside C
0
Benzoic acid, 4-amino-, 4-acetoxy-2,2,6,6-tetramethyl-1-piperidinyl ester
0
Calcimycin
120
DMABA-d4 NHS ester
0
Juanlimycin A
0
Lobenzarit disodium
0
N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide
0
N-(2-formyl-3-chlorophenyl)anthranilic acid
0
N-(2-methyl-3-chloro-4-hydroxyphenyl)anthranilic acid
0
N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-(4-iodo-2-methylanilino)benzamide
0
N-Methyl-4-aminobenzoate
0
N-Methylanthranilamide
0
N-acetyl-5-aminosalicylic acid
0
Obscurolide A1
0
Ochraspergillic acid A
0
Ochraspergillic acid B
0
Rubrulone B
0
Saccharothriolide A
0
Saccharothriolide D
0
Saccharothriolide F
0
Streptcytosine O
0
anthranilic acid +
1511
enfenamic acid
0
fenamic acid
14
lobenzarit
0
meclofenamic acid
11
mefenamic acid
35
onosmin A +
0
tolfenamic acid
19
Path 2
CHEBI ontology
19811
subatomic particle
19809
composite particle
19809
hadron
19840
baryon
19809
nucleon
19809
atomic nucleus
19809
atom
19809
main group element atom
19759
main group molecular entity
19759
s-block molecular entity
19628
hydrogen molecular entity
19614
hydrides
19087
inorganic hydride
18091
pnictogen hydride
18080
nitrogen hydride
17987
azane
17796
ammonia
17795
organic amino compound
17795
amino acid
15943
aromatic amino acid
3807
aminobenzoic acid
1641
(R)-2-(1-methyl-2-oxopropylamino)-benzoic acid
0
2,3,4,5-tetrafluoro-6-(3-methoxyanilino)benzoic acid
0
2-((2-hydroxyethyl)amino)benzoic acid
0
2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide
0
2-(pyridin-4-ylmethylamino)benzoic acid
0
2-Amino-3-methylbenzoate
0
2-Amino-4-chlorobenzoic acid
0
2-Amino-4-methylbenzoic acid
0
2-Amino-6-fluorobenzoic acid
0
2-[(1-acetyl-3-indolyl)amino]benzoic acid
0
2-[(3-Methyl-2-pentanyl)amino]-6-(methylsulfanyl)benzoic acid
0
2-[(6-butoxy-3-pyridinyl)amino]-4-chlorobenzoic acid
0
2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoic acid
0
2-amino-5-chlorobenzoic acid
0
2-amino-N-[[4-(1,3-benzodioxol-5-ylamino)-4-oxobutan-2-ylidene]amino]benzamide
0
2-hydroxylaminobenzoic acid
0
3-[(3,5-dibromo-6-oxo-1-cyclohexa-2,4-dienylidene)methylamino]-2-methylbenzoic acid
0
3-[[5-[[5-(4-carboxyphenyl)-2-furanyl]methylidene]-4-oxo-2-thiazolyl]amino]benzoic acid
0
3-amino-2,4-dihydroxybenzoic acid
0
3-amino-4-hydroxybenzoic acid +
0
3-amino-5-hydroxybenzoic acid
0
3-aminobenzoic acid +
3
3-hydroxy-4-methylanthranilic acid +
0
3-hydroxyanthranilic acid
0
3-methoxyanthranilic acid
0
4-(dimethylamino)-N-[1-(3-methoxyphenyl)ethylideneamino]benzamide
0
4-[cyclohexyl(methyl)amino]-N-(6-methyl-2-pyridinyl)-3-nitrobenzamide
0
4-amino-2-chlorobenzoic acid +
0
4-amino-N-(2-furanyl)benzamide
0
4-aminobenzoic acid +
31
4-aminosalicylic acid
9
4-nitroanthranilic acid +
0
5-amino-2-(dimethylamino)benzoic acid
0
5-fluoroanthranilic acid
0
5-nitroanthranilic acid
0
AMPK activator PT 1
0
Acetrizoic acid
0
Aminoansamycin D
0
Aminoansamycin F
0
Anthranoside C
0
Benzoic acid, 4-amino-, 4-acetoxy-2,2,6,6-tetramethyl-1-piperidinyl ester
0
Calcimycin
120
DMABA-d4 NHS ester
0
Juanlimycin A
0
Lobenzarit disodium
0
N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide
0
N-(2-formyl-3-chlorophenyl)anthranilic acid
0
N-(2-methyl-3-chloro-4-hydroxyphenyl)anthranilic acid
0
N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-(4-iodo-2-methylanilino)benzamide
0
N-Methyl-4-aminobenzoate
0
N-Methylanthranilamide
0
N-acetyl-5-aminosalicylic acid
0
Obscurolide A1
0
Ochraspergillic acid A
0
Ochraspergillic acid B
0
Rubrulone B
0
Saccharothriolide A
0
Saccharothriolide D
0
Saccharothriolide F
0
Streptcytosine O
0
anthranilic acid +
1511
enfenamic acid
0
fenamic acid
14
lobenzarit
0
meclofenamic acid
11
mefenamic acid
35
onosmin A +
0
tolfenamic acid
19